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Abstract
The gastrointestinal tract is replete with commensal microbes and dietary nutrients that provide homeostatic
signals. Antigen presenting dendritic cells (DC) residing in the underlying lamina propria (Lp) respond to
these signals; however, how they contribute to intestinal T cell homeostasis is unclear. In Chapter 2, LpDC are
revealed to uniquely induce naïve T cell differentiation into the Foxp3+ regulatory T cell (Treg) subset.
Further, the molecular mechanisms controlling this capacity both in vitro and in vivo are shown to hinge on
the vitamin A metabolite, retinoic acid (RA), which LpDC are equipped to synthesize, and the cytokine,
TGF-beta. T cell expression of retinoic acid receptor alpha (RARalpha) is shown to be critical for RA to
induce enhanced Foxp3+ Treg induction. Chapter 3 extends upon these findings and addresses the influence
of the commensal microbiota in the regulation of this pathway. A Toll like receptor (TLR) 9 ligand,
commensal derived DNA, is identified as a potent adjuvant in the gut mucosa, which shapes T cell
homeostasis in the GI tract. Accordingly Tlr9–⁄– mice display an intestinal site-specific increase in
Foxp3+Treg concomitant with a decrease in TH cells. Dysregulation in Foxp3+ Treg/TH homeostasis results
in mucosal-specific impaired immune responses in Tlr9–⁄– animals, which can be reversed upon partial
depletion of Foxp3+ Treg. Chapter 4 builds upon findings from Chapter 2. The role of vitamin A metabolism
in the regulation of mucosal immunity is examined. Vitamin A insufficient (VAI) mice, which lack vitamin A
and metabolic derivatives, mount impaired mucosal TH-1 and TH-17 responses. These defects are reversed
upon administration of RA. Moreover, Rara–⁄– mice recapitulate the homeostatic and immune defects
observed in VAI mice. Strikingly, loss of basal RA/RARalpha signaling hinders early T cell activation events.
Cumulatively, the data argue that steady-state cues from microbiota and nutrients shape the inflammatory
tone of the Lp to prime mucosal TH responses. These data also identify a fundamental role for vitamin A
metabolism in T cell activation and suggest this pathway may have evolved with the development of adaptive
CD4+ T cell responses to coordinate host protection.
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Abstract	  
 
Vitamin A metabolism and commensal stimulation in the promotion of mucosal immunity 
Jason A. Hall 
Yasmine Belkaid  
 
The gastrointestinal tract is replete with commensal microbes and dietary 
nutrients that provide homeostatic signals. Antigen presenting dendritic cells (DC) 
residing in the underlying lamina propria (Lp) respond to these signals; however, how 
they contribute to intestinal T cell homeostasis is unclear. In Chapter 2, LpDC are 
revealed to uniquely induce naïve T cell differentiation into the Foxp3+ regulatory T cell 
(Treg) subset.  Further, the molecular mechanisms controlling this capacity both in vitro 
and in vivo are shown to hinge on the vitamin A metabolite, retinoic acid (RA), which 
LpDC are equipped to synthesize, and the cytokine, TGF-β. T cell expression of retinoic 
acid receptor alpha (RARα) is shown to be critical for RA to induce enhanced Foxp3+ 
Treg induction. Chapter 3 extends upon these findings and addresses the influence of the 
commensal microbiota in the regulation of this pathway. A Toll like receptor (TLR) 9 
ligand, commensal derived DNA, is identified as a potent adjuvant in the gut mucosa, 
which shapes T cell homeostasis in the GI tract. Accordingly Tlr9–⁄– mice display an 
intestinal site-specific increase in Foxp3+ Treg concomitant with a decrease in TH cells. 
Dysregulation in Foxp3+ Treg/TH homeostasis results in mucosal-specific impaired 
immune responses in Tlr9–⁄– animals, which can be reversed upon partial depletion of 
Foxp3+ Treg. Chapter 4 builds upon findings from Chapter 2. The role of vitamin A 
metabolism in the regulation of mucosal immunity is examined. Vitamin A insufficient 
(VAI) mice, which lack vitamin A and metabolic derivatives, mount impaired mucosal TH-
 v 
1 and TH-17 responses. These defects are reversed upon administration of RA. 
Moreover, Rara–⁄– mice recapitulate the homeostatic and immune defects observed in 
VAI mice. Strikingly, loss of basal RA/RARα signaling hinders early T cell activation 
events. Cumulatively, the data argue that steady-state cues from microbiota and 
nutrients shape the inflammatory tone of the Lp to prime mucosal TH responses. These 
data also identify a fundamental role for vitamin A metabolism in T cell activation and 
suggest this pathway may have evolved with the development of adaptive CD4+ T cell 
responses to coordinate host protection. 
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CHAPTER	  1:	  Intestinal	  immune	  homeostasis:	  influential	  contributions	  by	  
the	  commensal	  microbiota	  and	  vitamin	  A	  metabolism	  	  
 
The	  intestinal	  microbiota	  establishes	  a	  commensal	  relationship	  with	  the	  
host	  
 
The mucosal surfaces are comprised of the oronasopharyngeal, urogenital, and 
gastrointestinal tracts and serve as the primary interface between the outside 
environment and the body. Although they are opportunistic sites for pathogen entry, they 
are also home to a dense array of microbial populations. The total number of these 
microorganisms exceeds the number of cells in the body by at least an order of 
magnitude (Garrett et al.). Far from bystanders, these microorganisms typically forge a 
commensal relationship with the host. Nowhere is this more apparent than in the 
gastrointestinal tract, which contains, by far, the densest microbial niche in the body. 
Studies using germ-free or gnotobiotic, as well as, antibiotic treated animals have 
highlighted the crucial role of the microbiota in the regulation of a broad range of 
processes, which include: 1) Metabolism via degradation of otherwise indigestible 
products and nutrient absorption (Hooper and Gordon, 2001; Hooper et al., 2002). 2) 
Intestinal tissue development via the elaboration of underlying microvasculature and 
isolated lymphoid follicles, respectively (Bouskra et al., 2008; Stappenbeck et al., 2002). 
3) Intestinal tissue repair and maintenance via regulation of growth factor expressing 
cells (Brown et al., 2007; Rakoff-Nahoum et al., 2004). 4) Immunity via growth and 
proper development of secondary lymphoid tissue (Pollard and Sharon, 1970; 
Stepankova et al., 1980). 5) Protection against opportunistic microbial invasion via 
elicitation of microbicidal proteins from epithelial cells, most prominently, Paneth cells, 
which reside at the base of intestinal crypts (Vaishnava et al., 2008); (Brandl et al., 
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2008). Release of these microbicidal proteins also regulates the composition of the 
commensal microbiota under steady-state conditions (Salzman et al.). 
 
Despite the plethora of benefits conferred onto the host by the presence commensal 
microbiota, itʼs important to bear in mind that its compartmentalization is central to 
maintaining a long-term advantage to the host, with impairments provoking an immunological 
imbalance that can drive aberrant local immune responses, such as inflammatory bowel 
disease (Nenci et al., 2007), and in other instances, distal or even systemic immune 
responses, the most extreme example being sepsis (Cohen, 2002).   
 
While the commensal barrier is maintained, in part, through goblet cell secretion of 
an overlaying mucus layer and a dynamic and resilient epithelial layer (Johansson et al., 
2008; Turner, 2009), other cell populations interdigitated within or beneath this barrier also 
play an essential role. These populations, which include cells of both the innate and adaptive 
arms of immunity, have evolved in close association with the commensals and in contact 
with their stimulatory ligands. Consequently, immune cells protecting this region, and by 
extension other mucosal sites, have acquired specialized functions to facilitate coexistence 
with the commensals, while maintaining the capacity to induce a potent immune response in 
the event of a pathogenic encounter. The execution of these dichotomous functions also 
contributes to the commensal composition, which is a critical factor in the establishment and 
maintenance of intestinal immune homeostasis (Fagarasan et al., 2002; Garrett et al.; 
Garrett et al., 2007). 
 
In addition to aberrant immune reactivity against the commensals, aberrant reactivity 
against dietary antigen also poses a substantial risk to intestinal immune homeostasis and 
can promote a variety of outcomes, ranging from tissue destruction in the case of celiac 
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disease to immunoglobulin E mediated anaphylaxis in the case of peanut allergy (Izcue et 
al., 2006; Jabri and Ebert, 2007; Li et al., 2000). Thus, the orchestration of tolerance to food-
borne antigen likely hinges on similar, if not, redundant immunological mechanisms with 
those that are in place to regulate the presence of commensals.  
 
The seemingly disparate tasks of the immune system protecting the GI tract, then, 
are to maintain a state of détente with commensals and food antigens, while retaining the 
capacity to mount a swift immune response upon pathogen encounter. Further, this must be 
achieved in a manner that avoids grossly jeopardizing host tolerance to commensals and 
food antigen. To begin to consider the cells and interactions that are involved in carrying out 
these duties it is important to understand the basic anatomy and organization of the GI tract 
and its associated lymphoid tissues. For conciseness and simplicity, the description to follow 
is intended to provide a framework for considering the complex and dynamic regulation of 
immunity in the small intestine. This tissue is of primary focus in the research to be described 
herein. 
The	  intestinal	  immune	  system	  is	  composed	  of	  inductive	  and	  effector	  sites	  
 
Broadly, the immune system of the gastrointestinal (GI) tract and the associated 
lymphoid tissues (GALT) can be separated into inductive sites and effector sites (Figure 
1).  
I. Inductive sites, including the mesenteric lymph nodes (mln), which drain 
the GI tract, and organized lymphoid aggregates called Peyer’s patches 
(Pp). These structures increase in frequency as the density of the 
commensal microbiota increases from the proximal duodenum to the 
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terminal ileum, underscoring their dependence on interactions with 
commensals (Neutra et al., 2001).  
II. Effector sites, which include the intestinal epithelial lymphocyte (IEL) 
and lamina propria (Lp) compartments (Mowat, 2003; Newberry and 
Lorenz, 2005). 
I.	  Lymphocyte	  activation	  in	  inductive	  sites	  
 
Under steady-state conditions, naive T cells constitutively enter into the Pp and mln from 
blood via high endothelial venules (HEV) (Jalkanen et al., 1987). Upon exit from HEVs, 
these cells may come into contact with dendritic cells (DC), which have captured and 
processed their cognate antigen (Ag) (Bajenoff et al., 2003). Ag is delivered into Pp 
usually via microvilli-lacking, specialized epithelial cells, called M cells. Upon trancytosis 
or endocytosis, these antigens are captured by DCs residing within the sub-epithelial 
dome (Cerutti and Rescigno, 2008). While Ag may also be captured in this manner 
within the Lp, upon entry into isolated lymphoid follicles (Jang et al., 2004; Vallon-
Eberhard et al., 2006), Ag can also be actively captured by DC that extend protrusions 
into the intestinal lumen; however, the physiological importance of this latter mode of 
capture remains controversial (Chieppa et al., 2006; Niess and Reinecker, 2005; 
Rescigno et al., 2001). Ag-bearing DCs from the Lp, then, migrate via the afferent 
lymphatics into the mln, where a cognate T cell potentially lies in wait. Intriguingly, the 
subset of LpDC that undergo migration (CD103+) is reportedly different from those 
capable of extending processes into the intestinal lumen (CX3CR1+CD103–) (Bogunovic 
et al., 2009; Schulz et al., 2009); however, it remains unclear whether CD103+ LpDC are 
also capable of this function (Chieppa et al., 2006).  
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During activation in the Pp and mln, CD4+ T cells receive signals that result in the 
upregulated expression of mucosal homing receptors including the chemokine receptor 
CCR9 and the integrin heterodimer, α4β7, which facilitate their migration to and retention 
in the Lp (Berlin et al., 1993; Iwata et al., 2004; Johansson-Lindbom et al., 2003; Kunkel 
et al., 2000; Mora et al., 2003). Activated CD4+ T cells within Pp can also undergo 
directed migration from T cell areas toward B cell areas and, in turn, induce 
immunoglobulin A (IgA) class switching in B cells, which then migrate into the Lp to 
undergo full differentiation into IgA secreting plasma cells (Allen and Cyster, 2008; 
Fagarasan et al.). This process also occurs independently of T cells in situ, specifically 
within ILFs (Tsuji et al., 2008). Although they were not investigated in the studies to be 
described herein, IgA+ B cells have potent regulatory capacity and shape the luminal 
composition of the commensal microbiota (Fagarasan et al., 2002).  
II.	  Lymphocyte	  organization	  in	  effector	  sites	  
 
In spite of their adjacent locations, the IEL and Lp compartments are, in fact, 
comprised of quite distinct lymphocyte populations during steady-state. One obvious 
distinction is the presence of γδT cells in the IEL, which are largely absent in the Lp 
(Bucy et al., 1988; Bucy et al., 1989). These cells were previously shown to promote 
intestinal epithelial cell (IEC) survival and maturation via incompletely defined 
mechanisms (Chen et al., 2002; Komano et al., 1995). Another striking distinction 
between the IEL and Lp is the MHC class restriction of αβ T cells: while most in the IEL 
are MHC I or MHC I-like restricted and are CD8+, the majority in the Lp are MHC II 
restricted and CD4+ (Bonneville et al., 1988; Chiba et al., 1986; Park et al., 1999). 
Nevertheless, MHC II restricted cells, such as Foxp3+ regulatory T cells, are still present 
in this compartment and serve important function. The immunological basis for this 
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dichotomy has several potential explanations. Notably, CD8+ cells are known to engage 
in a vivid dialogue with the IEC barrier and can dispose of infected/damaged IECs via 
the release of cytolytic granules without, necessarily, the concomitant release of pro-
inflammatory cytokines (Hayday et al., 2001; Jabri and Ebert, 2007). This feature implies 
that these cells are ideal sensors of tissue distress during steady-state conditions. 
However, in situations of extreme tissue distress, for instance, upon encounter with an 
alimentary allergen or infectious pathogen, resident CD8+ T cells may expand and 
become potent producers of pro-inflammatory cytokines (Jabri and Ebert, 2007). 
Moreover, such scenarios also foster the activation and recruitment of naive CD8+ αβ T 
cells from inductive sites.  
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Figure 1. Representation of the intestinal mucosal environment and several of 
the important mediators of innate and adaptive immune responses 
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LpDC	  actively	  sample	  luminal	  content:	  
 
While one could argue that the primary duty of the IEL compartment is to avoid 
direct engagement with antigen, the Lp compartment appears poised for active sampling 
of the luminal environment during steady-state conditions. Indeed, the Lp is host to a 
sizable population of antigen presenting cells (APC), which include resident 
macrophages, as well as CCR7– and CCR7+ resident and migratory DCs, respectively 
(Bogunovic et al., 2009; Chirdo et al., 2005; Jang et al., 2006; Johansson-Lindbom et al., 
2005; Mayrhofer et al., 1983; Schulz et al., 2009). Previous studies have shown that 
specific subpopulations of CD11c+ MHC II+ cells, which may also encompass 
macrophages in this tissue (Denning et al., 2007; Uematsu et al., 2008), are able to 
extend balloon-like protrusions into the luminal space (Chieppa et al., 2006; Niess and 
Reinecker, 2005). In this regard, the resident CX3CR1+ subpopulation (CCR7– CD103–) 
which was the first population characterized to display this property in an intact tissue, 
was revealed to readily take up both fluorescently-labeled non-pathogenic bacteria and 
food antigen from the intestinal lumen (Niess and Reinecker, 2005; Schulz et al., 2009). 
Although migratory CCR7+CD103+ LpDC are less phagocytic than their CX3CR1+CCR7– 
counterparts (Brian Kellsall, personal communication), this sub-population was found to 
possess inclusions of apoptotic cells, including epithelia, upon transit into the mln 
(Huang et al., 2000). It was recently speculated that migratory LpDC also acquire 
luminal-captured antigen from resident CX3CR1+CCR7– DC via a mechanism that 
remains to be clarified (Rescigno, 2009). Cumulatively, these findings indicate that the 
Lp compartment, via resident and migratory APC, constantly surveys the luminal 
environment. These processes likely play a significant role in the composition of CD4+ T 
cells residing within the Lp. 
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APC	  are	  influenced	  by	  IEC	  interactions	  at	  the	  barrier	  interface:	  
 
Another element to consider is the effect of the luminal content on the exchange 
of information between the IEC and Lp compartment. This conversation is likely 
dependent on the sensing of microbial components relayed by pattern recognition 
receptors, including: 1) intracellular nucleotide-binding-oligomerisation domains (Nod), 
which recognize muramyl dipeptides derived from bacterial cell wall components, and 3) 
extracellular and intracellular toll-like receptors (TLR), which recognize an array of 
structurally conserved molecules derived from microbes (Garrett et al.; Lavelle et al.). 
Nods, in particular Nod2, may influence microbiota composition via constitutive Paneth 
cell secretion of antimicrobial peptides (Kobayashi et al., 2005; Petnicki-Ocwieja et al., 
2009). TLRs signal through the adaptor proteins TRIF and/or MyD88 (Yamamoto et al., 
2004).  While TLR3 and TLR4 can utilize TRIF, all other TLRs, including TLR4, utilize 
MyD88, which is recruited following recognition of: lipopeptides (TLR2/1 and TLR2/6) 
peptidoglycans (TLR2), lipopolysaccharides (TLR4), flagellin (TLR5), ssRNA (TLR7/8) 
bacterial and viral DNA (TLR9) (Kawai and Akira). Importantly, the localization, 
expression, and regulation of each of these TLRs vary in the IEC and, therefore, may 
differentially contribute to intestinal immune homeostasis (Artis, 2008). Nevertheless, 
using a more encompassing strategy, Germain and colleagues found that the ability of 
LpDC to sample the luminal small bowel was dependent on MyD88 signaling in the 
epithelia (Chieppa et al., 2006). Thus, the rate at which LpDC sample the luminal 
environment is likely tailored to the types of constituents present in the microbiota. As 
such, one could imagine this mechanism especially coming into play when compositional 
shifts in the commensals occur, such as during infection or inflammation (Finlay and 
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Medzhitov, 2007; Heimesaat et al., 2006). Another example of IEC/Lp cross talk is the 
influence of IEC secreted thymic stromal lymphopoietin (TSLP). This cytokine inhibits the 
capacity of LpDC to induce proinflammatory cytokines (Rimoldi et al., 2005; Zaph et al., 
2007). Notably, the role of the commensal microbiota on the regulation of TSLP 
production remains unclear. However, one could speculate that it may inversely 
correlate with the pathogenicity of the microbiota. 
 
GALT	  activated	  lymphocytes	  are	  imprinted	  to	  traffic	  to	  intestinal	  effector	  sites:	  
 
 A general feature of activation in Pp and mln is T and B lymphocyte upregulation 
of α4β7 and CCR9, which equips these cells with the superior capacity to migrate into 
intestinal effector tissues (Mora et al., 2008; Sigmundsdottir and Butcher, 2008). 
Specifically, α4β7 enables activated lymphocytes to bind to mucosal vascular addressin 
cell-adhesion molecule-1 (MadCAM-1) present on post capillary venules in the intestinal 
Lp (Bargatze et al., 1995; Wagner et al., 1996). CCR9 reinforces adherence to post 
capillary venules via binding to the chemokine, TECK (CCL25), which is generated and 
secreted by small intestinal epithelia (Hieshima et al., 2004; Kunkel et al., 2000). 
Strikingly, the upregulation of α4β7 and CCR9 is critically dependent on nutrient 
metabolism of vitamin A, which will be discussed in greater detail further on (Iwata et al., 
2004; Mora et al., 2006).  
CD4+	  T	  cell	  composition	  in	  the	  Lp:	  
 
The composition of CD4+ T cells in the small intestinal Lp compartment is quite 
heterogeneous and strongly reflects: I) the cytokines produced by the local tissue and II) 
the types of antigens constantly available for survey in the intestinal lumen, which likely 
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also influence the local cytokine milieu.  Indeed, antigen sampling features heavily in this 
region, and plays a probable role in the control of both steady-state tolerance and 
responsiveness to pathogenic insult. In order to proceed with this crucial function intact, 
the Lp tissue requires T cells with both immunoregulatory and sentinel effector 
capacities. (I) On the immunoregulatory hand, this includes regulatory T cells (Treg), 
which, in particular express the transcription factor, forkhead box protein 3 (Foxp3). (II) 
On the effector hand, this includes T-Helper (TH) cells capable of producing pro-
inflammatory cytokines, in particular IFN-γ (TH-1) and IL-17A (TH-17). As discussed 
below, the balance of these opposing elements may exert a crucial influence on 
the ability of the host to mount an immune response when this site is challenged. 
The defining features of these cells, including their induction and their relevance to 
mucosal immunity will be outlined in the proceeding sections. 
I.	  Foxp3+	  regulatory	  T	  cells	  (Foxp3+	  Treg)	  
 
Foxp3+ Treg, which in most secondary lymphoid tissues during steady-state can 
be distinguished by constitutive expression of the high-affinity IL-2Rα (CD25), are key 
mediators of the coordination and maintenance of peripheral tissue homeostasis 
throughout the lifespan of the host (Bennett et al., 2001; Fontenot et al., 2003; Hori et al., 
2003; Kim et al., 2007; Wildin et al., 2001). Their absence culminates in fatal 
inflammatory lesions propagated by the activation and proliferation of self-reactive 
clones that have escaped negative selection in the thymus (Sakaguchi et al., 2008). 
Thus, even in the absence of a commensal microbiota, ablation of Foxp3+ Treg results in 
fatal autoimmunity, albeit with slower kinetics and altered pathogenesis (Chinen et al.). 
Nevertheless Foxp3+ Treg are still crucial for the prevention of spontaneous reactivity 
against both the commensal microbiota and food antigen and play an important role in 
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regulating the intensity of immune responses to foreign pathogens (Izcue et al., 2006; 
Josefowicz and Rudensky, 2009). They comprise typically 20% of the CD4+ T cell 
population within the small intestinal Lp and a variable proportion actively produces the 
potent immunoregulatory cytokine, IL-10, which can also be expressed by Foxp3 cells in 
this tissue (Maynard et al., 2007). Given their widespread influence, Foxp3+ Treg are not 
particularly limited in the means by which they can perform their regulatory duties, which 
include but are not limited to: (1) secretion of IL-10 and/or TGF-β(Belkaid, 2002; Li et al., 
2007; Rubtsov et al., 2008; Zhang et al., 2009a), (2) contact dependent suppression of 
APC function (Tadokoro et al., 2006; Tang et al., 2006), (3) control of DC homeostasis 
(Liu et al., 2009), (4) and abrogation of certain effector functions through an as yet 
defined mechanism (Mempel et al., 2006). Importantly, none of these mechanisms are 
mutually exclusive (Figure 2).  
 
 To date, the precise signals that govern the induction of the Foxp3+ Treg program 
remain an enigma (Gavin et al., 2007; Lin et al., 2007). Since, seminal thymectomy 
experiments indicated that thymic development of Foxp3+ Treg was required for the 
maintenance of self-tolerance (Sakaguchi and Sakaguchi, 1990), many studies have 
looked to the thymus for clues into the differentiation pathway of these cells. In this 
regard, several elegant studies have revealed that Foxp3+ Treg can develop and survive 
negative selection in the presence of strong agonist ligands (Jordan et al., 2001; van 
Santen et al., 2004). On the other hand, in the absence of a negatively selecting agonist 
ligand, which can be achieved experimentally upon crossing a naive TCR transgene with 
a recombination activating gene deficient (RAG–⁄–) mouse, these cells do not develop 
intrathymically (Walker et al., 2003). Such mice, in turn, have served as ideal tools to 
assess the extrathymic development of Foxp3+ Treg. 
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Figure 2. Foxp3+ Treg regulate immune responses through multiple pathways 
(1) Foxp3+ Treg produce immunoregulatory cytokines, including TGF-β and IL-10. (2) Their 
interactions with dendritic cells (DC) can prevent stable interactions between naïve T cells 
and antigen presenting DC. They can also inhibit immature DC maturation and/or 
migration. (3) Foxp3+ Treg inhibit the production of FMS-like tyrosine kinase ligand (Flt3L), 
which promotes DC maturation from precursor Pre DC. (4) They also can prohibit certain 
effector functions, including the capacity of CD8+ cytotoxic T cells to kill. This mechanism 
of suppression requires TGF-β signaling.  
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In an effort to determine whether Foxp3+ Treg development could occur 
extrathymically in vivo, Von Boehmer and colleagues administered prolonged sub-
cutaneous low-dose infusions of hemagglutinin (HA) peptide to thymectomized, RAG–⁄– x 
TCR-HA mice. This technique induced a long-lasting CD25+ population that 
concomitantly expressed high levels of Foxp3 transcript and possessed suppressive 
properties similar to Foxp3+ Treg (Apostolou and von Boehmer, 2004). Another study, in 
which OVA-specific, Foxp3– CD4+ DO11.10 T cells were transferred into lymphopenic 
hosts, engineered to secrete OVA, yielded similar findings (Knoechel et al., 2005). Using 
a more refined strategy, subimmunogenic targeting of peptides to DCs was also shown 
to induce antigen specific Foxp3+ Treg (Kretschmer et al., 2005). Altogether, these 
findings suggest that chronic exposure to low doses of antigen and DC presentation in 
non-inflamed settings can promote the de novo acquisition of Foxp3 by peripherally 
activated cells. These criteria bear remarkable similarity to what one may consider 
“status quo” in the GI tract, where, in fact, oral feeding of OVA was also shown to induce 
CD25+ with high transcript levels of Foxp3 (Mucida et al., 2005). However, the immune 
cells responsible for the coordination of this mechanism were not investigated. 
 
Are DC in the GI tract specially equipped to foster the differentiation of Foxp3+ 
Treg from naïve precursors? 
 
The cytokine, transforming growth factor-beta (TGF-β) is a heavily regulated 
cytokine (Annes et al., 2003), which plays a dominant role in immune homeostasis. In 
addition to promoting thymic Foxp3+ Treg survival and maintaining naïve T cell 
quiescence, it’s been showcased to potently induce Foxp3+ Treg differentiation from naïve 
CD4+ T cells upon stimulation, in vitro (Chen et al., 2003; Li et al., 2006; Marie et al., 
2006; Ouyang et al.). TGF-β is also produced in abundance by IEC; this source 
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potentially serves a non-redundant function in maintaining good relations with the host 
microbiota and dietary antigen (Barnard et al., 1993; Dignass and Podolsky, 1993). More 
recent studies have revealed that APC upon phagocytosis of apoptotic cells are also 
able to produce TGF-β (Perruche et al., 2008; Torchinsky et al., 2009). Assuming that 
the apoptotic inclusions present in their cytoplasm are a result of phagocytosis, 
migratory CD103+ LpDC may also be endowed with the capacity to produce this 
cytokine. Further, this implies that this population may be uniquely poised to induce 
Foxp3+ Treg under physiological settings. In Chapter 2, this possibility will be 
investigated and the role of other mucosal factors in the induction of Foxp3 will be 
considered.  
II.	  T-­‐Helper	  cells	  in	  the	  Lp	  compartment	  
 
Foreign microbial challenge results in the elicitation of an adaptive immune 
response, which accompanies CD4+ T helper (TH) cell differentiation. Analogous to this 
type of challenge, the presence of the commensal microbiota and dietary antigen in the 
GI tract also elicits an adaptive immune response, resulting in the sustained recruitment 
of IgA+ B cells and various TH subsets into in the Lp (Atarashi et al., 2008; Klaasen et al., 
1993; Mazmanian et al., 2005). Until recently, the categories of TH subsets were cast in 
essentially binary terms, namely TH-1 and TH-2, based on the classic experiments of 
Coffman and colleagues (Mosmann et al., 1986). However, recent studies have upended 
this paradigm, leading to the inclusion of several new subsets. While further study is 
necessary to reconcile these newer subsets, which appear to retain less committed 
features than their foregoing TH-1 and TH-2 counterparts (Locksley, 2009), one subset 
has emerged as quite an important player in infectious disease and mucosal immunity. 
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This subset of cells, referred to as TH-17, will be discussed along with TH-1 and TH-2 
cells. 
 
  TH-1 cells are defined by production of IFN-γ and canonical expression of the 
transcription factor, T-bet (Mullen et al., 2001; Szabo et al., 2000). They play 
instrumental roles in priming and sustaining inflammatory macrophage function (Hu and 
Ivashkiv, 2009), and as such help mediate adaptive immune responses against a range 
of intracellular pathogens, including, those which infect the host through the alimentary 
route, such as microsporidia and Toxoplasma gondii (Casciotti et al., 2002; Moretto et 
al., 2004). TH-2 cells are defined by production of IL-4, IL-5 and IL-13 and canonical 
expression of the transcription factor GATA-3 (Loots et al., 2000). They elicit an 
“alternatively” activated macrophage program that is linked with tissue repair and 
mediate protective immune responses against helminths (Maizels et al., 2009; Mosser 
and Edwards, 2008). Further, they are commonly associated with allergic responses 
(Kim et al.). In contrast to TH-1 development, previous studies have suggested that 
normal commensal microbiota derived signals actively constrain steady-state TH-2 
development (Mazmanian et al., 2005; Troy and Kasper). Consistent with these reports, 
broad-spectrum antibiotic treatment was revealed to trigger oral sensitization to a food 
allergen (Bashir et al., 2004). However, a more recent study found that cells from the 
terminal ileum of conventionally reared mice readily secreted TH-2 cytokines, including 
IL-4 and IL-13, upon polyclonal T cell restimulation (Gaboriau-Routhiau et al., 2009). 
Thus, whether the commensal microbiota actively restrains TH-2 cell development is a 
matter of debate.  
 
TH-17 cells are associated with the production of the cytokines: IL-17-A, IL-17F, 
IL-21 and IL-22 (Khader et al., 2009). While IL-17A and IL-17F are strictly dependent on 
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the transcription factor, Retinoic acid receptor-related orphan nuclear receptor gamma 
(RORγ) and, to a much lesser extent, RORα, IL-21 and IL-22 can be generated 
independently of these transcriptional programs (Ivanov et al., 2006; Korn et al., 2007; 
Nurieva et al., 2007; Yang et al., 2008; Zhou et al., 2007). Of interest, IL-22 production 
by TH-17 cells is strictly dependent on the environmental toxin-activated, transcription 
factor, aryl hydrocarbon receptor (AHR), which was also demonstrated to amplify 
production of IL-17A and IL-17F (Veldhoen et al., 2009; Veldhoen et al., 2008a). Shortly 
after the discovery of IL-17 (IL-17A, specifically) it became associated with human 
autoimmune syndromes, such as Rheumatoid Arthritis and Lupus (Kotake et al., 1999; 
Kurasawa et al., 2000; Ziolkowska et al., 2000). In mice, as well, these cells have been 
pegged as pivotal instigators of autoimmunity and have an extraordinary capacity to both 
stimulate the release and production of inflammatory mediators from myeloid cells and to 
recruit innate cells, such as neutrophils to sites of inflammation (Jovanovic et al., 1998; 
Ye et al., 2001). This has been amply demonstrated in mouse models of collagen 
induced arthritis and, in particular, experimental autoimmune encephalitis, which has 
been exploited to great lengths, resulting in an onslaught of molecular insights into the 
pathways that control the production of IL-17 (Hirota et al., 2007; Ivanov et al., 2006). As 
such, it is now clear that TGF-β signaling in the context of inflammatory mediators, such 
as IL-6, IL-1 and IL-21 are critical for TH-17 differentiation, while IL-23 regulates its 
effector function in vivo (Ahern et al.; Bettelli et al., 2006; Korn et al., 2007; Mangan et 
al., 2006; McGeachy et al., 2007; McGeachy et al., 2009; Nurieva et al., 2007; Veldhoen 
et al., 2006; Zhou et al., 2007). Although IL-23 shares an IL-12p40 subunit with IL-12, 
which drives TH-1 inflammation, this cytokine regulates distinct pathways (Cua et al., 
2003; Murphy et al., 2003; Trinchieri et al., 2003). Similar to the reciprocal inhibition of 
TH-1 and TH-2, both IL-4 and IFN-γ potently suppress TH-17 differentiation (Harrington et 
al., 2005). However, pathogenic TH-17 cells, at least, also appear to retain some TH-1 
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like features, and can, in fact, morph into IFN-γ producing cells during inflammation (Lee 
et al., 2009).  
 
Despite the association of this subset with auto-inflammatory disorders, multiple 
studies have revealed that TH-17 cells serve as critical effectors against fungal, 
extracellular bacterial, and in some instances, intracellular bacterial infections (Acosta-
Rodriguez et al., 2007; Aujla et al., 2008; Conti et al., 2009; Happel et al., 2005; 
Ishigame et al., 2009; Khader et al., 2009; LeibundGut-Landmann et al., 2007; Lin et al., 
2009; Pitta et al., 2009; Saijo et al.; Zheng et al., 2008). Among their protective 
functions, IL-17A, IL-17F and IL-22 each have been shown to mediate epithelial cell 
production of anti-microbial peptides, including β-defensins (Conti et al., 2009; Ishigame 
et al., 2009; Kao et al., 2004; Wolk et al., 2004) and lectins (Sanos et al., 2009; Zheng et 
al., 2008). Bearing this in mind, IL-17A secreting TH-17 cells, a proportion of which also 
express IL-22 (Ivanov et al., 2009), are typically detected in the small intestinal Lp during 
steady-state and express the chemokine receptor, CCR6, which favors their proximity to 
IEC (Ishigame et al., 2009; Ivanov et al., 2008; Nagler-Anderson, 2001). Thus, while 
clearly in possession of potent inflammatory capacity, in non-inflamed conditions TH-17 
cells seem to be well integrated into the intestinal immune system’s microbial 
containment strategy. Although not the focus of the work to be described, it is worth 
mentioning that other studies that have examined innate cells, such as γδT cells, 
lymphoid tissue inducer - like (Lti-like) cells, NK, NKp46+ NK-like cells, and even Paneth 
cells have noted their capacity to produce IL-17 (γδT, NK*, Lti-like*, Paneth cells*; *upon 
inflammatory stimulation) and/or IL-22 (γδT*, Lti-like*, NKp46+; *upon inflammatory 
stimulation) in various contexts, further emphasizing the importance of these cytokines 
to mucosal barrier regulation (Cua and Tato). Indeed, innate sources of IL-22 were 
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recently revealed to be absolutely required for the early phase of protection against 
bacterial pathogens that attach to and efface the IEC barrier (Zheng et al., 2008)  
 
III.	  Foxp3+	  Treg/TH	  populations	  are	  in	  a	  dynamic	  equilibrium	  
 
The preceding description may lead to the misapprehension that the immune 
system protecting the GALT is strictly designed for coping with the everyday stresses 
imposed by the commensal microbiota and food antigen; however, this site is also one of 
the most convenient ports of entry for foreign pathogen, and, therefore, must also be 
equipped with the capacity to stage a swift and simultaneous immune response. One 
possibility is that the steady-state immunological landscape in the IEL and Lp 
compartments has negligible bearing on how the host will respond to foreign microbial 
challenge. However, such an untethered strategy in this region could prove inefficient 
and impinge on the capacity of the host to mount a timely and robust immune response. 
Further, it could potentially disrupt the sensing mechanisms that are in place to maintain 
and/or restore mucosal homeostasis in the event of a pathogenic challenge. Another 
consideration, which casts further doubt on this possibility, is that the mucosal immune 
system is alerted to the presence of a pathogen via the same pattern recognition 
receptors that are engaged by the commensal microbiota (Sansonetti and Di Santo, 
2007). Rather, the alternative hypothesis - that the ongoing steady-state immune 
response in the GI tract heavily influences the ability of the host to respond to a 
pathogenic threat – is more likely. 
 
APC within the Lp compartment express a variety of pattern recognition 
receptors, particularly among the TLR family, suggesting that they can receive 
 20 
instructive signals directly from the commensal microbiota (Coombes et al., 2007; 
Uematsu et al., 2008). The precise nature of these signals and their influence on the 
regulation and distribution of Foxp3+ Treg and TH subsets within the Lp remain obscure. 
In view of their sensing, migratory, and priming characteristics, LpDC are potentially 
strongly equipped for processing and dispatching these cues to CD4+ T cells and, in 
turn, influencing the Foxp3+ Treg /TH landscape within the Lp. In Chapter 3 this 
possibility will be explored, first, using an in vitro assay to identify potential 
components of the microbiota, which impose natural constraints on the Foxp3+ 
Treg axis in the GALT.  
 
One paradigm that has emerged to provide a basic understanding of the 
homeostatic regulation of T cell subsets in this region is the documented reciprocal 
nature of Foxp3+ Treg and TH-17 cells. Both are dependent on TGF-β for their induction 
and/or survival (Bettelli et al., 2006; Liu et al., 2008; Manel et al., 2008; Mangan et al., 
2006; Ouyang et al.; Veldhoen et al., 2006; Volpe et al., 2008) however, where Foxp3+ 
Treg cells seem inclined to mediate the suppression of inflammatory cascades, TH-17 
cells seem inclined to do just the opposite. Their Janus-like relationship is also apparent 
in other contexts. In terms of gene regulation, Foxp3 was shown to sequester RORγ and 
to prevent its binding to DNA, while diversion of cells from the Foxp3+ Treg lineage was 
shown relieve cells of their inability to produce IL-17 (Gavin et al., 2007; Zhou et al., 
2008). In terms of cytokine regulation, IL-6−/− mice were shown to lack TH-17 cells in their 
Lp, but harbored an enhanced frequency of Foxp3+ Treg (unpublished finding) (Korn et 
al., 2007). On the other hand, IL-2−/− mice were shown to be unable to sustain Foxp3+ 
Treg cells in their periphery, but harbored an enhanced frequency of TH-17 cells (D'Cruz 
and Klein, 2005; Fontenot et al., 2005; Laurence et al., 2007).  
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Taking into account what is known about the intestinal mucosal environment: 
abundant TGF-β, a large proportion of Foxp3+ Treg, and the constitutive presence of TH-
17 cells, these findings suggest that the indigenous microbiota may be able to leverage 
this delicate relationship to shape the inflammatory tone of the tissue. Further, when 
pathogenic microbial signals converge onto these indigenously derived signals, skewing 
away from the Foxp3+ Treg axis of control may be amplified. In this regard, Littman and 
colleagues recently demonstrated that a commensal microbial community, which 
promotes a steady-state skewing toward the TH-17 subset, can potentiate immune 
responses to the TH-17 eliciting bacterial pathogen, Citrobacter rodentium (Ivanov et al., 
2009). This study also identified a microbial species known as segmented filamentous 
bacteria (SFB) that was particularly potent at inducing a prominent TH-17 subpopulation 
(Ivanov et al., 2009). However, the precise stimulatory pathways utilized by SFB to 
promote TH-17 activity were not completely clarified. Indeed, the individual 
contributions of discrete signaling pathways, which are engaged by specific 
microbial component/pattern recognition receptor interactions, to the regulation 
of intestinal homeostasis and mucosal immunity are unclear.  
 
Insofar as this paradigm applies to the Foxp3+ Treg and TH-17 subsets of T cells, it 
does not sufficiently encompass the heterogeneity of the microbial communities that are 
constitutively present in the GI tract, which also should add to TH diversity and potentially 
the functional characteristics of Foxp3+ Treg in the Lp compartment. Indeed germ-free 
mice that were reconstituted with a commensal microbiota from naturally colonized mice 
displayed dramatic increases in both TH-1 and TH-17 subsets within the ileal Lp 
compartment (Gaboriau-Routhiau et al., 2009). Moreover, commensal derived 
components, such as the polysaccharide of Bacteroides fragilis, have been shown to 
regulate the TH-1/TH-2 balance during steady-state (Mazmanian et al., 2005). Thus the 
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commensal microbiota was also demonstrated to affect sensitivity to food borne allergies 
(Bashir et al., 2004). Regarding Foxp3+ Treg cells, specific microbial interactions have 
been proposed to augment their regulatory activity, including TLR 4 and 5 (Caramalho et 
al., 2003; Crellin et al., 2005), while others involving TLR 2, 8 and 9 have been proposed 
to restrain their regulatory activity (Larosa et al., 2007; Liu et al., 2006; Pasare and 
Medzhitov, 2003; Peng et al., 2005; Sutmuller et al., 2006). Altogether, these data 
provide compelling evidence that the composition of the microbiota is able to 
exert a strong influence on the T cell landscape of intestinal effector sites, which 
in turn may condition the efficiency of the mucosal response to an invasive 
pathogen. This concept will be examined in Chapter 3. 
Convergence	  of	  nutrient	  metabolism	  with	  the	  mucosal	  immune	  system:	  
 
The essential function of the GI tract is to digest food and extract nutrients, some 
of which are otherwise inaccessible in the absence of the commensal microbiota (Wikoff 
et al., 2009). Accumulating evidence reveals that the intestinal immune system has 
adapted to this process through utilization of nutrient metabolites. Similar to microbial 
driven signals, nutrient metabolite driven signals appear to serve as key moderators of 
the immunological conversation taking place at mucosal barrier interfaces. In many 
ways, they are also as well tailored as microbial signals to provide the host with a local 
immunological advantage. For instance, butyrate, which is a short-chain fatty acid 
produced by the commensal microbiota upon metabolism of dietary fiber, was shown to 
inhibit the multiplication of pathogenic enteric bacteria and quelled the inflammatory 
profile of monocytes, in vitro (Bohnhoff et al., 1964; Saemann et al., 2000). Catabolism 
of the essential amino acid tryptophan, which occurs constitutively in the GALT, was 
shown to limit basal Ab production to commensal microbiota (Harrington et al., 2008). 
Recent data also support the hypothesis that tryptophan catabolism positively regulates 
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the Foxp3+ Treg/TH-17 ratio (Favre et al.). Another nutrient that especially bares this 
point is vitamin A and, in particular, its metabolic derivative, retinoic acid. 
 
Vitamin	  A	  is	  a	  critical	  nutrient	  for	  the	  GALT	  immune	  system:	  
 
In the early 20th century E.V. McCollum discovered that certain lipids contained a 
factor essential for growth, which he termed  “fat soluble factor A” or, Vitamin A (Mc, 
1952). Mammals and most higher order organisms are dependent on dietary ingestion 
for acquisition of this vitamin. Its sources include carotenoids, which are present in fruits 
and vegetables and retinyl esters, which are abundant in meats and poultry. These 
compounds are broken down into retinol (1) for absorption by the small intestine and 
subsequently esterified for storage in the liver (Harrison, 2005; Mc, 1952).  
Retinoic	  acid	  can	  be	  generated	  or	  obtained	  through	  multiple	  pathways:	  
 
Retinoic acid (RA) is the end product of a series of enzymatic steps in Vitamin 
A’s metabolism. When required, retinyl esters are hydrolyzed into retinol and deployed 
into circulation along with its chaperone, retinol-binding protein (RBP) (Wolf, 2007). It’s 
uptake into cells, including IEC and APC, is mediated by the surface receptor, STRA6, 
which binds with high affinity to RBP (Kawaguchi et al., 2007). Once in the cytosol, the 
ubiquitously expressed family of alcohol dehydrogenases (ADH) (2) reversibly catalyzes 
the oxidation of retinol to retinal (Mic et al., 2003). Retinal dehydrogenases (RALDH) (3) 
then bind to retinal and catalyze the final and irreversible step in RA synthesis. In the 
GALT, this predominantly results in all-trans RA, which can eventually isomerize to its 9-
cis form. However, this form has yet to be detected in vivo (Mic et al., 2003). Notably, 
RALDH expression is cell and tissue specific, making RA synthesis a controlled process 
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(Iwata et al., 2004). While the processes regulating RALDH induction are unclear, it was 
recently demonstrated that lipid mediators, which are widely present in the GALT, induce 
RALDH2 through the fatty acid binding receptor, PPAR-γ (Szatmari and Nagy, 2008).  
 
 
As previously mentioned, GALT DC promote lymphocyte homing to intestinal 
effector sites through coordinate upregulation of α4β7 and CCR9. The first clue that RA 
controlled the induction of these ligands was the finding that adding it exogenously to 
APC-free cultures induced their expression on stimulated T cells (Iwata et al., 2004). 
Then came the seminal observation that adult mice reared on a vitamin A deficient diet 
had a diminished number of T lymphocytes residing in intestinal effector sites (Iwata et 
al., 2004). Consistent with their ability to synthesize RA, PpDC and mlnDC expressed 
messenger RNA for RALDH1 and RALDH2, respectively. Nevertheless, IEC were also 
revealed to prominently express RALDH1. Therefore, GALT DC may also acquire RA 
passively from IEC (Iwata et al., 2004). Further, although its physiological significance is 
unclear, it should be noted that RA is also detectable in serum, albeit at very low levels 
(Kane et al., 2008a; Kane et al., 2008b). 
Retinoic	  acid	  contributes	  to	  lymphocyte	  function:	  
 
Apart from its immunological influence on homing, there are compelling data that 
link RA to the functional capacity of lymphocytes, particularly B cells. For example, DC 
and stromal derived, follicular DC from Pp were revealed to drive naïve B cell 
differentiation into IgA+ B cells and/or to preferentially induce IgA+ class switching in 
activated B cells (Mora et al., 2006; Suzuki et al.). RA was demonstrated to be essential 
to these processes, since antagonism of RA signaling inhibited the ability of PpDC to 
generate IgA+ B cells, while adding RA in conjunction with IL-6 and/or IL-5 dramatically 
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enhanced IgA production in peripheral LN DC cocultures (Mora et al., 2006). In concert 
with these data, Fagarasan and colleagues reported that activating peripheral LN 
follicular DC with RA synergized with TLR 2 and 4 ligands to induce production of active 
TGF-β, which is also a critical factor for IgA+ class switching (Cerutti and Rescigno, 
2008; Suzuki et al.). Thus, vitamin A metabolism appears to contribute to the generation 
of IgA+ B cells through both direct effects on B cells and indirect effects through DC 
modulation, although this has not yet been completely resolved.  
 
RA may also exert direct effects on T cells. For instance, RA was shown to 
enhance T cell proliferation under mitogenic stimulatory conditions, which was correlated 
with a gross increase in IL-2 production (Ertesvag et al., 2002). However, data have also 
suggested that RA can inhibit production of IL-2 during naïve T cell activation (Ertesvag 
et al., 2009). Notably, these findings were obtained in humans and mice, respectively; 
therefore system differences could account for these discrepancies. RA was also 
proposed to directly inhibit TH-1 polarization in vitro; however, the effect in these assays 
was relatively minor and a clear mechanism for the action of RA was not proposed 
(Iwata et al., 2003). Thus, what role RA plays in T cell activation and TH polarization, if 
any, is still ambiguous. 
 
Retinoic	  acid	  signaling	  is	  mediated	  through	  nuclear	  retinoic	  acid	  receptors:	  
 
 
RA signals through several families of nuclear hormone receptors in the nucleus. 
The best characterized are RA receptors (RAR) which form obligate dimers with retinoid 
X receptors (RXR) and in turn, transcriptionally activate RA response elements (RARE) 
in the promoter regions of various genes (Chambon, 1996). Recently, RA was also 
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shown to be able to signal through PPARβδ; however, the potential importance of this 
pathway in immune cell populations awaits further scrutiny and was not examined in the 
studies that will be described in the forthcoming sections (Schug et al., 2007). While 
RXRs dimerize with several nuclear receptors to transduce signals by other small 
molecules, RARs bind exclusively with RA (Ziouzenkova and Plutzky, 2008). Three, in 
particular, have been identified - α, β and γ. Underscoring their influence on a score of 
genes, as well as their complex regulation, aberrant expression of RARs (positive and 
negative) has been strongly linked to metabolic disorders and various cancers (de Lera 
et al., 2007; Hua et al., 2009; Walkley et al., 2007; Yang et al., 2005).   RA was shown to 
mediate TGF-β production in follicular DC via RARβ (Suzuki et al.). However, in contrast 
to RARα and RARγ, RARβ is not detectable in lymphocytes (Elias et al., 2008). 
Intriguingly, protein expression of RARα was found to increase dramatically upon CD4+ 
T cell activation in the presence of TGF-β, and as will be highlighted in the forthcoming 
chapters, may have a driving influence on Foxp3+ Treg/TH-17 regulation (Schambach et 
al., 2007). Furthermore, dysregulation of these receptors has been linked to various 
cancers, including leukemias. The prevalence of vitamin A metabolism occurring in 
the GALT, suggests that RA/RAR interactions may bear significance in the 
regulation of T cell homeostasis and immunity in this region. Work to be 
described in Chapter 2 and Chapter 4 will start to address this possibility.   
A	  role	  for	  retinoic	  acid	  in	  infection	  and	  immunity	  
 
On a typical western diet, retinol absorption exceeds the body’s homeostatic 
requirements. This results in the accrual of retinyl esters in the liver. However, in 
developing countries, where malnutrition and diarrhea are common, Vitamin A intake 
and absorption are reduced. When combined with pregnancy, which increases Vitamin A 
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metabolism, the risk of Vitamin A insufficiency (VAI) both to mother and unborn infant 
increases dramatically. According to the most recent WHO estimate, there are 
approximately 250 million children presenting with subclinical and/or clinical signs of VAI 
at this precise moment (informational website).  
 
VAI has long been linked to increased prevalence of diarrheal diseases and 
mortality from gastrointestinal infection (Duggan et al., 2002; Villamor and Fawzi, 2000). 
While numerous studies indicate that Vitamin A supplementation mitigates the incidence 
and severity of these infections, determining the impact of RA mediated mechanisms on 
these outcomes has proven difficult (Long et al., 2006a; Long et al., 2007a; Long et al., 
2007b; Long et al., 2006b). Complicating this task is the variability in degree of VAI and 
preexisting disease states within single cohorts. Rodent models of VAI, which prevent 
these complications, have shed some light on the role of RA in GALT immunity to 
infection. For example, RA signaling was required for the development of a proper TH-2 
response in mice infected with the helminth, Trichinella spiralis, whereas VAI resulted in 
an aberrant TH-1 response to this infection (Cantorna et al., 1994; Carman et al., 1992). 
However, another report demonstrated that RA administered concomitantly during 
infection with Mycobacterium tuberculosis enhanced TH-1 responses in vivo and 
facilitated bacterial clearance (Yamada et al., 2007). VAI mice were found to be 
significantly more susceptible to rotavirus than their WT counterparts. However, while 
this study compared architectural changes in various tissues, including the gut, immune 
responses were not assessed in these mice (Ahmed et al., 1990). Thus, the impact of 
RA mediated signaling on TH responses is still unclear and may depend on the local site 
of infection.  To date, there has been a paucity of studies that have considered the 
role of RA, in situ, during intestinal immune responses. Moreover, the precise 
mechanisms that underlie exacerbated enteric infections during VAI remain 
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undefined. Studies in Chapter 4 will tackle this question and help define how in situ Lp 
responses are impacted by VAI.  
 
Models	  of	  infection:	  
 
To gain mechanistic insight into the questions that have been raised in this 
section the following challenge models will be employed:  
Encephalitozoon	  cuniculi	  (E.	  cuniculi):	  
 
 
Microsporidia are spore forming obligate intracellular parasites that have recently 
been classified as fungi (James et al., 2006). They infect a wide range of hosts, primarily 
through oral transmission (Didier et al., 2004). Species that infect humans, such as E. 
cuniculi, tend to induce a sub-clinical chronic infection accompanied with mild or acute 
symptoms, most typically diarrhea. Upon ingestion, spores infect the epithelia of the 
duodenum and replicate in parisotophorous vacuoles (Mathews et al., 2009). 
Importantly, E. cuniculi can infect a variety of other cells, including APC (Orenstein et al., 
1992), and can readily disseminate to other tissues in the body. As such, these 
infections are particularly severe and problematic in immunocompromised individuals 
(Farthing, 2006; Ferreira et al., 2001; Mertens et al., 1997; Wanachiwanawin et al., 
1998).  E. cuniculi is also a natural mouse pathogen (Keeble, 2001). Studies in 
laboratory animals have shed light on the course of infection and the immunological 
requirements for control of this pathogen, which include both CD4+ and CD8+ T cells 
during the natural route of infection (Moretto et al., 2004; Salat et al., 2006). In order to 
address how enteric commensal driven signals influence host ability to respond to 
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infection, mice will be infected with this pathogen. The results obtained from these 
studies will be described in Chapter 3. 
 
Toxoplasma	  gondii	  (T.	  gondii):	  
 
Toxoplasma gondii (T. gondii) is a protozoan parasite naturally acquired through 
the oral route that infects up to a third of the world’s population (Montoya and Liesenfeld, 
2004). While primary infection manifests in a subclinical response, unless treated, T. 
gondii establishes a chronic phase of infection in the host, which is exemplified by the 
formation of Bradyzoite cysts in the muscle and brain tissue whose pathological 
consequences are limited by a multitude of host regulatory and inflammatory factors 
(Stumhofer et al., 2007; Wilson et al., 2005). Extensive mouse studies have established 
the critical importance of both CD4+ and CD8+ T cells and a controlled TH-1 response in 
the development and maintenance of immunity to this parasite (Combe et al., 2005; 
Gazzinelli et al., 1992; Gazzinelli et al., 1996; Liesenfeld et al., 1996). Consequently, T. 
gondii can have fatal consequences in immunocompromised individuals upon 
reactivation of the chronic phase (Israelski and Remington, 1988). Based on virulence in 
mice, T. gondii has been classified into 3 strains. Type I are acutely lethal, regardless of 
the dose of pathogen administered, while Type II and type III strains are generally 
considered non-lethal, depending on the strain of mice and dose administered (Bradley 
and Sibley, 2007). For the studies that will be highlighted in Chapter 4, a clone of the 
type II strain, ME-49 will be utilized. 
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Summary:	  
  
The immune system of the gastrointestinal tract has adapted in close apposition 
with the commensal microbiota, food protein and environmental antigens. As such, it 
maintains a dynamic presence of both effector and regulatory lymphocyte populations. 
Yet, the mechanisms in place to orchestrate this balanced dichotomy have not been well 
defined. To gain insight into this broad question, the studies, which will be discussed 
herein, were focused particularly on understanding CD4+ T cell regulation within the 
intestinal Lp compartment as a model of homeostasis. Chapter 2 explores the 
convergence of potentially redundant regulatory pathways in this region, specifically, 
Foxp3+ Treg generation and presents data that identifies retinoic acid as a cofactor in the 
extrathymic development of Foxp3+ Treg. Chapter 3 then examines how commensal 
components intersect with host regulatory strategies to favor the development of 
mucosal immune responses. Finally, Chapter 4 inspects more closely the role of vitamin 
A metabolism in immunity. 
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CHAPTER	  2:	  GALT	  Foxp3+	  Treg	  development	  is	  critically	  dependent	  on	  
vitamin	  A	  metabolism	  
 
Abstract:	  
 
The gastrointestinal tract is a home to a broad reservoir of regulatory T cells, 
including those which express the transcription factor, Foxp3. Although, most studies 
and differentiation models mark the origin of these cells as the thymus, recent evidence 
has showcased their potential to arise from naïve precursors and/or in the absence of a 
thymically generated pool. In this study, the GI tract and its associated lymphoid tissues 
(GALT) were studied as potential nucleating sites for the generation of extrathymic 
Foxp3+ Treg. The following findings emerged:  
 
1. Antigen introduced through the oral route robustly induced naïve T cell 
upregulation of Foxp3 protein in the GALT.  
2. Dendritic cells from the intestinal lamina propria (Lp) and those draining 
into the mesenteric lymph nodes (mln) uniquely promoted in vitro Foxp3+ 
Treg generation via active TGF-β  signaling and the synthesis of retinoic 
acid (RA). 
3. RA enhanced TGF-β  induced Foxp3+ Treg generation via retinoic acid 
receptor alpha.  
4. Vitamin A metabolism was essential for GALT Foxp3+ Treg induction. 
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Rationale:	  
 
Previous studies have demonstrated that TCR stimulation of naïve CD4+ T cells in 
the presence of TGF-β could promote the induction of Foxp3 (Chen et al., 2003; Fantini 
et al., 2004). Further, sub-immunogenic (Kretschmer et al., 2005) or chronic exposure to 
antigen (Apostolou and von Boehmer, 2004; Knoechel et al., 2005) was also shown to 
lead to long-lasting adoption of this transcription factor in extra-thymic naïve CD4+ T cells. 
Therefore, the immune system protecting the GI tract and associated lymphoid tissues 
(GALT) was hypothesized to serve as a candidate environment for peripheral Foxp3+ Treg 
development. Indeed, the small intestinal tissue was shown previously to constitutively 
express large amounts of TGF-β (Barnard et al., 1993) and is continuously exposed to 
gut commensal microbiota or dietary antigens in what is largely deemed a non-
immunogenic manner. 
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Results:	  
 
De	  novo	  generation	  of	  Foxp3+	  Treg	  cells	  can	  occur	  in	  the	  GALT	  	  
 
In order to address if the gastrointestinal tract and its associated lymphoid 
tissues (GALT) could favor de novo production of Foxp3+ Treg from naïve T cells, Ly5.2+ 
T cells from RAG1–/– OT-II Tg mice, which are specific for the peptide sequence 323-339 
of chicken ovalbumin (OVA) protein, were adoptively transferred into Ly5.1+ replete 
recipients. Because these cells bear a TCR that does not recognize endogenous 
antigen, they retain a naïve phenotype and are devoid of regulatory features, including 
CD25 (Jordan et al., 2001) and Foxp3 (Walker et al., 2003). Following transfer, the 
Ly5.1+ recipients were fed OVA antigen dissolved in drinking water for 5 consecutive 
days. This feeding regimen was previously demonstrated to suppress airway 
inflammation if implemented prior to immunization and intra-nasal challenge with OVA 
antigen, and was associated with upregulated Foxp3 mRNA expression in CD25+ CD4 T 
cells (Mucida et al., 2005). A recent study by the same group demonstrated that Foxp3 
was essential for this effect (Curotto de Lafaille et al., 2008).  
 
After 5 days of OVA administration, Ly5.2+ OVA-specific T cells had expanded 
and were readily detectable in the GALT, spleen, and even in distal lymph nodes, such 
as the sub-mandibular (subLN) (Figure 3A). However, in spite of the broad 
dissemination of transferred cells, Foxp3+ expressing T cells were only appreciably 
detected in the GALT, including the mesenteric lymph nodes (mln), small intestinal 
lamina propria (Lp) and the Peyer’s Patches (Pp) (Figure 3B). Although the highest 
frequency of Foxp3+ converted OVA-specific T cells was consistently found in the Lp, 
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with a mean frequency of 16.8 ± 6.5%, it is important to note that these mice were 
sacrificed only 24 hrs post-feeding and that longer resting periods may have led to the 
redistribution of the cells to other tissues. Nevertheless, these findings argue that in 
response to oral exposure to antigen, the GALT environment can promote the 
emergence of Foxp3+ T cells from a naïve population in an antigen dependent manner. 
Importantly, feeding irrelevant antigen, such as bovine serum albumin was shown to not 
be able to induce Foxp3+ upregulation in a similar setting (Coombes et al., 2007).  
 
 
 
Figure 3. Acquisition of Foxp3 in CD4+ T cells responding to orally delivered 
antigen. 
On day 6 after transfer, donor T cells were assessed flow cytometrically for Foxp3 
expression via intracellular staining in cell suspensions from the sub-mandibular lymph 
nodes (subLN), spleen (Sp), mesenteric lymph nodes (mln), Peyer’s patches (Pp), and 
small intestinal lamina propria (Lp). (A) Top dot plots were gated on total CD4+ cells. 
Ly5.2 was used to identify the transferred population.  Bottom contour plots show Foxp3 
expression by Ly5.2 gated cells (B) Summary of the percentage of Ly5.2+ RAG1-/- OT-II 
T cells expressing Foxp3. Each dot represents a single mouse. Data were combined 
from 2 individual experiments (3 mice each). Statistical comparisons were performed 
using the Student’s T test, with Sp tissue serving as the baseline comparison for each 
tissue. ns = not significant,, P < 0.001. 
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Characterization	  of	  lamina	  propria	  dendritic	  (LpDC)	  cells	  	  
 
The observations above suggest that the GALT microenvironment is particularly 
poised for the peripheral generation of Foxp3+ Treg. As detailed in Chapter 1, tissue 
resident dendritic cells (DC) constitutively migrate from the Lp into the mesenteric lymph 
nodes (Huang et al., 2000); this property is essential for the polarization of antigen 
specific T cells in the draining mln upon antigen feeding (Johansson-Lindbom et al., 
2005). It was plausible, therefore, that Lp derived DC may play a dynamic role in the 
generation of Treg. Examining the dual expression of CD11c and MHC II, which are the 
two surface antigens typically used to denote DC, in unfractionated Lp tissue 
suspensions indicated that these cells accounted for typically 25% of the hematopoietic 
cells within the Lp. As illustrated in Figure 4A, CD11c+ MHC II+ cells comprised a 
heterogeneous population, where two dominant subpopulations emerged: one (I) 
expressed higher levels of CD11c and slightly less MHC II, while the second (II) stained 
slightly lower for CD11c, but higher for MHC II. A third subpopulation has also been 
characterized by another laboratory, which stains much dimmer for CD11c and very 
bright for MHC II. Recent findings have identified these cells as the serosal 
macrophages (Bogunovic et al., 2009). As a side note, this population was not sorted in 
assays in which LpDC were isolated. Consistent with previous reports, when 
CD11c+MHC II+ cells were assessed for surface integrins, virtually all were CD11b+ 
(Niess and Reinecker, 2005), while up to 30% expressed αE, also known as CD103 
(Figure 4A) (Johansson-Lindbom et al., 2005). The majority of CD103+ LpDC co-
expressed CD11b. Unlike their counterparts in the Lp, SpDC were almost uniformly 
CD103–, although in some experiments a portion of the CD11b– subpopulation 
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expressed this marker, albeit it dimly (Figure 4A and data not shown). Moreover, while 
these observations were made in C57BL/6 mice, for unclear reasons, the CD11b–
CD103+ SpDC subpopulation is known to be more prominent in BalbC strains (Annacker 
et al., 2005). Thus, the basal status of activation within the host may affect the 
constitutive presence of this population in the spleen. Upon cell sorting, Giemsa staining 
revealed that LpDC displayed the characteristic features of conventional DC with a 
stellar shape comparable to freshly sorted SpDC (Figure 4B). Analysis of costimulatory 
molecules on LpDC indicated comparable levels of CD80 and CD86 to SpDC, while 
CD40 was enhanced (Figure 4C). MHC II was also more highly expressed in LpDC. In 
concert with these findings, LpDC were shown to be at least as efficient as SpDC at 
inducing T cell proliferation when pulsed with peptide (Johansson-Lindbom et al., 2005). 
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 Figure 4. Phenotypic traits of small intestinal lamina propria DC (LpDC).  
(A) Lp and Sp cell suspensions were labeled with αMHCII, αCD11c, αCD11b and 
αCD103 mAb. Higher panels indicate the percentages of CD11c+MHCII+ cells. Lower 
panels, gated on CD11c and MHCII, show CD103 versus CD11b expression. Numbers 
represent the percentage of events in each quadrant. (B) * Giemsa staining of sorted Lp 
(left) and Sp (right) CD11c+MHCII+ DC. (Magnification X 1000) (C) * Histograms depict 
the expression levels of CD40, CD80, CD86, and MHC II on LpDC (red) and SpDC 
(black). Isotype controls are shown in grey (Stained with pooled Lp and Sp samples). 
*Performed by Cheng Ming Sun, Ph.D. 
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LpDC	  preferentially	  induced	  Foxp3-­‐	  T	  cells	  to	  become	  Foxp3+	  Treg	  cells	  in	  Treg	  
polarizing	  conditions	  
  
LpDC were next assayed for their capacity to induce Treg generation.  To this end, 
DC from the Lp or spleen were isolated, co-cultured with purified Foxp3 negative CD4 T 
cells, and stimulated with polyclonal αCD3 mAb. In order to isolate live Foxp3– CD4 T 
cells, we used a transgenic reporter mouse in which an IRES eGFP construct was 
inserted downstream of the Foxp3 coding sequence (Bettelli et al., 2006). While αCD3 
was unable to efficiently induce Foxp3, provision of exogenous TGF-β resulted in the 
production of Foxp3+ T cells in both cultures, as determined by intracellular cytokine 
staining (Figure 5A). However, under the same conditions and at several T cell to DC 
ratios, the frequency of Foxp3+CD4+ T cells was typically 3 fold greater in LpDC cultures 
(Figure 5B). Notably, the intensity of Foxp3 expression was higher when induced in the 
presence of LpDC than with SpDC (mean fluorescence intensity (MFI): 90.9 vs. 57.4, 
Figure 5A). These findings were recapitulated in an antigen specific setting, in which 
OVA peptide was used to stimulate OT-II transgenic T cells in DC cocultures (data not 
shown). To test the functionality of the induced Foxp3+ T cells, eGFP expressing cells 
were isolated from cocultures and their suppressive capacity was tested in vitro 
(Thornton and Shevach, 1998). Foxp3+ T cells obtained from both LpDC and SpDC 
cocultures were as capable as freshly isolated, ex vivo, Foxp3+ Treg at curbing the 
proliferation of Foxp3- responder T cells upon stimulation, suggesting that these induced 
cells have regulatory capabilities (Figure 6).  
 39 
 
 
 
Figure 5. Small intestinal LpDC induce Foxp3+ Treg at a significantly higher rate of 
efficiency than SpDC.  
(A-B) 105 sorted, Foxp3– CD4+ T cells were cocultured with 104 – 2.5x103 Sp or LpDC 
for 5 days, with αCD3 mAb alone or in concert with TGF-β. Viable cells were then 
assessed for intracellular Foxp3 expression. (A) Contour plots show the percentage of 
CD4+ T cells that express Foxp3. MFI = mean fluorescence intensity. DC:T cell ratio  
1:10 (B) Bar graphs illustrate the frequency of Foxp3+ T cells detected upon termination 
of culture for each condition. Error bars indicate the high and low values (average of 
triplicate wells) from two experiments. 
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Figure 6. Induced Foxp3+ T cells 
behave similar to ex vivo isolated 
Foxp3+ Treg.  
5 x 104 eGFP–CD4+ T (Teff) cells were 
mixed with graded doses of eGFP+ T cells 
that were sort purified from day 5 SpDC or 
LpDC cocultures and then stimulated with 
irradiated splenocytes and αCD3 mAb (0.5 
mg/ml). Proliferation was measured by the 
incorporation of 3H-Thymidine during the 
last 6 hr of culture. eGFP+ T cells sorted 
ex vivo (nTreg) were used for comparison. 
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The induced Foxp3+ Treg expressed high levels of CD25 and GITR (data not shown) 
regardless of the origin of the stimulating DC, while CD103 expression was consistently 
enhanced when induced by LpDC (MFI: 594 vs. 275, Figure 7A). Since CD103 
expression was previously shown to be upregulated by TGF-β signaling (El-Asady et al., 
2005), the influence of the dose of TGF-β on Foxp3 T cell generation was examined in 
DC cocultures. Significantly, the ability of SpDC to induce Foxp3 was much more 
sensitive to the dose of TBF-β, where lowering the dose led to a precipitous reduction in 
the frequency of this induced population. Conversely, the ability of LpDC to induce a 
sizable Foxp3+ population remained robust across various TBF-β concentrations (Figure 
7B). These findings raised the possibility that TGF-β signal transduction is augmented in 
T cells stimulated by LpDC. Though not part of these studies, it would be intriguing to 
investigate the kinetics and degree of smad phosphorylation, which is downstream of 
TGF-β receptor signaling (Li and Flavell, 2008), in T cells during stimulation with Lp vs. 
SpDC. 
 
CD103 expression by DC is required for suppression of T cell mediated colitis in 
the adoptive transfer model, suggesting that this subset possesses regulatory function in 
vivo (Annacker et al., 2005). Therefore, it was important to test whether the CD103+ 
subset was the subpopulation of LpDC that was promoting preferential Foxp3+ Treg 
induction. To address this, LpDC were further sort purified based on CD103 expression. 
Strikingly, CD103+ LpDC, were uniquely able to induce Foxp3 expression in the absence 
of exogenous TGF-β (Figure 8). Moreover, in the presence of TGF-β they consistently 
induced a higher frequency of Foxp3+ cells, though this was not very dramatic, 
especially when compared with SpDC. Purification of the CD103+ DC subpopulation 
from the intestinal draining mln indicated that these cells shared the same competency 
 42 
to induce Foxp3+ Treg as their counterparts in the Lp. This held true both in absentia and 
in the presence of exogenous TGF-β (Figure 8). On the other hand, even with 
exogenous TGF-β, the CD103– subpopulation still induced less than half of the Foxp3 
frequency when compared to the CD103 expressing subset (Figure 8). These findings 
suggest that the CD103+ DC subset in the mln originates from the intestinal Lp, while the 
CD103– subset likely does not.  Consistent with this idea, an elegant study demonstrated 
that, although DC were readily detected, the CD103– subset was selectively excluded 
from lymph vessels draining the intestine (Schulz et al., 2009). 
 
 
Figure 7. TGF-β  responsiveness is enhanced in the presence of LpDC  
(A) eGFP–CD4+ T cells were cocultured at a 10:1 ratio with SpDC or LpDC in Treg 
polarizing conditions. On day 5, eGFP+ T cells were assessed for CD103 expression via 
flow cytometry. Red = SpDC, Black = LpDC. (B) As in A; however, the amount of TGF-β 
in coculture was tested at several concentrations.  
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Figure 8. CD103+ Lp and mln DC are specialized to induce Foxp3+ Treg in the 
absence of exogenous factors.  
eGFP–CD4+ T cells were cocultured at a 10:1 ratio with CD103+ or CD103– DC purified 
from Lp or mln tissues and stimulated with αCD3, in the presence or absence of TGF-β. 
Cells were harvested 5 days later, and eGFP expression was assessed on viable CD4+ 
T cells as a surrogate for Foxp3.  
 
 44 
LpDC	  induce	  sustained	  Foxp3	  expression	  
 
The relative paucity of converted Treg in SpDC cocultures may have been due to 
a lower viability or a reduced proliferative potential of cells that acquired Foxp3. To 
determine the potential contribution of these elements, the survival of in vitro activated T 
cells was measured. In both SpDC and LpDC cocultures, Foxp3+ T cells remained 
significantly more viable than the Foxp3 null population. Thus, the lower yield of Treg cells 
in SpDC cocultures was not the result of increased cell mortality (Figure 9A). T cell 
proliferation in cocultures was explored next. Since eGFP and CFSE share overlapping 
emission spectra, naïve CD4+ T cells (Foxp3 contamination was < 0.5%) were isolated 
from non-transgenic mice (However, in subsequent experiments it became clear that 
eGFP is not retained when fix/permeabilized with the Foxp3 staining buffer kit offered by 
eBioscience). Consistent with findings using CD4+ T cells from reporter mice, the 
proportion of converted Treg continued to dominate in LpDC co-cultures (54.5% vs. 
14.9%, Figure 9B). CFSE dilution profiles indicated that CD4+ T cells proliferated 
vigorously regardless of the origin of DC during the length of incubation. While the 
Foxp3+ Treg lineage is typically distinguished by its hypoproliferative characteristics (Ref), 
this observation may in part be explained by the polarizing system used, in which IL-2, a 
potent growth factor for Treg in these stimulating conditions, was added at 24 hrs and 72 
hrs post-culture. Importantly, even at late division cycles the proportion of Foxp3+ Treg 
remained high in LpDC cocultures (Figure 9C).  These data suggest an initiation of a 
more stable Foxp3+ Treg program in the presence of LpDC. 
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Figure 9. Maintenance of Foxp3 contributes to higher frequency of Foxp3+CD4+ T 
cells in the presence of LpDC.  
(A) eGFP–CD4+ T cells were co-cultured with purified DC at a 5:1 ratio in Treg polarizing 
conditions. At indicated time points, cells were harvested, and stained with 7AAD (dead) 
and annexinV (apoptotic). Foxp3 expression was determined based on eGFP 
fluorescence. The percentage of 7AAD– annexinV– cells is depicted by white bars for 
LpDC and black bars for SpDC. Data are from one of 2 independent experiments. (B) 
CFSE labeled naive CD4+ T cells were co-cultured with purified DC as described above. 
On day 5, cells were harvested and stained for CD4 and intracellular Foxp3. Dot plots of 
Foxp3 versus CFSE are illustrated. The percentage of Foxp3+ cells and the MFI was 
defined as the bordered population.  (C) The proportion of Foxp3+ cells among CD4 T 
cells is plotted as a function of the number of cell divisions. LpDC () of SpDC ().   
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LpDC	  are	  equipped	  to	  metabolize	  vitamin	  A	  derivatives	  in	  retinoic	  acid	   	  
  
 Prior to this work, a number of studies have attributed several unique functional 
properties to GALT DC. Specifically, these studies found that lymphocytes activated in 
the presence of GALT DC, including those from the Lp, selectively up-regulate the gut 
homing surface molecules CCR9 and α4β7, which as mentioned in Chapter 1 results in 
their preferential migration into intestinal tissue (Johansson-Lindbom et al., 2005; 
Johansson-Lindbom et al., 2003; Mora et al., 2003; Mora et al., 2006). This upregulation 
was recently shown to depend on retinoic acid (RA) (Iwata et al., 2004; Mora et al., 
2006). Corresponding to this feature, GALT DC from Pp and mln were found to uniquely 
express high levels of messenger RNA for certain retinaldehydrogenases (RALDH), 
which are the enzymes that irreversibly catalyze the metabolism of the vitamin A 
derivative, retinal, into RA (Mic et al., 2003).   In order to assess for the functional 
expression of this family of enzymes in LpDC, a cell-membrane-penetrating probe that 
fluoresces upon binding to active RALDH was incubated with Sp and Lp tissue cell 
suspensions, and then examined flow cytometrically. Strikingly, only LpDC displayed 
high levels of functional RALDH; more specifically, these high levels were restricted to 
the CD103+ LpDC population (Figure 10A). Nevertheless, inhibition of RALDH activity 
using the alcohol dehydrogenase inhibitor, diethylaminobenzaldehyde (DEAB), during 
incubation with the RALDH probe indicated that both CD103– LpDC and SpDC have 
marginal, albeit detectable RALDH activity. Consistent with more RALDH activity in 
LpDC, upregulated α4β7 expression was consistently observed on induced Foxp3+ T 
cells in LpDC but not in SpDC cocultures (Figure 10B).  
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Figure 10. LpDC synthesize retinoic acid, which can enhance Foxp3+ Treg 
generation in cooperation with TGF-β .  
(A) Sp and Lp cell suspensions were incubated with a RALDH substrate possessing a 
fluorescent indicator. Where indicated, cell suspensions were concomitantly treated with 
a RALDH inhibitor, DEAB. RALDH activity was assessed by flow cytometry, with gating 
strategy showed. (B) In vitro cocultured cells were stained for α4β7 and assessed for 
eGFP fluorescence (Foxp3) by flow cytometry. (C) The dose responsiveness of eGFP 
(Foxp3) expression by CD4 T cells cocultured with SpDC was determined by flow 
cytometry. Error bars represent the standard error of the mean (s.e.m.) of 3 individual 
samples from one experiment. Statistical significance was determined using the 
Student’s T test. , P < 0.05; , P < 0.01; , P < 0.001. 
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Retinoic	  Acid	  enhances	  Foxp3+	  Treg	  generation	  in	  SpDC	  cocultures	  via	  retinoic	  
acid	  receptor	  alpha	  (RARα)	  
 
 To proceed with the previous findings, the capacity of RA to enhance the 
generation of Foxp3+ T cells in Treg polarizing conditions was tested. To this end, 
SpDC/T cell cocultures were prepared with αCD3 and TGF-β in the presence of 
increasing doses of the synthetic RA, all-trans RA, which is the predominant 
physiologically detectable form of retinoic acid (Mic et al., 2003). While RA alone did not 
induce Foxp3 expression, RA in the presence of TGF-β enhanced the frequency of 
Foxp3+ Treg recovered in culture in a dose dependent manner, also leading to 
upregulated α4β7 on these cells (Figure 10C and data not shown). The enhanced 
generation of Foxp3+ T cells was markedly significant at RA concentrations of 1nM and 
above, and plateaued at 10nM, with the percentage of Foxp3+ cells reaching 40-55% 
(Figure 10C). Since exogenous RA in the absence of TGF-β was unable to induce Treg 
generation in vitro, the effects of this molecule seem to require TGF-β. In this regard, RA 
was recently shown to enhance smad3 phosphorylation and its nuclear translocation in 
Treg polarizing conditions (Nolting et al., 2009; Xiao et al., 2008). Nevertheless, RA was 
capable of augmenting the frequency of Foxp3+ cells in the absence of smad3 (Nolting 
et al., 2009).  Therefore, although RA may influence other aspects of TGF-β signaling in 
the absence of smad3, another plausible explanation is that RA signals complement the 
effect of TGF-β signals. Regardless of these interpretations, TGF-β appears requisite for 
the establishment of a baseline level of Foxp3 differentiation, in vitro, at least. 
  
 To determine the signaling pathway utilized by RA to induce this outcome, naïve 
CD4+ T cells deficient in retinoic acid receptor alpha (Rara), beta (Rarb), or gamma 
(Rarg), respectively, were incubated with WT SpDC in Treg polarizing conditions, with or 
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without RA. Strikingly, only in the absence of RARα did RA fail to enhance the frequency 
of Foxp3+ T cells recovered in cocultures (Figure 11A). Indicative that RARα was an 
important transcriptional effector of RA driven pathways, α4β7 upregulation was also 
attenuated in the absence of this gene (Figure 11B). Not examined in these 
experiments was whether the effect of other isoforms, such as 9-cis RA, was also 
diminished in the absence of RARα. This form of RA, although not readily detected in 
vivo, was also shown to enhance Foxp3 generation (Mucida et al., 2007).  
 
Figure 11. RA signaling through RAR-alpha enhances Foxp3+ Treg generation.  
(A) Naïve CD4+ T cells from Rara, Rarb, or Rarg deficient mice and their WT littermates 
were cocultured at a 10:1 ratio with WT SpDC in Treg polarizing conditions, ± RA (10nM). 
Intracellular Foxp3 expression was assessed on day 5. Bars depict the average percent 
increase (of duplicate samples) in the proportion of Foxp3+ T cells recovered when 
cultured with RA. Percent increase was calculated based on the average frequency of 
Foxp3+ T cells recovered from duplicate wells cultured w/o RA. Error bars mark the high 
and low values. (B) α4β7 expression was measured on total CD4+ T cells after coculture. 
 
 50 
LpDC	  facilitate	  Foxp3	  induction	  via	  retinoic	  acid	  mediated	  signaling	  
  
 Exogenous RA in the presence of TGF-β in LpDC cocultures also increased the 
proportion of Foxp3+ T cells generated and diminished the intrinsic differences between 
CD103+ and CD103– subsets’ abilities to induce Treg (Figure 12A). Notably, in LpDC 
cultures containing the CD103+ subset, in which the frequency of Foxp3+ cells was 
already high, RA exerted a more dramatic effect on α4β7 than on Foxp3 expression. This 
suggested that the signaling pathways evoked by RA for the generation of Foxp3 and 
upregulation of α4β7 may differ, independent of their dependency on RARα, and that the 
effects of RA on the regulatory pathway is saturated at smaller concentrations of RA. 
Interestingly, addition of RA to CD103+ LpDC cocultures stimulated without TGF-β, in 
which a small frequency of Foxp3+ T cells was already induced, did not lead to the 
expansion of this population (data not shown), indicating that the endogenous level of 
RA is not the limiting component in these conditions. 
 
The accumulating data suggested that the capacity of LpDC to synthesize RA 
was, in part, responsible for Foxp3+ Treg induction observed in these cocultures. To 
address this hypothesis the synthetic RA receptor antagonists LE540 and LE135 (RAi) 
were added to LpDC cocultures in an attempt to block RA mediated signaling. 
Remarkably, the addition of 1µM each of these inhibitors inhibited Treg conversion by 
67% and 57% in CD103+ and CD103– LpDC cocultures, respectively (Figure 12A). 
Drawing from these data, we hypothesized that RA signals conveyed by LpDC 
synergized with TFG-β to favor Treg induction. In support of this, either blockade of TGF-
β or RA receptor signaling resulted in a significant decline of spontaneous αCD3 induced 
Treg induction by CD103+ LpDC, (87%, P < 0.0005 and 73%, P < 0.001, respectively) 
(Figure 12B).  
 51 
 
Figure 12.  RA production by LpDC is requisite for optimal Foxp3+ Treg induction.  
(A) Foxp3– CD4+ T cells were cocultured with both CD103± LpDC at a 10:1 ratio in Treg 
polarizing conditions. However, in some wells, RA (100nM), or the RA receptor 
antagonists (RAi), LE540 and LE135 were added. Cells were subsequently stained and 
assessed for α4β7 and eGFP fluorescence (Foxp3) by flow cytometry. (B) Foxp3– CD4+ 
T cells were cocultured with CD103+ DC and stimulated with αCD3 ± TGF-β neutralizing 
antibody (isotype IgG1) or LE540 and LE135. Error bars depict the s.e.m. of three 
independent experiments. Statistical significance was determined using the Student’s T 
test. ns = non significant; , P < 0.001.  
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Although RA receptor blockade prevented Treg generation in vitro, it remained 
unclear whether vitamin A metabolism was an essential mediator of Treg induction in the 
GALT upon antigen feeding. To begin to address this, a natural model of diet-induced, 
vitamin A insufficiency (VAI) was employed, in which mice no longer received vitamin A in 
their diet starting at day 14.5 in utero (Smith et al., 1987). At 10 weeks of age, these 
mice, which displayed normal gut histology and thymic T cell development (data not 
shown), were deficient in vitamin A and its derivative metabolites as evidenced by 
diminished α4β7 expression on CD44hi CD4+ T cells (Figure 13A). Moreover, the capacity 
of LpDC to synthesize RA, based on assessment of functional RALDH, was abrogated 
during VAI (Figure 13B). These data suggested that the metabolism of vitamin A in LpDC 
is controlled by a positive feedback loop. Further, they indicated that even in the event 
that residual vitamin A/metabolites lingered in the VAI host, LpDC would be unable to 
induce RA mediated signals during polarization.  
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Figure 13. RA synthesis is abolished in vitamin A deficient diet fed mice at 10 wks 
of age. 
 (A) Cell suspensions from Sp, mln and Lp of Ctl and VAI mice were stained for T cell 
markers, α4β7, and CD44 and analyzed flow cytometrically. α4β7 expression was then 
assessed on gated CD44hi CD4+ T cells. Bars depict the average values (n = 4 per 
group). Error bars depict the standard deviation (s.d.). , P < 0.001. (B) Lp cell 
suspensions from Ctl and vitamin A insuffient (VAI) mice were pooled (2 per group) and 
incubated with the functional RALDH probe. RALDH activity on LpDC was assessed by 
flow cytometry. The RALDH inhibitor, DEAB, shows the specificity of the probe.  
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To determine whether VAI mice retained the capacity to promote GALT Treg generation 
upon antigen feeding, Foxp3–Ly5.2+ T cells from Foxp3eGFP X OT-II Tg mice were 
adoptively transferred into Ly5.1+ VAI recipients. As expected, after 5 days of OVA 
feeding, an appreciable frequency of transferred cells adopted Foxp3 in the Lp of mice 
fed a vitamin A sufficient diet (control – Ctl) (Figure 14A). In contrast, transferred cells 
failed to upregulate Foxp3 in any of the tissues analyzed in VAI hosts, including the Lp, 
Sp and mln (Figure 14A-C). This outcome was unlikely due to a defect in antigen 
presentation, as CFSE labeling indicated that OVA specific cells readily divided in 
response to OVA feeding. Nevertheless, despite the breakdown of this pathway, thymic 
Foxp3+ Treg development appeared grossly unimpaired in VAI animals (Figure 15A-B). 
Taken together, these results unequivocally reveal a requirement for vitamin A in GALT 
Treg induction in vivo. 
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Figure 14. Vitamin A insufficiency results in diminished GALT Foxp3+ Treg 
induction.  
(A) CD45.1+ WT and VAI mice were intravenously injected with CFSE labeled, sorted 
CD45.2+ Foxp3– OTII transgenic T cells and fed OVA antigen in their drinking water for 5 
consecutive days. Transferred cells were assessed in the Sp, mln, and Lp for de novo 
expression of intracellular Foxp3 via flow cytometry. Representative dot plots gated on 
CD45.2+ CD4+ T cells show Foxp3 as a function of CFSE.  (B) Summary of the 
frequency Foxp3 expression in transferred cells. (C) Summary of the absolute number of 
induced Foxp3+ Treg. Error bars illustrate the s.d. Statistical comparisons were performed 
using the unpaired Student’s t test , P < 0.05; , P < 0.01; , P < 0.001, ns = not 
significant. n = 3-4 mice per group.  
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Figure 15. CD4+ T cell development appears normal in VAI mice.  
(A) Thymic CD4 and CD8 profile of Ctl and VAI mice at 10 wks of age. Absolute number 
of CD4 single positive cells is displayed above each dot plot. n = 4 mice per group. (B) 
Cells were fixed and intracellularly stained for Foxp3. Dot plots illustrate CD25 versus 
Foxp3 expression upon gating on viable CD4+ cells. The frequency of Foxp3+ cells is 
summarized on the right-hand side. Each dot represents and individual mouse.  
 
 
 
 57 
Discussion	  
 
The data herein demonstrate that the GALT environment is able to promote the 
de novo generation of Foxp3+ Treg. Specifically, the findings described reveal that DC 
from the small intestinal lamina propria are uniquely endowed with the capacity to induce 
Foxp3+ Treg in vitro via a mechanism that, in addition to TGF-β, is dependent on the 
vitamin A metabolite, retinoic acid. Underscoring the relevance of this pathway for the 
development of peripheral Treg in vivo, mice devoid of RA are unable to induce Treg in 
the GALT upon antigen feeding.  
 
The induction of oral tolerance has been linked to a number of immunoregulatory 
processes, including: the polarization of TGF-β (TH-3) and IL-10 (TR-1) producing T cells, 
clonal deletion in the periphery, and more recently, the upregulation of Foxp3+ mRNA, 
which is essential for the programming of Foxp3+ Treg cell function (Chen et al., 1995; 
Chen et al., 1994; Gavin et al., 2007; Lin et al., 2007; Mucida et al., 2005). It is now clear 
that Foxp3 protein expression is acquired, as well, during this process (Coombes et al., 
2007; Sun et al., 2007). The high frequency of Foxp3+ Treg, sometimes exceeding 20%, 
detected within the small bowel Lp suggests that this site may serve as a niche for this 
population of cells. Lending support to this hypothesis, this lab has demonstrated using a 
lymphopenic transfer model that induced Foxp3+ Treg preferentially accumulate in the Lp 
(Sun et al., 2007).  
 
Based on the capacity of LpDC to induce Foxp3+ Treg, compounded with the high 
frequency of these cells that was recovered from the Lp, one interpretation is that de 
novo Foxp3 production occurs in situ. However, this possibility is unlikely for several 
reasons:   
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1. Naïve cells are rarely present in the intestinal tissue (<5% based on CD44 
and CD62L staining, data not shown).  
2. Though not tested on naïve T cells per se, Foxp3 could not be induced in 
CD4+ T purified from the Lp. Regardless, it would be worthwhile to repeat 
this experiment with Lp T cells that were isolated based on expression of 
naïve surface markers. 
3. From a kinetic standpoint, impressive Foxp3 induction initially occurred in 
the mln and Pp. One caveat of these findings, however, is that the 
adoptive transfer system that was used for these experiments involved 
the injection of 1x106 OT-II T cells or less. As such, it was difficult to 
identify transferred OTII cells within the Lp shortly after transfer (i.e. within 
36 hrs).  
4. Removal of the mesenteric lymph nodes or genetic disruption of the 
ability of LpDC to migrate into them was previously demonstrated to 
abrogate oral tolerance induction (Worbs et al., 2006). 
 
It was recently revealed that the CD103+ LpDC population is the predominant migratory 
subset of CD11c+MHCII+ cells within the intestinal Lp and is much more efficient than the 
CD103– subset at polarizing T cells (Bogunovic et al., 2009; Schulz et al., 2009). Thus, 
whether the CD103– subset plays a physiological role in GALT Foxp3+ Treg generation 
and maintenance of oral tolerance is unclear. Based on their capacity to promote Treg in 
vitro in the presence of exogenous TGF-β, as well as their capacity to efficiently take-up 
antigen (Schulz et al., 2009), it’s plausible that these cells could act to maintain or 
propagate de novo generated Foxp3+ cells. Arguing in favor for such a role, 
F4/80+CD11c+CD11b+ cells, i.e. surface markers, which correspond to the CD103– 
subset, were shown to prevent T cell mediated transfer colitis via IL-10 production and 
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the maintenance of the Foxp3 Treg (Murai et al., 2009). Intriguingly, another study 
described a macrophage-like subset, which expressed low/negative levels of CD11c, 
and potently induced Foxp3+ Treg generation in vitro via IL-10 (Denning et al., 2007). 
These cells were also found to express message for RALDH2 enzyme. 
 
Although the antigen-feeding model employed in these assays favors the 
emergence of Treg in the GALT, this protocol in other studies has been shown to limit 
airway inflammation in a Foxp3 dependent manner (Curotto de Lafaille et al., 2008), 
underscoring the circulatory capacity of these induced regulatory cells. Moreover, 
suggestive that a similar tolerogenic process occurs in tissues that are in contact with 
other natural sites of opportunistic entry, such as the nasal cavities, intranasal 
administration of antigen also was revealed to curb airway inflammation. It would be 
interesting to examine whether Foxp3+ Treg induction in this system also depends on 
vitamin A metabolism. Interestingly, RA was recently demonstrated to limit airway 
responses in a model of allergic asthma; however, the cellular-source of RA responsible 
for these effects was not clear, nor was the dependency on Foxp3+ Treg induction 
(Goswami et al., 2009).  
 
Indeed, the capacity to synthesize RA is not restricted to GALT DC. For example, 
epithelial cells are also endowed with this feature (Iwata et al., 2004). More recently, it 
was revealed that the stroma of the mesenteric lymph nodes also share this capability 
(Hammerschmidt et al., 2008). In fact, in elegant surgical experiments, this capacity was 
demonstrably essential for the effective upregulation of α4β7 and CCR9 on newly 
activated T cells upon antigen feeding. This finding indicates that, rather than merely 
serving as a collecting reservoir for migrating LpDC, the mln may actively participate in 
the fates of activated T cells. In this regard, it would be of interest to test how selective 
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ablation of RA synthesizing capacity in the mln stroma would effect Foxp3+ Treg induction 
and development of oral tolerance.  
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RA	  and	  TGF-­‐β :	  partners	  in	  oral	  tolerance	  
 
While the potential participation of other sources of RA in the induction and 
regulation of GALT Foxp3+ Treg generation remains enigmatic, the importance of 
vitamin A metabolism in this process is unequivocal. Thus, VAI mice that are devoid of 
vitamin A and its metabolites were unable to support the differentiation of Foxp3+ Treg in 
response to antigen feeding. Based on this finding, a reasonable question to test is 
whether oral tolerance is also hindered in these animals. Nevertheless, the manifold 
problems that accompany VAI may confound the interpretation of such experiments. 
Rather, with consideration to the importance of RA/RARα driven signals in Foxp3+ Treg 
generation in vitro, it may be more straightforward to test the requirement of RARα by T 
cells in this process in vivo and its significance in oral tolerance induction. However, this 
experiment would first require crossing Rara–/– mice to OTII transgenic mice.    
 
Although vitamin A metabolism is essential for GALT Foxp3+ Treg generation, it is 
not sufficient. TGF-β signaling was also critical for the capacity of LpDC to induce Foxp3 
in CD4+ T cells in vitro. This point was illustrated in experiments using αTGF-β mAb. 
This finding, however, was not altogether surprising, as virtually every report detailing 
the peripheral requirements for the generation of CD25+ or Foxp3+ Treg, both in vitro and 
in vivo, has noted the critical involvement of TGF-β (Chen et al., 2003; Fantini et al., 
2004; Kretschmer et al., 2005; Wan and Flavell, 2005). Nevertheless, this is the first 
demonstration that LpDC and their mln counterparts are capable to produce and/or 
process active TGF-β (Coombes et al., 2007; Sun et al., 2007). Indeed, in comparing DC 
subsets in the mln, Powrie and colleagues found that the CD103+ mlnDC subset was 
uniquely capable of expressing TGF-β related genes (Coombes et al., 2007). Further 
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highlighting the potential importance of this finding, it was recently demonstrated that the 
ability of DC to activate TGF-β on their surface via integrin alpha(v) is vital to the 
maintenance of intestinal homeostasis (Lacy-Hulbert et al., 2007; Travis et al., 2007). 
Assimilating these findings and putting them into context with the data reported above 
tempts speculation that the CD103+ LpDC population is selectively armed with this 
integrin. Importantly, CD103 expression on DC is important for protection against T cell 
transfer mediated colitis(Annacker et al., 2005), yet LpDC from animals genetically 
deficient in this marker are still capable of synthesizing RA (Jaensson et al., 2008). 
Thus, one possibility is that CD103 expression regulates the expression of alpha(v) 
integrins, potentially via cellular crosstalk, as CD103’s chief binding partner is E-
cadherin, which is broadly expressed throughout the GI tract. 
 
It is still unclear why RA acts merely as a cofactor with TGF-β to enhance Foxp3 
generation in vitro, yet seems absolutely required for Treg generation in the GALT. 
Perhaps this discrepancy could derive from alterations to the endogenous LpDC 
population in VAI mice that transcend a deficit in RA production. Related to this 
possibility, deficiency in vitamin A has been shown to alter the intestinal epithelial 
landscape, as well as mucous production (Cha et al.). Additionally, TGF-β activity may 
also be disrupted during VAI. Consistent with this possibility, a recent study showed that 
TGF-β production was impaired in follicular DC - which do not share their origin with 
hematopoietic DC - from Pp of VAI mice (Suzuki et al.). 
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Influence	  of	  environmental	  cues	  on	  Foxp3	  promoting	  capacity	  of	  LpDC	  
 
Importantly, changes in epithelial homeostasis may have broad implications on 
the conditioning of DC within the Lp. For instance, intestinal epithelial production of the 
cytokine, thymic stromal lymphopoietin (TSLP), was revealed to promote IL-10 secretion 
by DC and diminish their capacity to polarize a TH-1 response (Rimoldi et al., 2005) 
(Zaph et al., 2007). TSLP was also found to promote Treg induction in human thymic T 
cells via effects on DC maturation (Watanabe et al., 2005). In light of these discoveries, 
a potential role for TSLP in controlling the ability of LpDC to preferentially induce Foxp3+ 
Treg was evaluated. However, LpDC from TSLP receptor deficient (TSLPR–/–) mice were 
as competent as their WT counterparts at promoting high frequencies of Foxp3+ T cells 
in coculture (Figure 16). Moreover, these animals displayed no alterations in the 
frequency and absolute number of Foxp3+ Treg across several lymphoid and non-
lymphoid tissues (data not shown). Yet, it is still possible that other conditioning factors 
produced by epithelia contribute to the capacity of LpDC to drive a Foxp3 program.  
Highlighting this possibility, RA and TGF-β released from an intestinal epithelial line were 
 
Figure 16. TSLP signals are not 
required for the ability of LpDC 
to induce Foxp3+ Treg.  
Foxp3– cells were cultured with Sp 
or LpDC and stimulated in Treg 
polarizing conditions at a 10:1 
ratio for 5 days. Dot plots are 
gated on CD4+ cells and the 
percentages of Foxp3+ cells are 
shown.  
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shown to confer RA synthesizing capacity, CD103 and active TGF-β in conditioned bone 
marrow DC (Iliev et al., 2009). Alternatively, LpDC may receive environmental cues from 
other cells within the lamina propria. For example, GM-CSF secreted from an F4/80 
(macrophage like) population was proposed to potentiate RA synthesizing capacity in 
LpDC (Yokota et al., 2009).  
 
In summary, the data provided here suggest that the intestinal immune system, 
through the simultaneous production of TGF-β and RA, has evolved a self-contained 
strategy to promote Foxp3+ Treg induction. The dual necessity for these factors would 
likely restrict this process to lymphatic sites draining tissues that reside in close contact 
with opportunistic points of entry, such as the gastrointestinal, nasopharyngeal, and 
possibly the urogenital tract. Notably, in response to antigen feeding, Foxp3+ induced 
cells were found to preferentially accumulate in the Lp tissue and were detected less 
commonly in the draining mln. This may be a reflection of the sentinel role played by 
these cells, which could facilitate their rapid deployment into tissue. In this regard, it 
deserves mention that a recent and elegantly conducted study, which compared TCRα 
sequences across various CD4+ T cell subsets in an effort to correlate TCR specificity 
with peripherally versus thymically generated Foxp3+ Treg, concluded that the frequency 
of peripherally generated Foxp3+ Treg was quite low (Lathrop et al., 2008). However, 
several caveats in this study may have led to an underestimation of the contribution of 
peripherally induced Foxp3+ T cells to the Foxp3+ Treg repertoire. First, the mice used for 
analysis possessed a fixed TCRβ chain, so only alpha rearrangements could occur. 
Second, the authors did not evaluate Foxp3+ Treg and non-Treg repertoires in tissue sites, 
where the data described here would predict most of the induced Treg reside. Thus, 
based on a high probability that the thymus and gut, as well as other tissues exposed to 
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non-sterile environments maintain a degree of non-overlapping antigen repertoires, it is 
plausible that peripheral Foxp3+ Treg generation potentially expands the Foxp3+ Treg 
repertoire. 
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CHAPTER	  3:	  Commensal	  DNA	  limits	  peripheral	  Foxp3+	  Treg	  generation	  and	  
is	  an	  adjuvant	  of	  intestinal	  immune	  responses	  
 
Abstract:	  
 
The intestinal tract is in intimate contact with the commensal microbiota. Yet, how 
commensal signals communicate with cells in this tissue to ensure immune homeostasis 
is still unclear. In addition, the importance of these signals in the regulation and 
generation of mucosal immune responses has not been amply investigated. Continuing 
from findings described in Chapter 2, this study begins with an assessment of the 
influence of commensal components on the Foxp3+ Treg polarizing capacity of DC from 
the intestinal lamina propria. Remarkably, only TLR9 engagement was found to have a 
significant impingement on the induction of Foxp3+ Treg. Pairing these findings with work 
initiated by Dr. Nicolas Bouladoux, resulted in a collaborative effort (each figure that was 
a collaboration is indicated by an (*)), which produced the following data: 
 
1. TLR9 stimulation of LpDC limited Foxp3+ Treg generation in favor of the 
generation of Teff equipped with mucosal homing capacity. 
2. Commensal microbiota derived DNA (gfDNA) was a natural TLR9 ligand 
that impaired Foxp3+ Treg generation  
3. TLR9−/− mice experienced dysregulated Treg/TH homeostasis in the GI tract, 
and displayed an expansion of Foxp3+ Treg that contributed to impaired 
mucosal T cell responses following oral infection with 
Encephalitozoon cuniculi.   
4.  gfDNA was a natural adjuvant of mucosal TH responses. 
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Rationale: 
 
The ability of the gastrointestinal tract and its associated lymphoid tissues to 
support the induction Foxp3+ Treg may help curb untoward responses to dietary, floral 
and environmental antigens, which otherwise put the host at risk for allergic 
hyperresponsiveness and tissue damage (Curotto de Lafaille et al., 2008).  Yet this 
mode of regulation, as well as others that are constitutively supported in this tissue must 
be tempered in order to avoid compromising effective immunity. Commensal and 
pathogenic microbes routinely reveal and radio their presence to the host immune 
system through conserved ligands that are cardinal features of microorganisms, which 
commonly signal through the toll like family of receptors (TLR) and subsequently through 
the adaptor protein, Myd88 (Sansonetti and Di Santo, 2007) (Medzhitov et al., 1998). 
These signals positively regulate the sampling of luminal content by DC in the underlying 
Lp tissue (Chieppa et al., 2006; Niess and Reinecker, 2005), indicating that LpDC 
constitutively “sense” commensals and dietary antigen. Indeed, the constant exposure of 
the intestinal immune system to flora and its constituent ligands provides a rationale to 
consider the physiological impact of TLR signaling not just on GALT Treg generation, 
maintenance and regulation, but more broadly in the control of T cell homeostasis in this 
region. Such an understanding will be critical to unraveling how regulatory thresholds are 
set and overcome in the control of host tissue immunity.  
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Results:	  
TLR9	  signaling	  limits	  LpDC	  mediated	  Foxp3+	  Treg	  induction	  in	  vitro.	  	  
 
To begin to address how the commensal flora may influence peripheral Foxp3+ Treg 
induction in the GALT, LpDC were cocultured with naïve CD4+ T cells in Treg polarizing 
conditions and exposed to various purified and synthesized TLR ligands. With intent to 
avoid direct responses of the T cells to TLR stimulation, T cells from Myd88 deficient 
mice were used for these experiments. LpDC were revealed to express weak to 
undetectable levels of TLRs 2 and 4, yet readily expressed message for TLRs 5 and 9 
(Uematsu et al., 2008). Thus, the addition of peptidoglycan (PGN), or lipopolysaccharide 
(LPS), which engage TLRs 2 and 4, respectively, only marginally affected the outcome 
of Foxp3+ T cell generation in coculture (Figure 17A). The addition of flagellin (Flgn), 
which engages TLR5 (Uematsu et al., 2006), also had no obvious effect on Foxp3+ Treg 
induction even at a high input concentration, raising the possibility that TLR5 expression 
may vary depending on the animal facility in which the mouse is reared. Conversely, the 
addition of ODN1826 (CpG), which stimulates cells through TLR9, resulted in a potent 
reduction in the frequency of Foxp3+ Treg recovered at the end of coculture (Figure 17A-
B). This inhibition was observed at CpG doses equal to or exceeding 100ng/ml (Figure 
17A-B). Analysis of α4β7 revealed that rather than being inhibited, the expression of this 
retinoic acid signaling dependent integrin was increased, most notably on the Foxp3 
negative population (Figure 17C). Consequently, the tolerogenic and homing effects of 
RA are decoupled in the presence of a strong adjuvant, such as CpG.   
 
Cells that failed to up-regulate Foxp3 had potentially outgrown Treg cells in CpG 
stimulated cocultures. To assess this, naïve TLR9−/− T cells were CFSE labeled prior to 
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culture. However, gating on the Foxp3– cells indicated that they proliferated comparably 
in both CpG stimulated and non-stimulated cocultures (Figure 17D). The next question 
was whether TLR9 signaling could inhibit naïve T cell up-regulation of Foxp3 during 
differentiation. In fact, even before Foxp3 cells had undergone a single division, their 
frequency was reduced 50% in cocultures containing CpG.  
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Figure 17. TLR9 signaling inhibits LpDC induced Foxp3+ Treg generation.  
(A) FACS-sorted naïve CD4CD25–CD44lo T cells isolated from myd88–⁄– mice were 
cultured in Treg polarizing conditions with WT LpDC at a 10:1 ratio in the presence of the 
indicated TLR ligand for 5 days. PGN (TLR2), LPS (TLR4), Flgn (TLR5) or CpG (TLR9) 
was added at a starting concentration of 2 µg/ml, 10 µg/ml, 1 µg/ml or 10 µg/ml, 
respectively. Two subsequent five-fold dilutions of each ligand were tested (wedge). 
Results were then normalized to the frequency of Foxp3+ T cells generated in Treg 
polarizing conditions without TLR ligands Cross bars indicate the high and lows of 
duplicate cultures. (B) Dosage effect of CpG on LpDC induced Foxp3+ Treg generation. 
(C) Same as in A. Dot plots are gated on viable CD47-AAD– T cells and illustrate α4β7 
versus Foxp3 expression following culture with or without CpG (10 µg/ml). (D) Naïve 
CD4CD25−CD44lo T cells were isolated from TLR9−/− mice, labeled with CFSE, and 
cultured as in A. CFSE dilution was assessed as a function of Foxp3 at the indicated 
time points. Histogram overlay of CFSE dilution profiles for CD4Foxp3– T cells, 
indicated in the boxed in regions (solid line: control; dotted line: in presence of CpG).  
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TLR9	  signaling	  promotes	  TH	  cell	  differentiation	  in	  lieu	  of	  Foxp3
+	  Treg.	   
 
CpG stimulation of LpDC was found to induce their production of proinflammatory 
cytokines, including: IL-6, IL-12p40, and TNF-α (Figure 18A). The IL-12p40 subunit can 
form a heterodimer with IL-12p35 to comprise IL-12 or with IL-23p19 to comprise IL-23; 
however, these cytokines were not examined in these experiments. IL-27 was also not 
examined, although it deserves mention that LpDC have been shown to express both of 
the subunits comprising this cytokine, EBI3 and IL27p28 at steady-state (Oldenhove et 
al., 2009). Nevertheless, in comparison to other TLR stimuli, CpG was the only one that 
induced a strong proinflammatory cytokine profile by LpDC (Figure 18B). Consequently, 
in place of Foxp3, TLR9 activated LpDC differentiated naïve T cells into TH capable of IL-
17A, IFN-γ as well as IL-4 secretion (Figure 19). Thus, coupled with its ability to induce 
α4β7, TLR9 stimulation of LpDC may help shape Treg/TH composition throughout the 
GALT.  
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Figure 18. TLR9 stimulation of LpDC promotes robust pro-inflammatory cytokine 
production.  
(A) 5x104 FACS purified LpDCs were stimulated over night in the presence or absence 
of CpG (1 µg/ml) in complete media supplemented with 40 ng/ml of GM-CSF. 
Supernatants were assessed for cytokines by ELISA. (B) Lp cell suspensions were 
stimulated with the indicated TLR ligands (1µg/ml) for 4 hrs and subsequently surface 
stained with CD11b, CD11c, Class II, F4/80, and fixable live/dead dye. Upon 
fixation/permeabilization, cells were stained intracellularly for IL-6, IL-12p40 and TNF-α. 
Counter plots are gated on CD11chi and CD11chi CD11b+ cells. 
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Figure 19. TLR9 stimulated LpDC induce Teff 
programs in Foxp3+ Treg polarizing conditions.  
CD4 CD25–CD44loFoxp3– T cells from Tlr9–⁄– 
Foxp3eGFP mice were cultured in Treg polarizing 
conditions in the presence or absence of CpG for 
5 days and then restimulated with PMA + 
ionomycin for assessment of intracellular cytokine 
production. Cytokine percentages in bordered 
regions are expressed as a percentage of viable 
CD4 cells. 
 
 74 
TLR9	  signaling	  abrogates	  Foxp3+	  Treg	  generation	  through	  undefined	  innate	  
pathways	  	  
 
Among the innate cytokines, IL-6 and IL-27 were previously reported to potently 
inhibit Foxp3+ Treg generation in vitro (Bettelli et al., 2006; Korn et al., 2007). Depending 
on the conditions and source of costimulation, IL-12 was shown to have a marginal to 
moderate negative impact on Treg polarization (Bettelli et al., 2006; Wei et al., 2007), 
while IL-23, had a minimal influence (Izcue et al., 2008). To test the relative significance 
of TLR9-induced IL-6 production on the subversion of Foxp3+ Treg induction, IL-6 
signaling was blocked with anti-receptor and neutralizing Abs (αIL-6) or bypassed with 
LpDC genetically deficient for IL-6 (Il-6−/−). While both of these measures curbed IL-17A 
production, neither was sufficient to reverse the effect of TLR9 stimulation on Treg 
inhibition (data not shown and Figure 20A). Additional blockade with antibody against 
IL-27p28 also failed to induce any appreciable rebound; nevertheless it is important to 
note that the efficacy of this mAb was not confirmed for these assays (Figure 20A). 
Assuming that αIL-27 reduced IL-27 signaling in the assays described, these data 
indicated that TLR9 signaling hindered the capacity of LpDC to induce Foxp3+ Treg 
through complex innate pathways. In this regard, the group that showed that IL-23 was 
unable to inhibit Foxp3+ Treg induction in vitro more recently showed that the IL-23R was 
a cell intrinsic regulator of the differentiation/accumulation of Foxp3+ Treg in vivo (Ahern et 
al.). As such, IL-23 signaling may negatively regulate Foxp3+ 
differentiation/accumulation in concert with other cytokines. Although further addition of 
an Ab directed against IL-12p40, which has been validated to block both free IL-12p40 
and the IL-12 heterodimer, in cocultures containing Il-6−/− LpDC also failed to relieve 
Foxp3 inhibition, the efficacy of this Ab against IL-23 has not yet been tested (Figure 
20A). In light of the effectiveness of Abs directed against αIL-6/αIL-6R, it may be 
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worthwhile in the future to perform these experiments with LpDC obtained from 
IL12p40−/− mice. 
 
Intriguingly, blockade of IL-6 treatment consistently enhanced IFN-γ, IL-4, and IL-10 
production (Figure 20B). While IL-10 was recently demonstrated to only slightly reduce 
the frequency of Foxp3+ T cells generated in Treg polarizing conditions (Bettelli et al., 
2006), IFN-γ and especially IL-4, were revealed to antagonize Foxp3+ Treg generation in 
a Stat1 and Stat6 dependent manner, respectively (Wei et al., 2007). Moreover, 
enforced expression of TH-1 and TH-2 transcription factors was sufficient to effect this 
inhibition in the absence of these cytokines.  These findings coupled with the cytokine 
modulation that occurred in the face of IL-6 blockade indicated that deviation towards TH-
1 and TH-2 programs, in addition to TH-17, was potentially complicit in TLR9-induced 
Foxp3 inhibition. In accord with this hypothesis, the addition of neutralizing Abs against 
both IL-4 and IFN-γ, in addition to αIL-6, resulted in a ~70% rebound in the frequency of 
Foxp3+ Treg cells (Figure 21A and B). IL-4 neutralization drove a greater rebound in the 
frequency of Foxp3+ T cells at the end of culture than IFN-γ neutralization. 
Complementing these data, addition of each of these cytokines blocked LpDC-induced 
Foxp3 development in a dose dependent fashion, where IL-6 exerted the most potent 
inhibition at all concentrations tested. Notably, suppression was further enhanced when 
the cytokines were combined (Figure 21C). These data demonstrated that TLR9 
activation overrode preferential Treg induction via non-specific TH programming. 
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Figure 20. TLR9 stimulated LpDC redirect polarization of T cells in Foxp3+ Treg 
polarizing conditions via multiple innate pathways. 
 (A) CD4CD25–CD44loFoxp3– T cells from Tlr9–⁄– Foxp3eGFP mice were cocultured with 
LpDCs purified from WT or IL-6−/− mice for 5 days. In wells where CpG (10µg/ml) was 
added, the effect of various cytokine blocking Abs was assessed, including: αIL-27p28 
and αIL-12p40/p70. Each condition was tested in triplicate. (B) Supernatants from 
cocultures in A were assayed for IL-4, IFN-γ and IL-10 by ELISA. Error bars depict the 
s.e.m. (#, sample was tested in duplicate; , P <0.01; , P <0.001).    
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Figure 21. Partial rescue of Foxp3 development in the face of TLR9 activated 
LpDCs.  
(A) Naïve CD4CD25–CD44lo T cells from Myd88−/− mice were cultured in Treg polarizing 
conditions for 5 days in the presence or absence of CpG (10µg/ml). In wells containing 
CpG, antibodies to IL-6 and IL-6 receptor α (αIL-6), IL-4 (αIL-4) and IFN-γ (αIFN-γ) were 
added at the start of culture as indicated. Bracketed areas indicate the percentage of 
Foxp3 cells. (B) Summary of results in A normalized to baseline Treg induction. 
Crossbars represent the high and lows of conditions cultured in duplicate. (C) Blockade 
of LpDC induced Foxp3+ Treg generation by IL-6, IL-4 and IFN-γ. Naïve CD4CD25–
CD44lo T cells were cocultured with LpDCs in Treg polarizing conditions. Various doses of 
IL-6, IL-4, IFN-γ or a combination of all 3 cytokines were added at the start of culture. 
Cytokine concentration is shown on the x-axis. In wells containing cytokine 
combinations, the same concentration of each cytokine was used. 
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Engagement	  of	  TLR9	  by	  commensally	  derived	  gut	  flora	  DNA	  inhibits	  Foxp3+	  Treg	  
induction	  in	  vitro	  	  
 
TLR9 recognizes unmethylated CpG dinucleotides, which are abundant in the DNA 
of various prokaryotic species populating the GI tract (Dalpke et al., 2006). To test 
whether physiological ligation of TLR9 influenced LpDC in a manner similar to CpG, 
DNA was extracted from the gut content of caeca (gfDNA) and colons in naïve C57BL/6 
mice and added to LpDC cocultures in Foxp3+ Treg polarizing conditions. In the absence 
of a defined sequence length for gfDNA, a control condition to guarantee cellular uptake 
was also included. In this condition, gfDNA was complexed to the monocationic lipid 
transfection reagent, DOTAP, prior to stimulation (Bucci et al., 1992). Notably, 
cathelicidins, which are a family of cationic antimicrobial peptides secreted by intestinal 
epithelial cells, and innate cells, including neutrophils and macrophages, may serve a 
physiologically analogous role to DOTAP, by virtue of their ability to package DNA 
(Lande et al., 2007), Regardless of whether DOTAP was present, gfDNA consistently 
and significantly reduced the frequency of Foxp3+ Treg recovered from culture, and 
upregulated α4β7 on Foxp3− cells (Figure 22A-B). This effect was abolished when 
purified LpDC from Tlr9−/− mice were used, demonstrating that gfDNA targeted TLR9. 
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Figure 22. DNA enriched from the gut flora prevents Foxp3+ Treg production in a 
TLR9 dependent manner.  
(A) Naïve CD4CD25–CD44lo T cells isolated from WT or Tlr9–⁄– mice were cultured in 
Treg polarizing conditions with LpDC from WT or Tlr9–⁄– mice, respectively. In some 
culture wells, CpG (10µg/ml), DNA enriched from murine gut flora (gfDNA) or gfDNA 
formulated with the cationic liposome, DOTAP, was added (DO_gfDNA). (A) Foxp3 and 
α4β7 expression was analyzed on day 5. Dot plots are gated on viable CD4+ cells. (B) 
Summary of results from A (normalized to the baseline Treg frequency. Error bars 
represent the s.e.m. of triplicate cultures (, P <0.01; , P <0.001).  
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TLR9	  signaling	  regulates	  Foxp3+	  Treg/TH	  cell	  ratio	  in	  intestinal	  tissues	  
 
The preceding data suggested that gfDNA/TLR9 signaling contributed to T cell 
homeostasis in the GALT. To test this hypothesis, Foxp3+ Treg populations were first 
assessed in various tissues of naïve Tlr9−/− and WT mice. Strikingly, Tlr9−/− mice 
displayed greater percentages and absolute numbers of Foxp3+ Treg cells than their WT 
counterparts throughout the GALT, including the intestinal epithelial lymphocyte (IEL), 
small intestinal Lp, and Peyer’s patch (Pp) compartments (Figure 23A-C). This trend did 
not extend to the mesenteric lymph nodes (mln), nor was it observed outside of the small 
intestinal compartment. To exclude the possibility that these findings arose due to 
distinct commensal populations residing within these animal strains, these differences 
were assayed and reconfirmed in animals that were co-housed for several weeks (data 
not shown). Importantly, the selective expansion of Foxp3+ Treg in the GALT was 
observed in chimeric WT mice reconstituted with Tlr9−/− bone marrow, while it was 
reversed in chimeric Tlr9−/− mice reconstituted with WT bone marrow (Figure 23D). 
These data demonstrated that the hematopoietic compartment controlled Foxp3+ Treg 
homeostasis in the GALT. Further, based on the previous in vitro experiments, it was 
plausible that this likely occurred, at least in part, via constitutive gfDNA/TLR9 
interactions in LpDC.  
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To further probe how constitutive TLR9 signaling shaped the T cell landscape in the GI 
tract, Lp tissue cell suspensions, in which most conventional αβ T cells are of the CD4+ 
lineage, and IEL tissue cell suspensions, in which a majority are of the CD8+ lineage, 
from both WT and Tlr9−/− mice were restimulated with phorbol 12-myristate 13-acetate 
(PMA) and ionomycin, and then analyzed for cytokine production. In Tlr9−/− mice, a 
significant reduction in both the frequency and absolute number of IL-17A and IFN-γ 
producing cells was observed in the Lp compartment, while IL-10 was less affected 
(Figure 24A-B). A similar reduction in the frequency and absolute number of IFN-γ 
producing cells was also observed in the IEL of Tlr9−/− mice (Figure 24A-B). Thus, the 
loss of TLR9 signaling in the GI tract resulted in disequilibrium of T cell subset 
distribution within this tissue, culminating in an expansion of Foxp3+ Treg cells and a 
concomitant reduction in TH cells. 
 
Figure 23. (*) Hematopoietic derived TLR9 signals regulate Foxp3+ Treg 
homeostasis in the gastrointestinal tract during steady-state.  
(A) Comparative assessment of CD4Foxp3 Treg cells in the spleen (Sp), mesenteric 
lymph node (mln), intestinal epithelium lymphocyte (IEL), intestinal lamina propria (Lp) 
and Peyer’s patch (Pp) compartments of age-matched naïve WT and Tlr9–⁄– mice. Cells 
gated on CD4 and TCR-β were analyzed for expression of Foxp3 and CD25 by flow 
cytometry. Numbers in quadrants refer to the percentage of each subset. (B) Summary 
of Treg frequencies in naïve WT (closed circle) and Tlr9–⁄– (open circle) mice. cLp = colon 
lamina propria. Each dot represents the results from one experiment (three mice pooled 
per group). Crossbars depict the mean of three independent experiments. (C) Same as 
B, but a summary of the absolute number of Treg. (D) Frequency of Foxp3 Treg was 
analyzed in various tissues of BM chimeric mice, in which the hematopoietic or the non-
hematopoietic compartment lacked TLR9 expression. CD45.1+ cells were gated on CD4 
and TCR-β, and then analyzed for Foxp3 expression. (, P <0.05; , P <0.01; , P 
<0.001) 
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Figure 24. (*) TLR9 signaling contributes to the basal TH tone of the GI tract.  
(A) Thy 1.2 enriched cells from the Lp and IEL compartments were stimulated with 
PMA+ionomycin, and then stained intracellularly for IL-10, IL-17 and IFN-γ. Cytokine 
percentages in bordered regions are expressed as a percentage of CD4 cells. (B) A 
summary of the absolute numbers of CD4 and/or CD8α T lymphocytes expressing 
IFN-γ and IL-17 in naïve WT (closed circle) and Tlr9−/− (open circle) mice. Each dot 
represents a single mouse and each bar delineates the mean. (, P <0.05; , P <0.01; 
, P <0.001). 
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TLR9	  signaling	  is	  requisite	  for	  optimal	  responses	  to	  oral	  infection	  	  
 
The profound influence of constitutive TLR9 signaling on the activation status of 
T cells within the GI tract suggested that gfDNA/TLR9 interactions played a potential role 
in establishing and amplifying protective immunity to pathogenic encounters in the 
GALT. To test this, Tlr9−/− and WT mice were infected with the obligate intracellular 
fungal parasite, Encephalitozoon cuniculi, (E. cuniculi), which naturally infects its host 
through the alimentary tract and belongs to the microsporidia phylum (Didier, 2005).  In 
addition to the oral route, E. cuniculi induces a productive TH-1 response following 
intraperitoneal (IP) challenge (Khan and Moretto, 1999; Moretto et al., 2004). To assess 
whether any systemic priming defects were present in Tlr9−/− mice, animals were first 
inoculated with E. cuniculi IP Measurement of the cardinal TH-1 cytokine, IFN-γ, following 
in vitro antigen recall on day 11 of infection demonstrated that Tlr9−/− mice mounted 
immune responses that were comparable to their WT counterparts (Figure 25A). 
Parasite burdens were also similar between knockout and WT animals (Figure 25B). 
Together, these data indicated that systemic priming did not require TLR9 signaling. 
They further implied that TLR9 recognition of E. cuniculi was dispensable for triggering 
immunity to this parasite.  
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Figure 25. (*) Systemic priming and immunity to E. cuniculi is independent of 
TLR9 signaling.  
WT and Tlr9–⁄– mice were infected with 5×106 freshly isolated E. cuniculi spores i.p. 
(A) On day 11 of infection, pooled, single cell suspensions from various tissues were 
incubated in triplicate with uninfected (DC) or E. cuniculi-infected BMDC (inf. DC). 
ELISA was performed on supernatants 72 hrs later. Histograms depict the mean 
cytokine concentration ± s.d. (B) Measurement of parasite load in the duodenum and 
liver using quantitative real-time pcr. Each dot represents an individual mouse. n = 5 per 
group. Bars indicate the means. 
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In contrast to IP inoculation, oral inoculation with E. cuniculi produced a significantly 
different picture in Tlr9−/− and WT mice. Specifically, antigen specific IFN-γ and IL-17A 
production were severely impaired in the IEL and LP of Tlr9−/− mice, manifesting in 
defective parasite clearance both in the primary (duodenum) and dissemination (liver) 
sites of infection (Figure 26A-B). Consequently, systemic immune impairments, 
determined by splenocyte recall of IFN-γ and IL-17A production, were also observed 
(Figure 26A). There are numerous instances illustrating that inefficient control of 
parasitic infection can be a consequence of improper T cell polarization (Else et al., 
1994; Scott, 1991; Zaph et al., 2007). Nevertheless, although impaired TH-1 and TH-17 
responses were accompanied with higher systemic concentrations of IL-10 and IL-4, 
deviation towards a (TH-2) response was not observed in the GALT of Tlr9−/− mice 
(Figure 26C and data not shown).  
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Figure 26. (*) Immunity to oral infection with E. cuniculi is dependent on TLR9 
signaling.  
WT and Tlr9–⁄– mice were infected by gavage with 5×106 freshly isolated E. cuniculi 
spores. (A) On day 11 of infection, pooled, single cell suspensions from various tissues 
were incubated in triplicate with uninfected (DC) or E. cuniculi-infected BMDC (inf. DC). 
ELISAs for IFN-γ and IL-17 were performed on supernatants 72 hrs later. Histograms 
depict the mean cytokine concentration ± s.d. (B) Measurement of parasite load in the 
duodenum and liver using quantitative real-time pcr. Bars indicate the means. (C) Same 
as in A measuring IL-10 and IL-4. (# = not detected; n.s. = not significant; , P <0.01; 
, P <0.001). Each dot represents an individual mouse. n = 5 per group. 
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The	  expansion	  of	  GALT	  Foxp3+	  Treg	  in	  the	  absence	  of	  TLR9	  signaling	  contributes	  
to	  deficient	  mucosal	  immune	  responses	  	  
 
Increased Foxp3+ Treg cell frequencies within the intestinal tissue persisted in 
orally infected Tlr9−/− mice (Figure 27A). These cells have the capacity to negatively 
modulate the effector stages of infectious immunity through both antigen specific and 
non-specific means (Belkaid and Tarbell, 2009; Oldenhove et al., 2009; Shafiani et al.). 
Thus, it was possible that the enhanced number and frequency of Foxp3+ Treg in the GI 
tract contributed to the impaired TH response that ensued following oral inoculation with 
E. cuniculi. To address this hypothesis, WT and Tlr9−/− animals were treated with an 
antibody against CD25 (clone PC-61), an activation marker mainly restricted to Foxp3+ 
Treg during steady-state conditions (Fontenot et al., 2003; Khattri et al., 2003). This 
antibody was previously shown to reduce the absolute number of Foxp3+ Treg by as 
much as 50% in vivo and inhibit CD25 expression (Couper et al., 2007). Although CD25 
is also a hallmark of activated T cells, the depletion protocol employed for these assays 
consistently enhanced pro-inflammatory TH-1 cytokine production in both WT and Tlr9−/− 
mice, suggesting that bystander loss of TH cells did not pose a significant confounding 
element to consider in the interpretation of infectious outcomes in treated animals 
(Figure 27B). Strikingly, α-CD25 treatment markedly improved parasite clearance in the 
duodenum and liver of infected Tlr9−/− mice, while having no discernible effect in WT 
mice, in which parasite burdens were already relatively low (Figure 27C). While these 
data argue that the elevated proportion of Foxp3+ Treg (in the GI tract of Tlr9−/− mice) 
constituted a barrier to efficacious mucosal immunity upon oral challenge, Lp IFN-γ 
production was still reduced in α-CD25 treated Tlr9−/− animals in comparison to isotype 
Ab treated WT animals post-infection. Based on the low expression of CD25 on Treg in 
the Lp, one explanation was that α-CD25 failed to trigger sufficient depletion of these 
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cells in this tissue. The implication of this type of scenario could be that Foxp3+ Treg 
negatively regulate the amplitude and/or maintenance of TH responses in situ. However, 
a previous report demonstrated that TLR9 signaling in DC made TH resistant to Treg 
regulation (Pasare and Medzhitov, 2003), indicating that gfDNA/TLR9 interactions may 
also promote TH responses independent of Treg.  
 
Figure 27. (*) The expansion of Treg in the GI tract contributes to impaired mucosal 
immunity in the absence of TLR9.  
WT and Tlr9–⁄– mice were infected by gavage with 5×106 freshly isolated E. cuniculi 
spores. (A) On day 11 of infection, the percentage of CD4Foxp3 Treg cells in various 
tissues was assessed via flow cytometry. (B-C) Mice 3 days preceding and on day 0 and 
day 7 of infection were injected i.p. with αCD25 or isotype control Ab (Isot). (B) In vitro 
recall was performed as described in Figure 26A. Histograms depict the mean cytokine 
concentration ± s.d. (C) Measurement of parasite load in the duodenum and liver using 
quantitative real-time pcr. Each dot represents an individual mouse. n = 5 per group. 
(, P <0.05; , P <0.01; , P <0.001). 
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Gut	  flora	  DNA	  from	  conventional	  gut	  flora	  is	  a	  natural	  adjuvant	  of	  intestinal	  
immune	  responses	  
 
Taken together, the preceding in vitro and in vivo data suggested that 
commensal gfDNA engagement of TLR9 provided pro-inflammatory cues during both 
steady-state and pathogenic challenge, thereby promoting mucosal immunity. To test 
this, the impact of other gut floral signals in the GI tract were minimized by placing mice 
on a cocktail of antibiotics (ATB) (Rakoff-Nahoum et al., 2004), while LPS, CpG, or 
gfDNA was provided orally once per week. 6 wk into treatment, mice were orally infected 
with E. cuniculi. While the frequency and absolute number of CD4 and CD8 T cells 
remained comparable between all different treatment groups (data not shown), ATB 
treated mice mounted noticeably impaired IFN-γ and IL-17A responses in both the IEL 
and Lp compartments (Figure 28A). Paralleling these impairments, parasite burden was 
consistently elevated in ATB treated animals (Figure 28B). These data demonstrated 
that the commensal flora were required to promote and sustain mucosal immune 
responses. Providing back LPS (a TLR4 ligand) led to a restoration of the systemic 
immune response to E. cuniculi in ATB treated animals, based on the IFN-γ recall 
response in the spleen. However, this commensal product failed to boost the immune 
response in the small intestinal Lp (Figure 28C). As such, the parasite burden in LPS 
treated mice remained elevated and comparable to mice receiving ATB alone (Figure 
28B). In contrast, the addition of CpG induced a significant rebound in systemic cytokine 
production and propelled mucosal IFN-γ and IL-17A cytokine production to levels 
observed in control (Ctl) mice, which did not receive any ATB (Figure 28A and C).  
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This recovery of the mucosal response in CpG treated animals was also associated with 
a reduced parasite burden (Figure 28B). These data suggest that flora derived TLR9 
signaling is a significant driver of mucosal immunity. Nevertheless, ATB treating Tlr9−/− 
mice also resulted in a reduction in the mucosal immune response, confirming that other 
commensally derived components can amplify mucosal immune responses, either 
normally or through compensatory mechanisms when TLR9 signaling is deprived or 
disrupted (data not shown). Strikingly, gfDNA restored the mucosal response to E. 
cuniculi in WT ATB treated mice, but not in Tlr9−/− mice (Figure 28-B and data not 
shown). Thus, gfDNA functions as a natural TLR9 specific adjuvant of mucosal immune 
responses.  
Figure 28. (*) Gut floral DNA restores immune responses in commensally depleted 
mice orally infected with E. cuniculi.   
3 wk old mice received a commensal depleting antibiotic cocktail (ATB) in their drinking 
water for 6 weeks and, in tandem, received oral weekly treatments of PBS vehicle or 
100 µg of CpG, 500 µg gfDNA, or 25 mg/kg of lipopolysaccharide from Escherichia coli 
(LPS). Control mice received no ATB treatment. Mice were infected orally with 
E. cuniculi after 6 weeks of treatment. (A) On day 11 of infection, pooled IEL and Lp 
suspensions from each group were restimulated as previously described. Supernatants 
were assessed for IFN-γ and IL-17 by ELISA. Histograms depict the mean cytokine 
concentration ± s.d. (B) 8 wk-old mice were treated and infected as described in A. 
Parasite burden was evaluated in the duodenum and liver on day 11 of infection by 
quantitative real-time PCR. Each dot represents one mouse and each bar the mean of 
three or four mice analyzed (C) Cell suspensions from B were in vitro restimulated and 
IFN-γ production was measured by ELISA. n.s. = not significant; , P <0.05; , P <0.01; 
, P <0.001.  
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Discussion	  
 
The tissues of the GI tract are constantly exposed to TLR ligands harbored by 
the commensal gut flora (Pamer, 2007); yet how these interactions factor into the 
regulation and development of immunity in this region have not been investigated in 
depth.  The data revealed in this study, demonstrated that TLR9 stimulation, via gfDNA, 
antagonizes the Treg polarizing capacity of LpDC. As such, in the absence of natural 
TLR9 signals in vivo, the GI tract harbored an expanded frequency of Foxp3+ Treg and a 
concomitant reduction in TH, which in turn subdued the development of an efficient 
protective response upon mucosal challenge. Loss of TLR9 signaling in the 
hematopoietic compartment recapitulated this homeostatic dysregulation.  Strikingly, 
orally introduced gfDNA potently adjuvanted the mucosal response to infection with E. 
cuniculi, when signals from other gut floral compents were diminished. Altogether, these 
data highlight the importance of in situ signaling from gut floral components in the 
generation of protective immune responses at sites of mucosal challenge. 
Stromal	  vs	  hematopoeitic	  TLR9	  engagement	  	  -­‐	  controlling	  injury	  vs	  immunity	  
 
In contrast to hematopoeitic cells, which recognize TLR9 intracellularly (Ahmad-
Nejad et al., 2002; Latz et al., 2004), epithelia in the GI tract basally express TLR9 on 
their surface (Ewaschuk et al., 2007; Lee et al., 2006). Although intracellular 
compartmentalization was revealed as a prerequisite for TLR9 activation in antigen 
presenting cells (Ewald et al., 2008), physiologically acidic environments may confer 
functional activity to TLR9 expressed on epithelial surfaces. In this regard, epithelial 
driven TLR9 signals were shown to promote the expression of proteins that drive Paneth 
cell maturation and have the potential to regulate flora composition, thereby linking 
lumenal signals from gfDNA to intestinal homeostasis (Lee et al., 2006). Accordingly, the 
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absence of TLR9 led to exacerbated colitis induced by oral administration of the 
polysaccharride, DSS, which disrupts epithelial integrity and facilitates bacterial 
translocation (Lee et al., 2006; Okayasu et al., 1990). These findings were reminiscent of 
an earlier study, which revealed that commensal sensing by the intestinal epithelial 
compartment was essential for recovery from DSS induced colitis (Rakoff-Nahoum et al., 
2004).  Coupled with a study demonstrating the MyD88 dependece of Paneth cell 
mediated barrier protection (Vaishnava et al., 2008), these findings suggest that 
gfDNA/TLR9 interactions on the intestinal epithelia promote barrier protection and 
facilitate recovery from acute intestinal epithelial injury. 
 
While intestinal epithileal sensing of gfDNA appears to drive mucosal 
homeostasis through barrier repair and maintenance of tissue integrity, this function is 
distinct from gfDNA‘s impact on steady-state T cell equilibrium within the GI tissue. Thus, 
the absence of TLR9 expression in the hematopoeitic compartment was sufficient to 
promote Foxp3+ Treg expansion within the GI tract. Further, although the data were not 
presented here, this absence resulted in an attenuated immune response to oral 
infection with E. Cuniculi (Hall et al., 2008). The question then to arise from these 
findings is which hematopoeitic cells does gfDNA signal through to drive robust mucosal 
immune responses. In this study, LpDC were singled out: first, for their known function in 
initiating primary immune responses (Banchereau and Steinman, 1998); second, for 
their capacity to sense luminal bacterial components (Chieppa et al., 2006). Indeed, 
engaging LpDC with TLR9 ligands, including gfDNA, hindered their capacity to promote 
a Foxp3+ Treg program in Treg polarizing conditions, and instead could promote T cell 
differentiation into TH-17, TH-2 or TH-1 cells. This in vitro finding remarkably paralleled 
the differences in ex vivo activation statuses that was observed between CD4+ T cells 
isolated from the Lp of WT versus Tlr9−/− mice. Consistent with a role for LpDC in the 
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effector status of T cells in the GI tract, temporary ablation of LpDC via oral 
administration of diptheria toxin (DT) to mice expressing a Diptheria toxin receptor 
transgene under the control of the CD11c promotor (CD11c-DTR) was shown to reduce 
constitutive TH-17 production in the Lp (Denning et al., 2007).  
TLR9	  signaling	  on	  other	  immune	  cells	  
 
 Nevertheless, gfDNA signaling may act on other immune cell populations 
besides DC within the GI tract, which in turn could contribute to the promotion and 
maitenance of mucosal immune responses. In this regard, DT administration to CD11c-
DTR mice would likely ablate resident macrophages in addition to DC in the Lp, since 
they also express CD11c. Indeed, based on the current controversy and difficulty 
associated with discerning Lp macrophages from classical LpDC (Varol et al., 2009); 
Schulz, 2009 #1360}, it is possible that the LpDC preperations used in the experiments 
described above contained some proportion of contaminating macrophages. As such, 
TLR9 ligands may also act directly on macrophages, which themselves or indirectly via 
effects on LpDC could provide inflammatory cues to naive T cells in culture or to already 
activated cells in situ. Plasmacytoid DC also reside within the intestinal Lp (Yrlid et al., 
2006a) and their activation in situ can direct the migration and maturation of CD103+ 
LpDC (Yrlid et al., 2006b). Thus, it would be interesting to assess whether gfDNA can 
induce pDC activation, which may facilitate antigen transport into the draining mln. 
Based on their potent capacity to produce type I IFNs upon stimulation, secretion of 
these cytokines upon stimulation in vitro could first be examined to address this 
possibility (Theofilopoulos et al., 2005). 
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 Recent studies have indicated that MyD88 intrinsic signals promote sustained T 
cell responses in various infection models (LaRosa et al., 2008; Rahman et al., 2008). 
Along these lines, TLR9 expression has been reported in naive and activated CD4+ T 
cells (Gelman et al., 2004). Further, TLR9 activation via CpG was shown to directly 
enhance T cell proliferation and Teff survival (Gelman et al., 2006). Based on these 
findings, one could speculate that gfDNA also provides survival/activation cues directly 
to T cells in the GI tract. This possibility could be investigated with the generation of 
50:50 (Tlr9−/−/WT) mixed bone marrow chimeras.   
TLR9	  signaling	  –	  polarization	  versus	  amplification	  	  
 
 The implication that other immune cell populations are directly affected by the 
sensing of gfDNA and that these TLR9 interactions contribute to the efficacy of mucosal 
immune responses raises another important question, at what step of the immune 
response is gfDNA sensing the mucosal response? The evidence that the ability of 
LpDC to polarize a regulatory respnse is abrogated upon TLR9 engagement would 
suggest that gfDNA sensing plays a role in polarization. However, this has not been 
confirmed in vivo, and is difficult to do in an infection for which immunodominant 
peptides are not known, such as E. cuniculi.  
 
Although not described in the data section, the importance of TLR9 stimulation in 
the GI tract was also verified using the mucosal adjuvant, LT(129G) (a non-toxic mutant 
of the E. coli labile toxin) (Chong et al., 1998), which was administered in conjuntion with 
OVA as a model antigen. This vaccination protocol is typically administered several 
times prior to assessment of the immune response; however, if the vaccine were 
introduced into WT or Tlr9−/− mice that were adoptively transferred with CD4+ T cells 
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expressing the OT-II transgene, then a potential contributing role of gfDNA/TLR9 
interactions to Teff polarization could be better investigated. A role for gfDNA/TLR9 
interactions in GALT Teff polarization notwithstanding, the sensing of gfDNA may also 
amplify mucosal immune responses directly in situ. While this possibility could still 
implicate LpDC, gfDNA interactions with resident macrophages, resident plasmacytoid 
DC, TH, as well as Foxp3+ Treg, would need to be considered.  
In	  situ	  regulation	  of	  immune	  responses	  via	  Foxp3+	  Treg	  
 
The selective expansion of Foxp3+ Treg in the GI tract of Tlr9−/− mice strongly 
correlated with the specificity of the immune impairments in response to the mucosal 
route of challenge. Moreover, partial Treg depletion with αCD25 during infection led to a 
resurgence both in mucosal cytokine production and parasite clearance. Together, these 
data argue that the expansion of these cells was complicit in the suboptimal 
development/maitenance of mucosal immune responses in the absence of gfDNA 
sensing. In addition to augmented numbers, there is also recent evidence that the 
absence of TLR9 increases Foxp3+ Treg suppressive function in a cell intrinsic manner. 
This is based on unpublished data from Dr. Nicolas Bouladoux of the lab as well as a 
recent report showing that CpG hindered Treg suppressive capacity in vitro (data not 
shown) (Larosa et al., 2007). As there have been multiple recent demonstrations of the 
ability of Foxp3+ Treg to inhibit a variety of innate processes, including: DC differentiation 
from immediate precursors (Liu et al., 2009), DC migration from tissues (Zhang et al., 
2009a), not to mention inflammatory chemokine production from multiple cell sources, 
such as DC, NK cells and stroma (Lund et al., 2008), the impact of augmented Treg 
proportions in the GI tract of Tlr9−/− mice could be two-fold. 
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gfDNA/TLR9	  intreactions	  and	  T	  cell	  homeostasis	  in	  the	  GI	  milieu	  	  
 
Although their steady-state increase is likely one of the root causes of impaired 
mucosal immunity, the mechanisms that drive Foxp3+ Treg expansion in the absence of 
TLR9 signals within the GI tract are still unclear. Based on the in vitro data presented 
here, one potential explanation is that gfDNA/TLR9 interactions place natural constraints 
on extrathymic GALT Treg generation. Indeed TLR9 engagement of LpDC drove multiple 
proinflammatory signals, including: IL-6, IL-12/23p40, and likely IL-27 (although not 
investigated in these studies), which alone or in concert have been shown to impede the 
development of Foxp3+ Treg in vitro and/or in vivo (Bettelli et al., 2006; Korn et al., 2007) 
(Ahern et al.; Wei et al., 2007). IL-6−/− mice, in particular, display several features that are 
reminiscent of Tlr9−/− mice. First, they lack TH-17 cells in the intestinal Lp during steady-
state (Ivanov et al., 2006). Second, they fail to mount robust immune responses, on 
account of an inability to overcome Treg suppression (Korn et al., 2007; Pasare and 
Medzhitov, 2003). Thus, the effect of IL-6 blockade on LpDC induction of Foxp3+ Treg 
was tested during TLR9 stimulation in vitro. Rather than restoring Foxp3+ cell 
generation, both antibody blockade and coculture with IL-6−/− LpDC resulted in enhanced 
TH-1 and TH-2 cytokine production, while impeding TH-17. These data emphasize that 
TLR9 sensing induces an inflammatory cytokine profile with the potency to induce a 
diversity of Teff programs, which are indeed observed in the GI tracts of WT mice during 
steady-state. While further attempts at innate cytokine inhibition also failed to rescue 
Foxp3+ Treg generation (suggesting that a microarray screen of TLR9 engaged LpDC 
versus an unstimulated control may be useful, to acquire a full sense of the inflammatory 
signature that results), antibodies against IL-4 and IFN-γ in addition to IL-6 led to a 
significant restoration. Both IL-4 and IFN-γ were recently revealed to inhibit Treg 
development in vitro (Wei et al., 2007). Further, IL-4 in conditions containing TGF-β was 
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shown to induce IL-9 secretion by T cells (TH-9) (Dardalhon et al., 2008; Veldhoen et al., 
2008b), a cytokine whose role in intestinal homeostasis is not clear and which was not 
examined in these experiments. The transcription factor, interferon regulatory factor -4 
(IRF-4) is essential for TH-2, TH-17, and TH-9 development (Brustle et al., 2007; Staudt et 
al.). In light of these findings, it would be interesting to assess how steady-state IRF-4 
expression in T cells within the GI tract is affected by gfDNA sensing. 
Controll	  of	  extrathymic	  Foxp3+	  Treg	  generation	  	  
 
If extrathymic GALT Foxp3+ Treg generation is controlled by gfDNA sensing, an 
important consideration is the stage at which this inhibition is occurring. The two 
scenarios that are known to induce Foxp3 in T cells within the GALT are lymphopenia 
and oral exposure to antigen in the absence of pathogenic signals (Coombes et al., 
2007; Lathrop et al., 2008; Sun et al., 2007; Zheng et al.). Mice are obviously in a state 
of lymphopenia immediately after birth and the time after weaning might also represent a 
time of dynamic change within the GI tract upon loss of maternal antibodies. Thus, it 
would be worthwhile to measure the number and frequency of Foxp3+ Treg within the GI 
tract of WT and TLR9−/−  mice as a function of age, which would offer insight into when 
gfDNA sensing limits the de novo generation and/or expansion of these cells. Foxp3+ 
Treg induction in response to exposure to antigen traversing the gut is also likely a 
dynamic process. As such, these cells may turn over very fast and their acquisition of a 
Foxp3 program may at early time points be subject to destabilizing factors, such as 
gfDNA, both at sites of priming and in Lp tissue itself. Therefore, the absense of TLR9 
signals may promote an induced Foxp3+ Treg that is longer lived. An alternative possibility 
with a similar outcome is that in the absence of TLR9 signaling, signaling by other TLRs 
can gain precedence. TLR2 signaling, for example favors Treg cell expansion through 
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both cell intrinsic (Liu et al., 2006; Sutmuller et al., 2006) and cell extrinsic means. The 
latter being regulated via the induction of retinoic acid synthesizing capacity in DC  
(Manicassamy et al., 2009). Accordingly, Foxp3+ Treg cell frequencies are decreased in 
TLR2−/− mice (Liu et al., 2006; Sutmuller et al., 2006). Altogether, these findings  suggest 
that TLR ligands can discretely influece T cell homeostasis in the GI tract, which may 
explain why MyD88−/− and MyD88−/− Trif−/− mice have no apparent gross changes in the 
frequency of Foxp3+ Treg or TH-17 cells in this tissue (Atarashi et al., 2008; Cha et al.; 
Ivanov et al., 2008; Min et al., 2007). 
Not	  all	  TLR	  ligands	  are	  created	  equal	  
 
 Minimization of gut floral signals with broad-spectrum antibiotic treatment 
(ATB) also impaired the mucosal immune response to infection with E. Cuniculi and 
resulted in a concomitant increase in parasite burden. TLR9 but not TLR4 activation was 
sufficient to rescue immune responses in ATB treated animals, illustrating both the 
discrete functions of individual TLR ligands in the promotion and regulation of immunity 
and the potency of TLR9 engagement as an adjuvant. Intriguingly, TLR4 activation with 
LPS, while failing to improve parasite control and immune responses within the GI tract, 
elicited a complete rebound in the systemic cytokine response to oral E cuniculi 
infection. This finding is consistent with recent reports illustrating that peripheral TLR4 
signals, which occur upon floral translocation, can enhance the activation status of T 
cells (Brenchley et al., 2006; Paulos et al., 2007). Despite these findings, however, TLR4 
signals may also operate in other ways, specifically within the GI tract. In this regard, 
exposure of the intestinal epithelia to LPS during birth was found to result in tolerance of 
this tissue to subsequent LPS stimulation (Lotz et al., 2006). More recently, LPS 
engagement of TLR4 was also revealed to temper T cell activation via enhancement of 
 101 
phosphatase activity in a cell intrinsic manner (Gonzalez-Navajas et al.). This may be 
especially relevant in sites where T cell interactions with LPS are likely, such as the 
GALT. 
 
The experiments in this study illustrated that DNA purified from the entire gut 
flora exerted an adjuvant effect on mucosal immune responses; yet it is important to 
bear in mind that gut flora bacteria possess differential capapacities to stimulate TLR9 
(Dalpke et al., 2006). Moreover, some DNA motifs may, in fact, exert inhibitory effects on 
TLR9 activation or actively promote regulatory features, which are still dependent on 
TLR9 (Trieu et al., 2006). As such, experiments are currently underway by other 
members of the laboratory to address whether gfDNA derived from different commensal 
species imparts specific effects on the development, control and maintenance of 
mucosal immune responses and whether these effects can be extrapolated to the types 
DNA motiffs present in these species. 
TLR9	  in	  other	  infections	  
 
In contrast to sterile sites, mucosal sites in the body are in ritual contact with 
commensals and their byproducts. The finding that Tlr9−/− mice exhibited a specific 
mucosal defect in response to infection, in this instance the fungal parasite, E. cuniculi, 
suggested that gfDNA/TLR9 interactions in the GI tract shape mucosal immune 
responses through release of immunoregulatory elements. One in particular that was 
showcased in these findings was immunosuppression via Foxp3+ Treg. Previous 
immunological studies of infections that are initiated at mucosal sites, such as 
Toxoplasma gondii and Herpes simplex virus, have also defined a role for TLR9 in the 
regulation of mucosal inflammation and viremia, respectively (Lund et al., 2006; Minns et 
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al., 2006). Although TLR9 is clearly important in the recognition of these microbes, it is 
also plausible that the absence of gfDNA/TLR9 interactions at these sites of challenge 
both during steady-state and infection could have additional bearing on the phenotype 
observed.  
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CHAPTER	  4:	  Essential	  role	  for	  retinoic	  acid	  in	  the	  promotion	  of	  CD4+	  T	  cell	  
effector	  responses	  via	  retinoic	  acid	  receptor	  alpha	  
	  
Abstract:	  
 
The data presented in Chapter 2 along with numerous recent reports indicate 
that the vitamin A metabolite, retinoic acid (RA), promotes Foxp3+ Treg induction in vitro 
and in vivo. However, incorporation of the data from Chapter 3 into these findings also 
suggested that RA signaling, rather than suppressing the differentiation of Teff cells, 
could also promote their migration into the intestinal mucosa. While an initial 
interpretation of these findings could suggest context dependent roles of RA during 
tolerance and infection, they also could imply that RA possesses a more fundamental 
function in the regulation of T cell activation/differentiation. To begin to address this 
hypothesis, immune responses to the parasite, T. gondii, and the mucosal adjuvant, 
LT(R129G), were examined in mice reared on a vitamin A deficient diet. Unexpectedly, 
these studies led to the following insights: 
 
1. TH-1 and TH-17 immunity were abrogated in the absence of vitamin A 
metabolites. 
2. Retinoic acid rescued TH-1 and TH-17 immune responses in the absence of 
vitamin A. 
3. RA receptor alpha expression was necessary for CD4+ T cell immunity and 
homeostasis. 
4. RA receptor driven signals maintained the ability of T cells to properly 
respond to TCR/CD3 stimulation in a cell intrinsic manner. 
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Rationale:	  
 
 In Chapter 2, LpDC and their migratory counterparts in the mesenteric lymph 
nodes were revealed to be specially equipped with the capacity to induce Foxp3+ Treg 
(Coombes et al., 2007; Sun et al., 2007). This feature was dependent on their ability to 
convey both TGF-β and retinoic acid mediated signals to T cells. At approximately the 
same time that these findings emerged, other groups demonstrated that exogenous RA 
was able to: reduce TH-17 polarization via inhibition of IL-6 and IL-23 receptors  (Elias et 
al., 2008; Mucida et al., 2007; Xiao et al., 2008); facilitate Foxp3 induction in the face of 
high levels of costimulation (Benson et al., 2007), and negatively modulate cytokine 
production by effector/memory T cells during restimulation (Hill et al., 2008). Prior to 
these reports, RA was also shown to promote IgA-secreting plasma B cell differentiation 
(Mora et al., 2006). Altogether, these findings reinforced an emerging perception that RA 
drove anti-inflammatory programs and synchronized with the paradigm of mucosal 
tissues as hypo-responsive environments during steady-state conditions. Nevertheless, 
in the event of pathogenic exposure, overcoming these regulatory hurdles is essential 
and how RA is integrated into this framework is unclear. In Chapter 3, adjuvant 
activated LpDC were revealed to lose their capacity to induce Foxp3+ Treg; however, this 
effect was likely not a consequence of impaired RA signaling, as the RA-inducible 
integrin heterodimer, alpha4beta7 (α4β7) was strongly upregulated on Foxp3– T cells. 
Indeed, α4β7 upregulation is a well-appreciated hallmark of T cells activated in the GALT, 
which in turn drives their migration into the GI tract (Johansson-Lindbom et al., 2003).  
 
Deficiency in vitamin A, which is the precursor of RA, is known to manifest in 
susceptibility to mucosal infections (Sommer, 2008; Underwood, 2004). Although this 
susceptibility, in part, may be driven by impairments in epithelial barrier protection 
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(Biesalski and Nohr, 2004; Stephensen, 2001), to date, the in situ regulation of mucosal 
CD4+ T cell responses via RA and/or other retinoids has not been investigated. Gaining 
an understanding of these pathways will help unravel how vitamin A metabolism 
contributes to host protective immunity. 
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Results:	  
Retinoic	  acid	  mediated	  signaling	  occurs	  during	  systemic	  inflammation	  
 
To address the role of vitamin A metabolism in immunity, the induction of 
mucosal homing markers was evaluated during oral infection with Toxoplasma gondii (T. 
gondii). This parasite induces a strong inflammation and a robust systemic TH-1 
response (Gazzinelli et al., 1992; Suzuki et al., 1988). Mice were inoculated with 10 
cysts of the type II avirulent T. gondii strain, ME-49, and CD4+ T cells were examined 
during the acute stage of infection, at which time they are the predominant responding T 
cell subset. Accordingly, a large proportion of activated cells within the small intestinal 
lamina propria, the draining mesenteric lymph nodes, and the spleen expressed the 
transcription factor, T-bet, which mediates interferon gamma (IFN-γ) production (Figure 
29A). Expression of, α4β7 and CCR9, which are indicative of retinoic acid signaling 
(Iwata et al., 2004; Svensson et al., 2008), were also observed on a proportion of 
activated CD4+ T cells in each of these tissues (Figure 29A and data not shown). 
Notably, expression of these markers was mainly confined to T-bet+ cells (Figure 29A). 
To determine whether α4β7 induction was unique to the oral route of infection with T. 
gondii animals were next inoculated intraperitoneally (IP). Strikingly, a large proportion of 
activated CD4+ T cells expressed α4β7, and, again, most of these coexpressed T-bet 
(Figure 29B).  These results suggested that RA signaling was sustained and occurred 
systemically during inflammatory responses.  
 
An alternate scenario compatible with these findings was that signaling 
molecules, other than RA, contributed to α4β7 expression in response to infection. To 
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address this possibility, vitamin A insufficient (VAI) mice at 10 wks of age were 
inoculated with T. gondii.  
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Figure 29. Vitamin A metabolite dependent signaling is sustained and systemic 
during T. gondii infection  
(A) C57BL/6 mice were infected per-orally with 10 bradyzoite cysts of ME-49 clone C1. 
On day 8 post-infection (p.i.), single cell suspensions prepared from the spleen (Sp), 
mesenteric lymph nodes (mln) and small intestinal lamina propria (Lp), were stained with 
fluorochrome labeled antibodies and assessed for a4b7 and T-bet expression by flow 
cytometry. Dot plots are gated on Foxp3- CD44hi CD62Llo CD4+ T cells and 
representative of 3 mice per group. (B) C57BL/6 mice were infected intraperitoneally 
with 10 bradyzoite cysts of ME-49 clone C1. On day 8 p.i., single cell suspensions 
prepared from the Sp were stained and assessed as described in A  (C) Ctl and VAI 
mice were infected per-orally with T. gondii. On day 8 single cell suspensions were 
stained for α4β7. Bar graphs summarize the average frequency of Foxp3- CD44hi CD4+ T 
cells expressing α4β7, n = 3-4 mice per group. (D) Ctl and VAI mice were infected 
intraperitoneally with T. gondii and assessed as described in part c. n = 6-8 mice.  For C 
and D, error bars illustrate the s.d. Statistical comparisons were performed using the 
unpaired Student’s t test , P < 0.001, ns = not significant.  
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Significantly, 8 days post infection, α4β7 remained virtually absent on activated CD4+ T 
cells in VAI mice infected either by the oral or IP route with T. gondii, strongly suggesting 
that its upregulation was strictly dependent on RA during both steady-state and 
inflammatory conditions (Figure 29C and D). Thus, RA signaling was sustained during 
infection and exerted a systemic influence on CD4+ T cells regardless of the route of 
infection, an indication that vitamin A metabolism may imprint features that exceed 
homing potential during infection.  
Mucosal	  and	  systemic	  CD4+	  T	  cell	  immunity	  is	  impaired	  in	  the	  absence	  of	  
vitamin	  A	  metabolites	  
  
To explore the functional consequence of vitamin A insufficiency during infection, 
the acute-phase TH-1 response in VAI mice was evaluated following oral inoculation with 
T. gondii. To this end, magnetically enriched T cells from mice on day 8 post-infection 
were restimulated with soluble T. gondii antigen (STAg) in the presence of BMDC in 
vitro. 48hrs later, IFN-γ in supernatants was measured. Strikingly, T cells enriched from 
the mln, Lp, as well as the Sp of infected VAI mice produced significantly smaller 
amounts of IFN-γ than their control counterparts upon recall (Figure 30A). The reduction 
in TH-1 responsiveness was reflected in the enhanced parasite burden observed both 
systemically (Sp) and in the Lp of VAI mice (Figure 30B). IP infection with T. gondii 
yielded similar findings, in which, CD4+ T cells removed from VAI animals and 
rechallenged with STAg produced lower levels of IFN-γ on a per cell basis (MFI = 
1800±380 in VAI versus 5300±870 for Ctl, p < 0.003). Enhanced parasite burdens in the 
peritoneal exudates (Pecs) and Sp of these animals were also observed (Figure 30C), 
emphasizing that impaired TH-1 immunity to T. gondii during vitamin A insufficiency is not 
solely a consequence of defective responsiveness in the GALT. These data suggested a 
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direct or indirect role for vitamin A metabolites in the capacity of CD4+ T cells to acquire 
effector function during infection.  
  
 T. gondii infects all nucleated cells and triggers multiple innate pathways that 
synergize to induce a strong adaptive TH-1 response. Therefore, the influence of vitamin 
A metabolism on mucosal immunity was also tested in a non-infectious system with a 
model antigen. To this end, mice were orally vaccinated with a mixture of OVA and the 
mucosal adjuvant, LT (R129G), a non-toxic mutant of the heat-labile enterotoxin of 
Eschericia coli. This regimen previously was demonstrated to induce a TH-1 and robust 
TH-17 response (Hall et al., 2008); the latter distinguished by expression of the 
transcription factor, ROR(γ)t, in T cells (Ivanov et al., 2006). After two rounds of 
vaccination one week apart, abundant IFN-γ and IL-17A were detected in the 
supernatants of in vitro restimulated Lp and Peyer’s patch (Pp) tissues from control 
mice, while less was detected in the mln (Figure 30D). Coincident with IL-17A protein, 
flow cytometric analysis revealed substantial expression of ROR(γ)t in Foxp3– CD4+ T 
cells from the Lp (44.8±6.4%) and Pp (9.3±0.4%) (Figure 30E-F). Yet, GALT cells from 
VAI mice secreted only marginal amounts of IFN-γ and IL-17A.  This reduction in IL-17A 
corresponded with diminished ROR(γ)t expression in both the Lp (13.7±5.9%) and Pp 
(1.7±0.8%). Moreover, the frequency of CD4+ T cells expressing the nuclear proliferation 
antigen, Ki-67 (Gerdes et al., 1983), was significantly reduced, indicating decreased 
activation/proliferation in response to vaccination in VAI mice (Figure 30E-F). 
Collectively, these results suggest that vitamin A is critical for optimal T cell responses.   
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RA	  restores	  CD4+	  T	  cell	  immunity	  in	  the	  absence	  of	  vitamin	  A	  
 
Impaired TH-1 and TH-17 responses in VAI mice could also emerge from a 
developmental defect in these animals, and not reflect a genuine role for vitamin A 
metabolites on TH-1 and TH-17 development (Mora et al., 2008; Ziouzenkova et al., 
2007). Vitamin A metabolism produces several derivatives with signaling capacity in the 
host. RA, in particular, has been shown previously to induce strong effects on a variety 
of immune cell populations in vitro (Geissmann et al., 2003; Mora et al., 2008) and in 
vitamin A-replete settings in vivo (Mucida et al., 2007; Xiao et al., 2008). However, the 
effect of RA on T cell immunity in the absence of other vitamin A metabolites, which may 
exert confounding influences, has never been interrogated. To test if RA could restore 
protective immunity in vivo, VAI mice were prophylactically treated with RA every other 
day. On day 5 of treatment, they were innoculated orally with T. gondii. Administration of 
RA or the vehicle control continued every other day until day 8 of infection, when the 
animals were analyzed. In contrast to vehicle treated animals, T. gondii infected VAI 
Figure 30. TH-1 and TH-17 immune responses are impaired in the absence of 
vitamin A metabolites  
(A-B) Ctl and VAI mice were infected per-orally with T. gondii (A) At day 8 p.i., pooled 
tissue suspensions were enriched for T cells and cultured with irradiated BMDC +/- 
soluble T. gondii antigen (STAg) for 48 hr. IFN-γ was measured in triplicate supernatants 
by ELISA. n = 4-5 mice per group. (B) Parasite burdens in Sp and Lp of individual mice 
from A were determined by plaque assay. Results are expressed as plaque forming 
units (PFU). Each dot represents an individual mouse (C) Ctl and VAI mice were 
infected intraperitoneally with T. gondii. Parasite burden was assessed day 8 p.i. as 
described in B. n = 6-8 mice per group. (D-F) Ctl and VAI mice were immunized orally 
with a mixture of OVA and the mutant E. coli labile toxin, LT(R129G), once per week. On 
day 14, pooled cell suspensions from mln, Pp and Lp were cultured with BMDC infected 
with recombinant vaccinia virus expressing OVA (iDC) for 72 hours. Triplicate 
supernatants were assayed for IFN-γ and IL-17A by ELISA. n = 3-4 mice per group. (E-
F) Lp (E) and Pp (F) suspensions from individual mice were assessed for intracellular 
RORγ(t) and Ki-67 by flow cytometry. Representative dot plots from Lp of WT and VAI 
mice gated on viable Foxp3– CD4+ T cells are shown. Bar graphs summarize the 
frequency of Ki-67+ and RORγ(t)+. Error bars in A and D depict the s.e.m.; error bars in E 
and F depict the s.d. , P < 0.05; , P < 0.01; , P < 0.001.  
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mice that received short-term RA displayed a striking recovery in ex vivo T cell IFN-γ 
responses to STAg, both in the Sp and Lp (Figure 31A). Assessment of intracelular IFN-
γ further revealed that Lp CD4+ T cells responded as potently as their control 
counterparts to antigen restimulation (Figure 31B). Importantly, this rebound culminated 
in functional immunity to toxoplasmosis, enhancing parasite clearance so that parasite 
burdens mirrored those observed in control infected animals (Figure 31C-D). The effect 
of RA was also examined on TH-17 responses via oral vaccination with LT(R129G) and 
OVA. For these experiments, mice were treated with the same drug regimen. To 
accommodate this, the vaccination schedule was performed four days apart, rather than 
one week. Significantly, Lp Foxp3– CD4+  T cells from RA treated animals regained their 
capacity to produce IL-17A, in some instances to a degree that exceeded what was 
observed in control animals (Figure 31E). This capacity was coupled to a rebound in 
RORγ(t) expression and markedly enhanced T cell proliferation, as measured by 
intracellular Ki-67 (Figures 31E-F). The efficacy of short-term treatment with RA, argued 
that rather than a developmental deficit causing impaired CD4+ T cell immunity in VAI 
mice, this metabolite provided essential signals to mediate TH-1 and TH-17 responses.   
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RARα 	  regulates	  CD4+	  T	  cell	  immunity	  and	  homeostasis	  	  
 
As mentioned in Chapter 1, RA signals through several families of nuclear 
hormone receptors. The best characterized are RA receptors (RAR) α, β and γ, which 
transcriptionally regulate gene expression in partnership with retinoid X receptors 
(Chambon, 1996). Previously, TGF-β was shown to induce RARα expression 
(Schambach et al., 2007). Accordingly, it was also shown in Chapter 2 that this receptor 
was required for RA to enhance Foxp3+ Treg differentiation in vitro (Hill et al., 2008; 
Nolting et al., 2009). Using real time quantitative PCR, naïve CD4+ T cells were found to 
readily express mRNA for RARα. RARγ was also detected. Similar to observations in 
activated cells, RARβ was not detectable (#) (Figure 32A) (Elias et al., 2008). To 
deduce whether RARα played a role in RA directed immunity, RARα deficient (Rara−/−) 
mice were orally vaccinated with LT (R129G) and OVA. Unlike VAI mice, which after 16 
weeks begin to succumb to a wasting disease, these animals display no overt 
Figure 31. Retinoic acid is required for CD4+ T cell immunity  
(A-D) Ctl and VAI mice treated with RA or vehicle were infected orally with T. gondii. n = 
3 mice per group. (A) At day 8 p.i., pooled cell suspensions from Sp or Lp were enriched 
for T cells and cultured with irradiated BMDC +/- STAg for 48 hr. Bar graphs present the 
average amount of IFN-γ in duplicate or triplicate supernatants. (B) Lp samples treated 
as described in A were incubated for 14 hrs with STAg, and analyzed for intracellular 
IFN-γ via flow cytometry. Stacked histograms are gated on viable, Foxp3– CD4+ T cells. 
(C) Parasite burden in Sp and Lp of individual mice was measured by PFU. (D) 
Visualization of parasite localization in duodenal-jejunal sections of individual mice on 
day 9 p.i. (E-F) Ctl and VAI mice treated with RA or vehicle were immunized orally with a 
mixture of OVA and LT(R129G) on day 0 and 4. n = 3 mice per group. (E) On day 7, 
suspensions pooled from Lp were enriched for T cells and cultured with SpDC +/– OVA 
for 14 hr and examined for intracellular IL-17A and IFN-γ. Contour plots are gated on 
viable, Foxp3– CD4+ T cells. (F) Lp cells from individual mice were analyzed for 
intracellular RORγ(t) and Ki-67 by flow cytometry. Bar graphs depict Ki-67 and RORγ(t) 
as a frequency of Foxp3– CD4+ T cells. (A-F), RA treated groups received 250mg RA 
intraperitoneally 5 days prior to infection or vaccine and every other day thence until 
takedown. Error bars in A depict the s.e.m.; Error bars in C and F depict the s.d. , P < 
0.05; , P < 0.01; , P < 0.001; ns = not significant.  
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impairments as adults (Lufkin et al., 1993). Notably, this vaccine regimen was unable to 
induce an antigen specific TH-17 response in mice on this mixed 129 background (data 
not shown). Nevertheless, relative to WT littermates, CD4+ T cells from Rara−/− mice 
expressed attenuated levels of the TH-1 driving transcription factor, T-bet, after 
vaccination and secreted virtually no IFN-γ upon antigen recall (data not shown and 
Figure 32B), Thus, abrogation of Rara impaired CD4+ T cell immunity.  
 
In Chapter 2, disruption of RA/RAR signaling, either by antagonism in vitro or by 
loss of RA in vivo was shown to inhibit peripheral Foxp3+ Treg generation. Other 
laboratories corroborated in vitro inhibition of Foxp3+ Treg generation using RAR 
antagonists, as well (Coombes et al., 2007; Mucida et al., 2007). Despite the inability to 
generate GALT Foxp3+ Treg upon oral feeding (Figure 14), a paradoxical increase in the 
frequency of Foxp3+ Treg was observed within the Lp of VAI mice (Figure 32C). As noted 
previously, a parallel increase was also observed in the frequency of Lp Foxp3+ Treg in 
Rara−/− mice (Hill et al., 2008). However, in both VAI and Rara−/− animals, thymic 
production of Foxp3+ Treg was unperturbed (Figure 15 and data not shown).  Thus, 
upon loss of RA or RARα mediated signaling, impaired GALT Foxp3+ Treg generation 
was coupled with an aberrant increase in the frequency of thymically derived Foxp3+ Treg 
in the Lp. Based on their potential to raise the threshold of immune activation, which was 
demonstrated in Chapter 3 (Figure 27), the relative increase in thymically derived 
Foxp3+ Treg in this region was considered a potential cause of impaired CD4+ T cell 
responses. In order to test this, VAI DEREG mice were generated (Lahl et al., 2007), in 
which Foxp3+ Treg could be selectively depleted upon injection of diphtheria toxin (DT). 
Oral vaccination in conjunction with DT treatment readily depleted Foxp3+ Treg and 
restored Foxp3- CD4+ T cell proliferation in the Lp (Figure 32D). However, TH-1 and TH-
17 cells remained undetectable in VAI mice after this treatment (Figure 32E).  
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Thus, the enhanced frequency of Foxp3+ Treg in the Lp was not a primary cause of 
impaired mucosal immune responses upon loss of vitamin A dependent signaling.  
 
The increase in the frequency of Lp Foxp3+ Treg revealed that GALT T cell 
homeostasis was perturbed in both Rara−/− and VAI mice. Quantification of CD4+T cell 
subsets indicated that in both these animals, the increase in Lp Foxp3+ Treg frequency 
was due to a 2 to 4 fold selective reduction in the number of Foxp3- CD44hi CD4+ T cells 
within the Lp (Figure 32F). Importantly, treating VAI mice with RA during T. gondii 
infection and vaccination restored GALT T cell equilibrium in addition to TH responses 
(Figure 32G). These findings demonstrated that deficiency in RARα alone could 
Figure 32. The RA/RARα  signaling axis regulates CD4+ T cell immunity and 
homeostasis. 
(A) mRNA from sort-purified naïve CD4+ T cells (Foxp3– CD25– CD44lo) was assessed 
for RARs: α, β, and γ via quantitative RT-PCR and normalized to the house-keeping 
gene, hypoxanthine phosphoribosyltransferase. # = not detected. (B) Rara−/− and 
littermate control WT mice were immunized orally with a mixture of OVA and the mutant 
E. coli labile toxin, LT(R129G), once per week. On day 21, suspensions pooled from Sp 
were enriched for T cells and cultured with BMDC infected with recombinant vaccinia 
virus expressing OVA (iDC) for 72 hours. IFN-γ was quantified in triplicate supernatants. 
Results are representative of 2 independent experiments. (C) Lp cell suspensions from 
VAI, Rara−/− and their respective control counterparts were assessed for Foxp3+ Treg via 
flow cytometry. Results are expressed as a proportion of viable TCRβ+ CD4+ T cells. (D-
E) Ctl, VAI and VAI DEREG mice immunized orally with a mixture of OVA and 
LT(R129G) on days 0 and 4 were treated with 1mg of diphtheria toxin72 and 24 hrs prior 
to vaccination and every subsequent 48 hrs through termination of experiment. (D) On 
day 7, suspensions from individual mice were assessed for intracellular Foxp3 and Ki-67 
by flow cytometry. Data are gated on CD4+ T cells. Each dot represents an individual 
mouse. (E) Suspensions pooled from the Lp were enriched for T cells and cultured with 
purified SpDC +/– OVA for 14 hr, then assessed for intracellular IL-17A and IFN-γ via 
flow cytometry. Contour plots are gated on viable Foxp3– CD4+ T cells. n = 3-4 mice per 
group (F) Summary of the absolute number of Foxp3+ and Foxp3– CD4+ T cells in the Lp 
of mice. (G) Vehicle or RA treated mice were orally infected with T. gondii or vaccinated 
as described in Figure 3. A summary of the frequency of Lp Foxp3+ Treg ± s.d. as a 
proportion of viable CD4+ T cells is shown. n = 3 mice per group. Data are representative 
of 2-3 experiments. Error bars in A and B depict the s.e.m. , P < 0.01; , P < 0.001; 
ns = not significant.  
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recapitulate the effects of vitamin A insufficiency on T cell homeostasis. Further, they 
identified a crucial contribution of RA/RARα signaling to vitamin A dependent CD4+ T cell 
homeostasis and protective immunity.  
RARα 	  regulates	  T	  cell	  activation	  	  
 
Although RA mediated enhancement of protective immunity could involve 
multiple cellular targets, expression of RARα in naïve CD4+ T cells, combined with 
impaired T helper immunity in Rara−/− mice, suggested a potential cell intrinsic 
requirement for this receptor in T cell responses. To address this, magnetically isolated 
naïve WT or Rara−/− CD4+ CD62Lhi T cells were stimulated in an APC-free system under 
TH-1 and TH-17 polarizing conditions, in vitro. After 48hrs in culture, relative to WT T 
cells, significant reductions of IFN-γ and IL-17A were detected in supernatants from TH-1 
and TH-17 polarized Rara−/− T cells (Figure 33A). However, these cultures contained 
significantly fewer cells than WT cultures, indicating that differences in cytokine levels 
were potentially secondary to impaired cell proliferation. Confirming this hypothesis, 
intracellular cytokine staining revealed that surviving Rara−/− T cells were as capable as 
WT T cells to produce cytokine (data not shown). Indeed, T cells lacking RARα failed to 
proliferate as efficiently as their WT counterparts upon polyclonal T cell receptor (TCR) 
activation with anti-CD3. The lack of proliferation persisted in the presence of co-
stimulation and upon exogenous provision of IL-2 (Figure 33B), suggesting that the loss 
of RARα signaling may cause a fundamental activation and/or survival defect. A 
potential defect in activation was explored first. After 16 hrs of stimulation, there was less 
upregulation of the activation markers: CD69, CD25 and the iron transferrin receptor, 
CD71, on Rara−/− T cells (Figure 33C). Expression of CD71 was recently shown to 
depend on activation of the mammalian target of rapamycin kinase (mTOR) (Zheng et 
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al., 2007), which regulates cell growth, proliferation, survival and differentiation pathways 
via two distinct complexes, mTORC1 and mTORC2 (Guertin et al., 2006; Loewith et al., 
2002; Wullschleger et al., 2006); (Delgoffe et al., 2009; Lee et al.). mTORC1 activity 
regulates protein translation via activation of the ribosomal S6 kinase (S6K1) (Holz et al., 
2005), while mTORC2 activity regulates cell growth, proliferation and survival via 
activation of AKT (kinase mediated phosphorylation of serine 473) and additional 
pathways. In accord with a reduction in CD71, phosphorylation of the S6K1 target, 40S 
ribosomal protein S6, (pS6) was decreased by as much as 50% in Rara–⁄– T cells relative 
to WT T cells, indicating a reduction in mTORC1 activity (Figure 33D). Suggesting a 
global reduction in mTOR activity, short stimulation with plate-bound anti-CD3 and anti-
CD3 + anti-CD28 resulted in less efficient Akt phosphorylation at serine position 473, in 
Rara–⁄– T cells (Figure 33E).   
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Figure 33. Role of RARα  signaling for T cell activation  
(A) CD4+ CD62Lhi T cells purified from Sp and lymph nodes of Rar−/− and 
littermate/WT mice were activated with plate-bound α-CD3 + soluble α-CD28, in TH-1 
or TH-17 polarizing conditions for 48 hrs. IFN-γ and IL-17A ± s.e.m. in culture 
supernatants were measured by ELISA. ***, P < 0.001 (B) CD4+ T cells were plated 
for 48 hrs in the following conditions: I. unstimulated II. α-CD3 III. α-CD3 + α-CD28 
IV. α-CD3 + α-CD28 + IL-2. After 48 hrs, cells were rested overnight in IL-2 and 
assayed for CFSE intensity by flow cytometric analysis. Histograms are gated on 
viable CD4+ T cells. (C) CD4+ CD62Lhi T cells were isolated and activated with α-CD3 
+ α-CD28 + IL-2 for 16 hrs, then assessed for the activation markers: CD69, CD25, 
and CD71. (D) Naïve T cells were activated as described in C and stained for pS6. 
Roman numerals indicate same conditions used in B. (E) CD4+ T cells (5x106) were 
stimulated with plate-bound α-CD3 (2µg/ml) and/or α-CD28 (10µg/ml) for the 
indicated times and then lysed. Total cell lysates were immunoblotted for 
phosphorylated (Ser473) and total Akt. 
 
 122 
Basal	  RARα 	  activity	  regulates	  responsiveness	  to	  signaling	  via	  TCR/CD3	  complex	  	  
 
TCR engagement results in the orchestration of signaling pathways, which 
promote naïve T cell transition into effector T cells. The observed decrease in activation 
markers at 16hrs suggested that an upstream defect might impair signal transduction 
pathways in Rara−/− T cells. Ca2+ mobilization is a critical biochemical mediator of early T 
cell activation events, which is initiated upon stimulation through the T cell receptor 
(TCR)/CD3 complex. To determine whether RARα signaling was involved in the 
regulation of these events, the rate and magnitude of cytoplasmic Ca2+ flux was 
assayed. Strikingly, upon anti-CD3 crosslinking, Ca2+ mobilization was dramatically 
reduced in Rara–⁄– CD4+ T cells relative to WT counterparts (Figure 34A). As RA and its 
metabolic precursors are constitutively present in serum (Kane et al., 2008a; Kane et al., 
2008b), we could not exclude the possibility that that deficiency in Rara may result in a 
long-lasting metabolic defect that may also impair T cell activation. As such, we also 
incubated WT cells with the pan-RAR antagonist, LE540, prior to T cell activation. 
Treatment with this antagonist recapitulated the Rara–⁄– phenotype, manifesting in 
impaired Ca2+ mobilization upon anti-CD3 crosslinking (Figure 34B). Supporting the idea 
that RARα exerts a function downstream of the TCR/CD3 complex, Ca2+ mobilization 
was unaffected in LE540 treated cells stimulated with the Ca2+ ionophore, ionomycin (Liu 
Table 1. Impaired proliferation of Rara–⁄– T cells upon activation 
The percent of cells that underwent proliferation and calculated  
proliferation index are indicated. 
 
% (Cell 
divided) WT Rara-/- 
Prolif 
Index WT Rara-/- 
II 51 8 II 2.2 1.5 
III 74.8 15.8 III 3.4 2.1 
IV 76.4 15.4 IV 3.5 2.2 
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and Hermann, 1978). These findings imply that transient blockade of RARα signaling is 
sufficient to impede signal transduction events upon TCR recognition. Consequently, 
RARα is a crucial regulator of T cell responses.  
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Figure 34. Loss of basal RARa signaling impairs responsiveness to TCR/CD3 
engagement  
(A) Analysis of Ca2+ fluxes in Rara–⁄– (grey line), and WT mice (black line). Cells are 
gated on total CD4+ T cells. (B) Vehicle treated (black line) versus LE540 (grey line, 
2.5µM) treated cells. Black-tipped arrow denotes the addition of biotin α-CD3 
(10µg/ml). White-tipped arrow denotes the addition of streptavidin (20µg/ml). White 
arrowhead denotes addition of ionomycin. Cells are gated on total CD4+ T cells. 
Histograms depict the median ratio of DAPI-A/Indo-1-A of Ca2+ fluxing cells as a 
function of time (sec = seconds).  
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Discussion:	  
 
Although vitamin A insufficiency has long been linked to impaired immunity to 
pathogens, the role of vitamin A metabolism in the regulation of CD4+ T cell responses 
remains poorly understood. The experiments detailed herein indicate that the retinoic 
acid/RARα signaling axis is essential for adaptive CD4+ T cell immunity. Specifically, 
mucosal TH-1 and TH-17 responses to oral infection and vaccination were compromised 
upon loss of vitamin A. These impairments were unlikely to be manifestations of a 
developmental defect propagated upon loss of vitamin A, as RA rapidly restored 
mucosal TH-1 and TH-17 responses. This finding, in particular, suggested that this 
metabolite is the cardinal mediator of vitamin A dependent immunity in vivo. Strikingly, 
genetic ablation of Rara was sufficient to recapitulate the phenotype of VAI mice, both at 
steady-state and during infection. Furthermore, T cells lacking RARα or subjected to RA 
receptor antagonism display early activation defects and proliferate less efficiently in 
response to T cell stimulation.  Thus, the RA/RARα axis controls the fate of adaptive 
immunity, at least in part, via cell autonomous effects on CD4+ T cells and reveals one 
potential explanation for the broad control of this pathway over various T cell fates.  
RA	  does	  not	  impair	  adaptive	  TH-­‐1	  responses	  	  
  
RA has been proposed to foster the reciprocal development of Foxp3+ Treg and 
TH-17 cells (Mucida et al., 2007); however, the findings described here suggest that on 
some fundamental level RA is a physiological mediator of TH-17 responses, as well as 
TH-1 responses. Importantly, the majority of CD4+ T cells that displayed a RA signature 
(based on α4β7), co-expressed T-bet, the transcription factor required for TH-1 
commitment (Szabo et al., 2000). Further, in vivo add-back experiments demonstrated 
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that RA was capable of restoring TH-1 responses in VAI mice. These data are somewhat 
in conflict with previous reports that have suggested that RA is a negative regulator of 
TH-1 inflammation (Cui et al., 2000). For instance, VAI mice produced abnormally high 
levels of IFN-γ during infection with the nematode, Trichinella Spiralis and failed to elicit 
a proper and robust TH-2 response (Carman et al., 1992). In this system, RA was shown 
to decrease IFN-γ production when added to in vitro restimulated cell suspensions and 
was, hence, as a TH-1 suppressor (Cantorna et al., 1994). However, this type of “add-
back” experiment is difficult to interpret physiologically, especially when considering that 
the cells treated in culture were likely of a heterogeneous activation status. In this 
regard, RA was shown to be able to inhibit effector/memory T cell cytokine production 
(Hill et al., 2008). Integrating these data into a working model suggests that RA signaling 
is potentially biphasic - driving T cell activation/differentiation during the early stages of 
an immune response, but regulating the amplitude at later stages. In terms of tissue 
immunity, this could be a particularly effective strategy to minimize tissue damage. 
RA	  may	  potentiate	  TH-­‐17	  through	  a	  multitude	  of	  effects	  in	  the	  intestinal	  mucosa	  	  
 
TH-17 cells are elicited via the actions of multiple cytokines, including TGF-b, and 
any combination of IL-6, IL-21, IL-23 and/or IL-1 (Korn et al., 2009). The data described 
here demonstrate that diminished vitamin A prevented the acquisition of a robust TH-17 
response in vivo. The ability of RA to restore TH-17 responses in VAI mice was also 
unexpected in light of recent studies that have reported negative effects of RA on IL-17 
production in vitro (Elias et al., 2008; Mucida et al., 2007) and in certain animal models of 
autoimmune disease (Xiao et al., 2008). Nevertheless, in systems that have scrutinized 
the effects of RA at low doses (Wang et al.) and in conjunction with microbial stimuli, 
such as TLR5 ligands (Uematsu et al., 2008), TH-17 generation was shown to be 
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unaffected or enhanced, respectively. Thus, in physiological settings and microbial rich 
environments, RA may favor the generation of TH-17 cells. Compatible with this idea, two 
recent studies revealed that TH-17 cells were virtually ablated in the Pp and Lp of VAI 
mice during steady-state (Cha et al.; Wang et al.). In one of these studies, the authors 
attributed this result to impeded migration of TH-17 cells into the gut; however, deficiency 
did not result in their increase elsewhere(Wang et al.). Therefore, at the minimum, the 
intestinal mucosal environment is requisite for promoting TH-17 development and/or 
maintenance. Moreover, the other study, which observed TH-17 depletion, detected this 
defect while the mice were young and TH homing capacity to mucosal sites would have 
been intact (Cha et al.). Strikingly, this study also reported large shifts in the commensal 
microbial phyla that were present within the intestinal ileum when mice were reared on a 
vitamin A deficient diet. Not only was the total amount of bacteria decreased in these 
animals, but SFB, which was present in the control diet fed mice, was also completely 
missing. This finding indicates that RA may be able to influence both the density and the 
composition of the commensal microbiota, which when considered alongside the 
findings described in Chapter 3, could also explain, in part, the attenuation of TH 
responses in VAI mice. Supposing that the influence of RA and TLR ligands on follicular 
DC can extend to LpDC, another possibility is that RA may foster TH-17 development via 
promotion of TGF-β production (Suzuki et al.). Importantly, these potential modes of TH-
17 generation are consistent with the proposed biphasic model of RA on T cell 
activation, where RA could provide a source of active TGF-β in situ. 
Potential	  roles	  of	  RA/RARα 	  in	  the	  regulation	  of	  T	  cell	  activation	  	  
 
Rara−/− mice complemented VAI mice on multiple levels. First, the number of Lp 
effector T cells was reduced in both animals compared to their control counterparts (~3 
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fold for VAI; ~2 fold for Rara−/−). These findings suggest that RARα is critical for 
upregulation of homing receptors, which fits with the data presented in Figure 11 of 
Chapter 2. In that experiment, Rara−/− T cells failed to upregulate α4β7, when cultured in 
the presence of RA, albeit in Foxp3+ Treg polarizing conditions. Remarkably, transient 
provision of RA restored both T cell equilibrium and the CD4+ T cell response within the 
Lp of VAI mice. Since RA restored both of these parameters, it is difficult to comment on 
the relative contribution of homing versus effects on T cell activation to the restoration of 
immunity in this tissue. However, suggesting that RA/RARα signals impart more than 
merely homing features to T cells, systemically infecting VAI mice with T. gondii still 
resulted in a markedly impaired TH-1 response. This outcome could be the product of 
both direct and indirect actions of RA/RARα signaling on T lymphocytes. 
 
Nevertheless, indicative that this pathway can function directly through T cells, 
RARα was observed to mediate signal transduction events downstream of TCR 
recognition, which governed T cell activation. In the absence of RARα CD4+ T cells 
failed to respond efficiently to T cell stimulation and growth factors. While this deficiency 
could potentially reflect a T cell developmental defect in Rara−/− mice, retinoic acid 
receptor antagonism of WT cells also impaired Ca2+ mobilization upon TCR activation, 
which was similarly observed in RARα deficient T cells. Prolonged Ca2+ mobilization 
induces the dephosphorylation and subsequent translocation of a series of transcription 
factors collectively referred to as the nuclear factor of activated T cells (NFAT), into the 
nucleus (Winslow et al., 2003). Transcriptional events mediated by NFAT result in a host 
of genetic changes, culminating in cell growth, proliferation and effector function (Feske 
et al., 2001). Thus, one possibility is that loss or antagonism of RARα results in delayed 
translocation of NFAT.  
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Recent findings indicate a role for nutrient metabolism in T cell activation. For 
instance, vitamin D/vitamin D receptor (VDR) signaling was shown to promote the 
proliferation of human T cells in response to TCR stimulation via the induction of 
PLCγ (von Essen et al.). The DNA binding capacity of VDR presumably mediates this 
induction via transcription. RARα is also recognized to regulate gene expression in the 
same fashion (Chambon, 1996). As RA, as well as other retinoids, are present in the 
serum and tissues of mice (Kane et al., 2008a; Kane et al., 2008b), it is intriguing to 
speculate that these compounds exert constitutive effects on the phosphorylation status, 
localization and/or conformation of RARα in T cells, which may in turn regulate this 
protein’s function. Short-term incubation (< 1 hr) with a pan-RAR antagonist impaired T 
cell Ca2+ mobilization in a manner similar to that observed in the absence of RARα. One 
explanation for this finding is that nuclear RARα regulates the expression or kinase 
activity of a mediator of T cell activation through its function as a transcription factor. 
Another possibility is that extra-nuclear RARα molecules facilitate TCR dependent signal 
transduction. Indeed, unconventional roles for RARα in mitogen-activated protein kinase 
as well as PI3K regulation have been reported in non-hematopoietic cells (Rochette-Egly 
and Germain, 2009). In line with these activities, RARα was shown to localize to the 
plasma membrane of a neuroblastoma cell line in an RA dependent manner (Masia et 
al., 2007).  
 
It is also worth noting that RARα expression is not necessarily restricted to 
expression in T cells and may also affect the function of APC, including DC. In this vein, 
RARα ligands were shown to synergize with inflammatory mediators and enhance the 
activation of human Langerhans cell-type dendritic cells (Geissmann et al., 2003). 
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Therefore, it is possible that altered APC function also contributes to impaired adaptive 
CD4+ T cell responses in VAI and Rara−/− mice. 
  
In summary, the GI tract must be able to tolerate constant exposure to food 
antigen and commensals, while maintaining the capacity to rapidly respond to 
encounters with pathogen. These conflicting pressures confront the host immune system 
defending the GI tract with a unique challenge. One would predict that the most judicious 
strategy to respond to this spectrum of recurring challenges would involve a conserved 
pathway that can readily adjust to environmental cues. Here we identify the RA/RARα 
signaling pathway as fitting this mode of host control, promoting Foxp3+ Treg generation 
and likely tolerance during steady-state conditions, while adaptive T cell responses in 
the face of pathogen. As such, we propose that RA regulates adaptive immunity in a 
manner that is symmetrical to TGF-β, where accompanying signals dictate whether a 
response ultimately becomes regulatory in nature or inflammatory. An important 
consideration is that adaptive immune responses often involve multiple waves of antigen 
presenting cell recruitment. Based on the systemic RA mediated signals that we observe 
during infection, it will be interesting to examine how newly recruited APC contribute to 
the RA/RARα signaling axis during inflammation. Finally, the requirement of RARα for T 
cell activation suggests that this pathway may have evolved early with the development 
of adaptive CD4+ T cell responses to coordinate host protection. 
 131 
CHAPTER	  5:	  Conclusion	  
 
Vitamin	  A	  metabolism	  drives	  Foxp3+	  Treg	  generation	  in	  vitro	  and	  in	  response	  to	  
oral	  antigen,	  in	  vivo	  
 
The ability of the GI tract to provide a nutrient source to the body is dependent on 
maintaining homeostasis in the face of constant exposure to the external environment 
and the intestinal microbiota. To adapt to the constant level of stimulation in this 
environment, the intestinal immune system has evolved a multitude of regulatory 
strategies. In Chapter 2, one of these regulatory strategies, the local generation of 
Foxp3+ Treg, was revealed to depend on a specialized population of migratory GALT 
dendritic cells, which was able to synthesize retinoic acid from vitamin A derivatives. RA 
receptor antagonism was shown to hinder LpDC-induced Foxp3+ Treg generation, while 
RA was shown to enhance SpDC-induced Foxp3+ Treg generation, thus, highlighting the 
potential importance of this metabolite in GALT Foxp3+ Treg development (Sun et al., 
2007). Reinforcing this idea, the induction of Foxp3+ Treg in the GALT was abrogated in 
mice, which lacked vitamin A and its associated metabolites (VAI mice). Studies on VAI 
mice further revealed that vitamin A was required for LpDC to retain the capacity to 
synthesize RA. This finding indicates the intestinal immune system has adapted to take 
advantage of the abundant intake and remarkable storage capacity of vitamin A. Indeed, 
RA is also an important mediator of IgA+ class switching in B cells (Mora et al., 2006; 
Suzuki et al.), and the upregulation of intestinal-homing surface markers on lymphocytes 
(Iwata et al., 2004). 
 
At the time that the findings in Chapter 2 were published (Sun et al., 2007), 
several other groups reported similar data with mesenteric lymph node DC, particularly 
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the CD103+ subset, which derived from the intestinal lamina propria (Coombes et al., 
2007; Mucida et al., 2007). A host of other groups also reported that RA could enhance 
Foxp3+ Treg generation in vitro under a variety of circumstances, including: during high 
costimulatory activity, in the presence of TH cytokines, and in otherwise non inhibitory 
conditions (Benson et al., 2007; Elias et al., 2008; Hill et al., 2008; Nolting et al., 2009). 
Despite several demonstrations that RARα was required for RA to be able to enhance 
Foxp3+ Treg induction, the molecular mechanism by which RA/RARα signaling stimulates 
Foxp3 activity remains unclear (Hill et al., 2008; Nolting et al., 2009). One interesting 
conjecture is that RA mediates these effects through the inhibition of the transcriptional 
complex, activation protein – 1 (AP-1), in T cells (von Boehmer, 2007). Rao and 
colleagues recently demonstrated that NFAT partnering to Foxp3 rather than AP-1 
favors the development of Foxp3+ Treg in lieu of effector T cells (Wu et al., 2006). 
Therefore, inhibition of AP-1 may promote Foxp3+ Treg generation. Indeed RA/RARα has 
been shown to inhibit several aspects of the AP-1 pathway, including: upstream 
activation of JNK (Lee et al., 1999; Xu et al., 2002), subunit expression (Fisher et al., 
1998; Talmage and Lackey, 1992), and DNA binding (Schule et al., 1991).  
TLR9	  /	  Commensal	  microbial	  DNA	  interactions	  are	  requisite	  for	  mucosal	  T	  cell	  
homeostasis	  and	  immunity	  
 
While GALT mediated Foxp3+ Treg induction may represent a default pathway to 
promote tolerance to food antigen and commensals, data presented in Chapter 3 
suggested that this process is tightly controlled by components of the commensal 
microbiota. Specifically, engagement of TLR9 by microbiota derived DNA strongly 
inhibited the capacity of LpDC to promote the generation of Foxp3+ Treg and instead 
drove the formation of TH cells, including TH-17, TH-1 and TH-2. Complementing this 
finding, Tlr9–⁄– mice were found to have an increased ratio of Foxp3+ Treg / TH within 
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intestinal effector sites. Although this shift had no bearing when Tlr9–⁄– mice were 
infected systemically with E. cuniculi, the adaptive immune response in these animals 
was dramatically impaired upon infection through the oral route. Together, these findings 
suggest that commensal DNA sensing is a critical mediator of adaptive immune 
responses to pathogens that gain access to the host through the gastrointestinal tract. 
Previously, Nod2 was shown to affect immune responses to bacterial infection in a 
similar manner, i.e. Nod2–⁄– mice were susceptible specifically to the oral route of 
challenge (Kobayashi et al., 2005). However, the data described in Chapter 3 also 
illustrate that perturbation of the Foxp3+ Treg / TH ratio can markedly influence adaptive 
immune responses at mucosal sites of challenge. This finding may have significant 
bearing on oral vaccination strategies and also provides a framework for thinking about 
how the composition of the microbiota could influence the ability of the host to respond 
to intestinal challenge. In particular, more comprehensive analyses of the commensal 
microbiota may facilitate the identification of immuno-stimulatory/regulatory DNA motifs 
that can be utilized in oral vaccine design.  
 
Around the time that the TLR9 findings were published (Hall et al., 2008), Littman 
and colleagues demonstrated that TH-17 cells were strongly diminished in the absence 
of the commensal microbiota (Ivanov et al., 2008). Another study showed that TH-1 cells 
were also strongly diminished in germ-free conditions (Gaboriau-Routhiau et al., 2009). 
The fact that TH-1 and TH-17 cells are not altogether ablated in these conditions may be 
due to residual TLR ligands present in the diet fed to these animals (Hill et al.). 
Surprisingly, Littman and colleagues also noted in their study that the frequency of TH-17 
cells was unaffected in mice lacking both MyD88 and TRIF. However, Chapter 3 
showed that both the frequency and absolute number of TH-1 and TH-17 cells were 
decreased in mice deficient in Tlr9, which is known to signal through MyD88 (Hemmi et 
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al., 2000). One possibility is that discrete microbial components, via signaling through 
distinct canonical pattern recognition receptors (TLR, Nod, and C type lectin) 
differentially contribute to the induction, proliferation and/or maintenance of TH-1, TH-17 
and Foxp3+ Treg cells. It is also possible that combinatorial signals through these 
receptors influence the composition of these cells in intestinal effector sites.   
 
In regard to toll like receptor signaling, microbial sensing and the type of 
response that it evokes are dependent not only on the nature of the microbe, but also on 
the cellular compartmentalization of the TLR in question. Surface TLRs, especially those 
expressed on intestinal epithelial surfaces are in direct apposition to the commensal 
microbiota, and are thus more inclined to experience receptor engagement. With the 
exception of industrialized countries and areas with access to water sanitation, IECs are 
also commonly in apposition with intestinal dwelling parasites. These pressures have 
likely compelled tissue adaptations, which regulate the ability of surface TLRs to 
promote signal transduction cascades that terminate in pathological situations. For 
example, TLR4 signaling in IEC results in the down-regulation of IRAK1, and thereby 
prevents the induction of an inflammatory program (Chassin et al.). TLR9 is also readily 
present on the surface of IEC (Lee et al., 2006); however to what extent these receptors 
are functional is unclear, as environmental pH plays a critical role in regulating functional 
TLR9 activity (Engel and Barton). Other mechanisms to avoid gross activation of the 
epithelial barrier upon recognition of luminal derived TLR ligands also likely exist.  
 
Hematopoietic cells in the intestinal lamina propria have also evolved 
mechanisms to sustain constitutive TLR engagement in the absence of an undue 
pathological response. For instance, expression of the ubiquitin-editing enzyme, A20, in 
APC prevents spontaneous reactivity to the commensal microbiota (Turer et al., 2008). 
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Such a pathway illustrates the importance of having regulatory mechanisms in place to 
modulate the activation status of APC within the intestinal tract and also demonstrates 
that these cells constitutively receive commensal dependent signals. This 
notwithstanding, constitutive recognition of commensal DNA via TLR9 endows APC with 
the capacity to elicit TH responses in intestinal effector sites in the absence of overt 
pathology. Given that TLR9/bacterial DNA interactions are predicated on an active 
sensing mechanism in these cells, it stands that the ability of this pathway to drive an 
inflammatory response is conserved in the event of pathogen encounter. 
Vitamin	  A	  metabolism	  promotes	  TH-­‐1	  and	  TH-­‐17	  adaptive	  immune	  responses	  via	  
retinoic	  acid/RARα 	  
 
A summary of the data in Chapter 2 and Chapter 3 indicates that signals 
dependent on vitamin A metabolism and TLR9 engagement contribute to T cell 
homeostasis in the GI tract, which in turn, shapes host responsiveness to mucosal 
pathogens. Although vitamin A metabolism in LpDC appears to favor Foxp3+ Treg 
development and/or maintenance in the GALT, while commensal DNA interactions with 
TLR9 in LpDC appear to favor TH development and/or maintenance, how the signaling 
pathways downstream of these cues converge and regulate one another in T cells is 
unclear and merits further investigation. Studies in this regard will also help to further 
clarify findings in Chapter 4, which demonstrate that vitamin A metabolism is required 
for GALT Foxp3+ Treg differentiation and optimal TH-1 and TH-17 responses. Previous 
studies have demonstrated the importance of RA precursors, such as retinol and retinal 
in the maintenance of energy homeostasis (Acin-Perez et al.; Ziouzenkova et al., 2007). 
However, work here suggests that these precursors are dispensable for adaptive 
immune responses. In support of this, administration of RA to VAI mice orally challenged 
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with T. gondii or vaccinated with a mutated E. coli labile toxin, completely restored CD4+ 
T cell responses to levels observed in WT animals.  
 
RA signals are transduced by at least four known nuclear receptors including: 
RARα, RARβ, RARγ, and PPARβδ, which are expressed differentially in multiple cell 
types (Mora et al., 2008). Given the nature of the add-back experiments performed in 
Chapter 4, it is difficult to propose a precise and all-inclusive mechanism for the 
coordinated activities of RA, which would account for the restoration of adaptive immune 
responses. One receptor that appeared particularly important was RARα, which has in 
fact been shown to facilitate accessibility to other genes involved in vitamin A 
metabolism, including RARβ2, which also controls other inducible RA responsive genes 
(Corlazzoli et al., 2009; Ren et al., 2005). An examination of the GALT in Rara–⁄– mice 
indicated that they shared several overlapping immunological defects with VAI mice. In 
addition to a disrupted T cell equilibrium in GALT effector sites, the immune response 
upon oral vaccination was similarly impaired in Rara–⁄– animals. But, perhaps, the most 
unexpected finding in Chapter 4 was the importance of RA/RARα signaling in T cell 
activation and proliferation.  
RARα 	  regulates	  the	  acquisition	  of	  effector	  T	  cell	  function	  in	  a	  cell	  intrinsic	  
manner	  
 
In the absence of RARα, T cell activation, proliferation, and survival were 
impaired as a result of a cell intrinsic defect. Mammalian TOR activation, which regulates 
multiple pathways essential for cell growth, proliferation, survival and differentiation 
(Wullschleger et al., 2006), was noticeably reduced. Further, Ca2+ mobilization in 
response to TCR/CD3 engagement was impaired in Rara–⁄– T cells, as well as, WT T 
cells exposed to the pan RAR antagonist, LE540, prior to activation. As retinoids are 
 137 
constantly present in the serum (Kane et al., 2008a; Kane et al., 2008b), and naïve T 
cells were observed to actively transcribe Rara, it is possible that steady-state RA/RARα 
signals constitutively modulate protein expression and/or kinase activity to facilitate T 
cell activation upon TCR engagement. In this regard, it may be worthwhile to examine 
steady-state RA activity in T cells, which could be performed using mice that have been 
engineered with a transgenic RA-responsive element reporter (Svensson et al., 2008). 
Although these findings would theoretically impact the development of all TH subsets, 
including Foxp3+ Treg, it is important to note that the foregoing studies did not assess TH-
2 responses in VAI mice nor in Rara–⁄– mice. Therefore, it is still not clear precisely how 
defects in RA/RARα signals contribute to TH-2 development.  
 
Previously, it was demonstrated that the strength of signal through the TCR could 
function as a crucial determinant in TH-1 versus TH-2 polarization. In particular, weaker 
stimulation achieved with a low-dose of cognate peptide or an altered peptide ligand 
favored the development of TH-2 cells, both in vitro and in vivo (Constant et al., 1995; 
Hosken et al., 1995; Pfeiffer et al., 1995). Conversely, increasing the antigen dose or 
strength of peptide/MHC interactions with TCR favored the development of TH-1 cells. 
These findings set the stage for more recent data highlighting that TH-1 and TH-2 cell 
induction may have different signaling requirements. For instance, altered peptide 
ligands, which skew T cell polarization in the TH-2 direction, were observed to induce 
sustained reductions and more transient spikes in Ca2+ mobilization (Brogdon et al., 
2002). Pharmacological inhibition/reduction of extracellular signal-related kinase (ERK) 
activity was also shown to sensitize cells for TH-2 polarization under normally TH-1 
polarizing circumstances (Yamane et al., 2005). As for a TH-2 polarizing antigen, 
Schistosoma mansoni egg antigen was recently shown to contain a ribonuclease that 
specifically impaired conjugate formation between dendritic cells and CD4 T cells, 
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presumably lowering the strength of TCR signaling (Steinfelder et al., 2009). Based on 
these findings, it is tempting to speculate that the activation defects observed in the 
absence of RA/RARα may have a less pronounced impact on in vivo TH-2 responses. 
Nevertheless, there is a notable correlation between the incidence of worm infection, 
which requires a TH-2 response for effective expulsion (Paul and Zhu), and micronutrient 
deficiencies, particularly in vitamin A (Koski and Scott, 2001). Importantly, epithelial cells 
and accessory cells, such as basophils, often play critical roles in the initiation and 
amplification of TH-2 responses in vivo (Anthony et al., 2007; Paul and Zhu). The 
function of these cells may be dysregulated in the absence of RA/RARα signaling. 
Multipotent progenitors and innate lymphoid cells, which are also important mediators of 
TH-2 responses (Moro et al.; Neill et al.; Saenz et al.), may also be affected in these 
conditions.  
 
Based on the data reported above, a tentative model for the influence of 
RA/RARα in mucosal immunity may be constructed. Antigen derived from 
food/environmental constituents, commensals or invasive pathogens is captured in the 
lamina propria by antigen presenting cells, which include both migratory and resident 
subsets. The migratory APC that captures antigen is the CD103+ lamina propria DC, 
which is able to synthesize RA. The resident APC that captures antigen is CD103– and is 
less capable to synthesize RA. How antigens captured by these cells end up being 
transferred to and presented by the migratory CD103+ subset remain unclear, though it 
may involve a mechanism such as exosomal transfer and apoptosis (Thery et al., 2009; 
Trombetta and Mellman, 2005). Upon entry into the draining mesenteric lymph nodes, 
CD103+ LpDC may form a cognate interaction with a naïve T cell constitutively 
expressing RARα. RA secreted by LpDC may influence the phenotype of the T cell 
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during activation, including the upregulation of mucosal homing markers and the 
acquisition of Foxp3. Ultimately, however, the cytokines and costimulatory signals 
elicited by the antigen and environment shape the polarity of the response (Figure 35, 1 
versus 2). There is also a possibility that autocrine/paracrine interactions with RA 
influence cytokine production by LpDC and contribute to the polarity of the response. For 
instance, RA was shown to enhance TGF-β production by follicular DC, and may 
potentially exert similar effects on LpDC (Figure 35, 3). As TGF-β is critical for the 
development of both Foxp3+ Treg and TH-17 cells, this could explain why the induction of 
both of these subsets is impaired in VAI mice. Nevertheless, these aspects are 
secondary to the role of RA/RARα signals in controlling early T cell activation and 
proliferation. The data in Chapter 4 also suggest that RA/RARα plays a role in 
regulating tonic T cell signal transduction. Therefore, other sources of RA, including the 
serum and stroma may be critical for the coordination of early T cell activation events 
(Figure 35, 4). 
Understanding	  the	  localization	  of	  RARα 	  will	  provide	  clues	  into	  how	  it	  regulates	  
T	  cell	  activation.	  
 
RARα is a complexly regulated protein, making it difficult to draw any immediate 
conclusions on how precisely it regulates signaling events involved in T cell activation 
and proliferation. In addition to it’s clear function as a transcriptional modifier, extra-
nuclear activities of RARα have previously been noted in non-hematopoietic cells 
(Rochette-Egly and Germain, 2009). For example, RARα has been described to interact 
with the p85 subunit of phosphoinositide 3-kinase (PI3K) (Masia et al., 2007), which is 
involved in activating the Akt pathway. Although, little is known about the steady-state 
regulation and localization of RARα in T cells, a mechanism on par with this is at least 
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consistent with the reduction of Akt phosphorylation observed upon activation of Rara–⁄– 
T cells in Chapter 4. Of course, RARα has also been linked to other pathways involved 
in T cell activation, most notably the AP-1 pathway. In particular, RARα has been shown 
to induce expression of the phosphatase, MKP-1, which negatively regulates JNK 
activity through both transcriptional dependent and independent means (Lee et al., 1999; 
Xu et al., 2002). This in part explains the inhibitory effect of RA on AP-1 activity. 
Although it is unclear whether RA/RARα positively regulates MKP-1 in T cells, loss of 
this protein was shown to impair T cell activation, as well as TH-1 and TH-17 responses in 
vivo (Zhang et al., 2009b). Importantly, proper regulation of JNK activity has also been 
demonstrated to be crucial for T cell proliferation, where early over-activation promotes 
cell death, while lack of activation promotes proliferation (Berger et al.; Dong et al., 
2000). Future studies on the role of RA/RARα in T cell function will benefit by a better 
understanding of the localization and regulation of RARα, in addition to the target 
molecular pathways. 
Influence	  of	  RA	  on	  T	  cell	  responses	  in	  situ:	  
 
 The potential inhibitory effect of RA/RARα signaling on AP-1 activation in T cells 
coupled with recent data showing that RA can curb cytokine production by 
effector/memory T cells suggest that RA may down-modulate T cell activity in situ 
(Figure 36, 1). RA may support yet another regulatory circuit, as previously discussed, 
via activation of TGF-β in this tissue environment. In these ways, RA may contribute to 
the preservation of tissue integrity and barrier protection. These regulatory effects may 
promote the maintenance, functional differentiation, and/or expansion of Foxp3+ Treg and 
also counter the risk of excessive responsiveness to bacteria lying in close apposition to 
the epithelial barrier, such as SFB, the presence of which also depends on vitamin A 
(Figure 36, 2 and 3). Although a recent report pointed out that deficiency in vitamin A 
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can result in perturbations to the commensal microbiota, including the loss of SFB, a 
comprehensive metagenomic analysis of the differences between commensal microbial 
communities in vitamin A replete versus deficient hosts has not been undertaken. From 
an evolutionary perspective, the model proposed here argues that vitamin A metabolism 
may not only permit the propagation and survival of commensal bacterial species with 
more immunostimulatory features, but also facilitates host evolutionary mechanisms to 
tolerate these species. 
Closing	  Remarks:	  
 
 
The experiments described in this thesis highlight the importance of commensal 
DNA and retinoic acid in the promotion of mucosal immunity. Constitutive signals derived 
from both of these cues were essential to the maintenance of T cell homeostasis in the 
GI tract, without which adaptive mucosal immune responses could not proceed 
efficiently. Although TLR9 signaling was revealed to possess a non-redundant function 
in the GI tract, it was dispensable for immune responses to systemic challenge. In 
contrast, RA was required for both mucosal and systemic adaptive immune responses 
and was revealed to regulate the acquisition of effector T cell responses in a cell intrinsic 
manner. Evolutionarily, these findings correspond with the compartmentalization of these 
elements: where commensal DNA is typically restricted to the GI tract; while RA, through 
robust storage and chaperone mechanisms, is able to traverse the entire body. Given 
this ubiquity, the capacity of RA to induce both regulatory and inflammatory responses 
also likely constitutes an adaptation. Overarchingly, these data support the premise that 
the successful integration of commensal microbial and nutrient derived signals provides 
a crucial immunological advantage to the host. 
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Models:	  
Figure 35. Retinoic acid in the induction of Foxp3+ Treg and helper T cell 
responses. 
(1) In the absence of an inflammatory stimulus, LpDC are poised to induce Foxp3+ Treg. 
This process may occur in response to food or environmentally derived antigen (2) 
Commensal microbiota potentially alter the ability of LpDC to induce Foxp3+ Treg. For 
example, commensal derived DNA provide a potent tonic signal that favors the 
development of various TH programs. Other inflammatory stimuli, especially invasive 
pathogens, also lead to the induction of TH programs. These studies, in particular, were 
focused on the development of adaptive TH-1 and TH-17 responses. (3) Migratory 
CD103+ lamina propria DC possess classical DC functions, including the ability to 
initiate T cell responses. Their polarizing capacity may be modified in situ via autocrine 
or paracrine RA signaling. (4) RA/RARα signaling critically controls early T cell 
activation and proliferation. Although LpDC derived RA is likely instrumental for 
upregulation of mucosal homing molecules and acquisition of Foxp3, other sources, 
including serum and stroma, may regulate T cell signal transduction events. 
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Figure 36. Retinoic acid in the regulation of adaptive T cell responses and 
composition in intestinal tissue 
(1) RA can directly inhibit cytokine production by effector/memory T cells (Hill et al., 
2008). This metabolite was also shown to suppress T cell expression of IL-6R and IL-
23R, which may also down-modulate their effector capacity (Hill et al., 2008; Xiao et al., 
2008)   (2) The ability of RA to promote the activation of TGF-β may also limit the 
outgrowth of TH cells and promote Foxp3+ Treg activities and/or expansion. (3) Vitamin A 
sustains the presence of certain commensal microbiota, including SFB, and may be an 
important factor for establishing and maintaining commensal diversity. 
 
 144 
CHAPTER	  6:	  Material	  and	  Methods	  	  
General	  methods:	  
 
Mouse strains: 
C57BL/6 (WT), B6.SJL (CD45.1), OTII transgenic, and OT-II transgenic RAG-1–/– mice 
were purchased from Taconic Farms (Rockville, MD). Foxp3eGFP and DEREG mice were 
originally obtained from Dr. M. Oukka (Bettelli et al., 2006) and Dr. T. Sparwasser (Lahl 
et al., 2007), respectively, and bred in house. B6.129P2-Tlr9tmAki (Tlr9–/–) (Hemmi et al., 
2000) mice were obtained from Dr. S. Akira (Osaka University) via Dr. R. Seder (Vaccine 
Research Center, NIH) and backcrossed 11 generations onto the C57BL/6 background 
from Taconic Farms. OTII transgenic Foxp3eGFP mice were generated by crossing the F2 
progeny of OTII x Foxp3eGFP breeders. Tlr9–/–Foxp3eGFP mice were generated by crossing 
the F1 progeny of Tlr9–/– x Foxp3eGFP breeders. Tlr9–/–B6.SJL mice were generated by 
crossing the F1 progeny of Tlr9–/– x B6.SJL breeders. Rarα–/– mice were a generous gift 
of Dr. P. Chambon (Chapellier et al., 2002) and obtained via Dr. C. Benoist (Harvard 
Medical School), then bred in house. Experiments with Rarb–/– and Rarg–/– mice were 
performed under the guidance of Dr. N. Ghyselinck (igbmc, France). B6.129S6-Il6tm1Kopf 
(Il-6–/–) mice were purchased from the Jackson Laboratory and B6.129P2-Myd88tmAki 
(Myd88–/–) mice were kindly provided by Dr A. Sher.  
 
All mice were bred and maintained under pathogen-free conditions at an American 
Association for the Accreditation of Laboratory Animal Care accredited animal facility at 
the NIAID and housed in accordance with the procedures outlined in the Guide for the 
Care and Use of Laboratory Animals under an animal study proposal approved by the 
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NIAID Animal Care and Use Committee. For each experiment, mice were gender, aged 
and/or littermate matched. All mice were used between 9 and 13 weeks of age. 
 
Vitamin A diet studies: 
Vitamin A deficient (TD.09838, yellow) and sufficient (20,000 IU vitamin A/kg, TD.09839, 
orange) diets were purchased from Harlan Teklad Diets. At day 14.5 of gestation, 
pregnant females were administered either Vitamin A deficient or sufficient diet and 
maintained on diet until weaning of litter. Upon weaning, females were returned to 
standard Harlan chow, while weanlings were maintained on special diet until use. Diet 
was replaced in feed hopper every 3-4 days to prevent degradation and stored at 4-8oC. 
Diet stocks were stored in vacuum-sealed packages and discarded 3 weeks after 
opening. For breeding, females were rested on a standard Harlan chow diet for at least 2 
weeks prior to re-mating. After 3 birth cycles under the vitamin A deficient diet, females 
were retired.  
 
Tissue preparations: 
Cells from Spleen (Sp) and mesenteric lymph nodes (mln), were prepared by teasing 
and gently smashing the tissue through a 70-µm cell strainer with the rubber end of a 
plunger from a 3ml syringe (BD).  
 
In order to prepare small intestinal lamina propria (Lp) tissue cell suspensions, adventitial 
fat was carefully stripped away from the whole small intestine. Peyer’s patches (Pp) 
were then carefully excised, and the remaining tissue was cut longitudinally, extensively 
washed in cold HBSS w/o Ca2+ and Mg2+ (cellgro), then cut into ~ 1cm segments. 
Segments were treated with RPMI-1640 medium (Hyclone) containing: 3% FCS, 
100µg/ml Penn/Strep, 25 mM HEPES (Hyclone), 50 µM β-mercaptoethanol (β-ME) 
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(Gibco 1000X), 5mM EDTA, and 145 µg/ml of Dithiothreitol (DTT) for 20 min in an 
incubator at 37ºC/5% CO2 with constant magnetic stirring.  
IEL fraction: Tissue was then collected into a hand-held, fine mesh, sieve placed atop a 
collection beaker on ice. The pieces were then collected and placed into a 50ml conical 
containing 10-15ml of serum free media. Tissue was then further digested in serum free 
media containing: 25 mM HEPES and 50 µM β-ME with liberase CI (200 µg/ml, Roche) 
or liberase Tl (100 µg/ml, Roche) in conjunction with DNase I (500 µg/ml, Sigma-Aldrich) 
under continuous magnetic stirring in an incubator at 37ºC/5% CO2 for 26-30 min. 
Digested tissue was then immediately diluted in RPMI-1640 medium containing: 3% 
FCS, 100µg/ml Penn/Strep, 25 mM HEPES and 50 µM β-mercaptoethanol, and serially 
mashed through 70- and 40-µm cell strainers (BD Biosciences). Cell suspensions were 
spun down and resuspended in complete RPMI-1640 medium (Complete) containing: 
10% FBS, 100µg/ml Penn/Strep, 25mM HEPES, 2mM L-glutamine, 1 mM Na Pyruvate 
(cellgro), 1X MEM nonessential amino acids (MEM) (cellgro) and 50 µM of β-ME – prior 
to use.  
 
For Pp preparations, lymphoid aggregates were treated with RPMI-1640 medium 
containing: 3% FCS, 100µg/ml Penn/Strep, 25 mM HEPES, 50 µM β-ME, 5mM EDTA, 
and 145 µg/ml of DTT for 20 min in an incubator at 37ºC/5% CO2. They were then 
washed up-and-down several times with a 1ml pipette and strained from media, which 
was then discarded. Next, tissue was resuspended with serum free RPMI-1640 
containing: 25mM HEPES, 50 mM β-ME, liberase CI (100 µg/ml) or liberase Tl (50 
µg/ml) and 150 µg/ml DNase I, minced, and digested for 20 min prior to serially 
smashing through 70- and 40-µm cell strainers. 
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CD4+ T cell purification for in vitro studies: 
Sp and peripheral LNs were harvested, teased apart and gently passed through a 70µm 
filter. After washing, cells were RBC lysed in ACK-lysis buffer (Lonza) for 1.5 min on ice, 
washed again and then enriched for CD4+ T cells using a negative selection CD4 T cell 
isolating kit and an autoMACs™ as outlined above. The enriched fraction was further 
labeled with a mAb cocktail containing: α-CD4 (RM4-5), α-CD25 (7D4), α-CD44, (IM7) 
and α-CD62L (MEL-14), where indicated. Cells were then sort purified on a 
FACSVantage™ or FACSAria™. When eGFP reporter strains were used, eGFP+ cells 
were also excluded. All antibodies were purchased from eBioscience. 
 
CFSE labeling of T cells: 
Cells were labeled at a final density of 1x107cell/ml in 1µM CFSE (CellTrace™ Kit, 
Invitrogen) dissolved in HBSS w/o Ca2+ and Mg2+ for 7 min in an incubator at 
37oC/5%CO2. Labeling was quenched by washing cells 2X in complete RPMI 
supplemented with 30% FBS. Finally, cells were resuspended in ice-cold PBS for 
adoptive transfer via tail vein injection or, alternatively, in complete RPMI as described 
above for in vitro assays. 
 
Dendritic Cell (DC) purification: 
For LpDC, Lp tissue cell suspensions were obtained as described. Cells were then well 
resuspended in a 1.077 g/cm3 iso-osmotic NycoPrep™ medium (Accurate Chemical & 
Scientific Corp.) and gently overlaid with serum free media (one intestine: 5ml 
NycoPrep™ medium + 2ml serum free media in 15ml conical). The low-density fraction 
was collected after centrifugation at 1650 x g for 15 min with the brake off. Note: The 
NycoPrep™ gradient excludes debris, red blood cells and decreases lymphocyte 
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numbers without significantly altering the composition of the different subsets of LpDC. 
Cells were then washed in 4 volumes of RPMI-1640 medium containing: 3% FCS, 
100µg/ml Penn/Strep, 25 mM HEPES, 50 µM β-mercaptoethanol and incubated with a 
mixture of mAb containing: blocking α-CD16/32 (2.4G2) and Rat IgG (Jackson 
Immunoresearch); α-CD11c (HL-3), α-MHC II (I-Ab, AF6-120.1); a non-DC component 
including, α-NK1.1 (PK136) and α-B220 (RA3-6B2); and the DNA intercalater 7-Amino-
actinomycin D (7-AAD, eBioscience) in order to exclude dead cells. α-CD103 mAb (2E7) 
was added in experiments where these cells were desired. All antibodies were 
purchased from eBioscience unless noted. LpDC were defined as CD11c+MHCII+ cells 
and were sort purified on a FACSVantage™ or FACSAria™. In some experiments 
CD103+ and CD103– LpDC were separated. Purity was verified and always exceeded 
90% or cells were not used.  
 
For SpDC, Sp were thoroughly perfused with Liberase CI (100 µg/ml) and DNase I (150 
µg/ml) in serum free media, prepared as described above using a tuberculin syringe 
(BD). Perfused Sp were then cut into fragments and digested for 25 min in an incubator 
at 37ºC/5% CO2. During the last 5 min, 5mM EDTA was added. Sp cell suspensions 
were then gently smashed through a 70µm filter, washed, and enriched for mononuclear 
cells using the NycoPrep™ gradient, as detailed for LpDC. Cells were subsequently 
labeled using the CD11c+ magnetic bead positive selection kit (Miltenyi Biotec) per the 
manufacturer’s instructions, washed, 40µm filtered, and ran through an autoMACs™ 
machine using the purification program, Posseld2. Cells were then washed and 
incubated with a mixture of mAb containing: blocking α-CD16/32 (2.4G2), α-CD11c (HL-
3), α-MHC II (AF6-120.1), and 7-AAD. Labeled cells were sorted as described above to 
purity resulting in > 98%.  
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Flow cytometry: 
All antibodies used were obtained from eBioscience unless specified otherwise. All cell 
acquisition was performed using an LSRII machine with FACSDiVa software (BD 
Biosciences). Data were analyzed using FlowJo software (TreeStar). To calculate 
absolute numbers, the fraction of a particular subset to singlet gated, total living cells 
was multiplied by the total cellularity of the tissue based on trypan blue exclusion. 
 
Statistics: 
Groups were compared with Prism software (GraphPad) using the unpaired or paired 
Student’s t test. 
Chapter	  2:	  
 
In vivo generation of Foxp3+ Treg (oral feeding protocol): 
Cells were extracted from the mesenteric lymph nodes (mln) of OT-II transgenic RAG-1–
/– mice and then adoptively transferred into B6.SJL (CD45.1) hosts. Alternatively, cells 
were extracted from the spleen (Sp) and secondary LNs of OTII transgenic Foxp3eGFP 
mice (CD45.2). They were then labeled using a negative selection CD4 T cell isolating 
kit (Miltenyi Biotec) per the manufacturer’s instructions, washed, 40µm filtered, and ran 
through an autoMACs™ on the sensitive mode to obtain highly enriched CD4 T cells. 
These cells were labeled with a non-CD4+ T cell cocktail of mAb, including: blocking α 
-CD16/32 (2.4G2), α-CD8α (53-6.7), α-NK1.1 (PK136), and α-B220 (RA3-6B2); and 
α-CD25 (7D4). Cells were then sort purified on a FACSAria™ to obtain a pure 
CD4+CD25–eGFP– population, subsequently labeled with CFSE, and then adoptively 
transferred into 10 wk-old B6.SJL (CD45.1) hosts on diet study. In each case, recipients 
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received 1x106 cells and were fed 1.5% OVA (grade V; Sigma-Aldrich) dissolved into 
autoclaved drinking water for 5 consecutive days. Solution was replaced every 48 hrs. 
Tissues were collected on day 6, and Foxp3 expression was assessed in transferred 
cells by intracellular staining as detailed below.  
 
Assessment of DC costimulatory activity:  
MHC II+ CD11c+ DC were stained with the following fluorescent dye-conjugated mAb: 
α-CD11b (M1/70), α-CD103 (2E7), α-CD40 (3/23, BD Biosciences), α-CD80 (16-10A1, 
BD Biosciences) and α-CD86 (GL-1, BD Biosciences)  
 
In vitro Foxp3+ Treg induction assay and analysis: 
105 CD4+eGFP– T cells or CD4+CD25–CD62+CD44– naïve T cells from WT, OT-II, Rara–/–
, Rarb–/– or Rarg–/– mice were cultured with 2.5 x 103 – 2 x 104 purified Lp or SpDC in 
250µl of complete medium (10% FBS, 25mM HEPES, 2mM L-glutamine, 100µg/ml 
Penn/Strep, 1 µM Na Pyruvate, 1X MEM, 50 µM of β-ME) with soluble α-CD3ε mAb (1 
µg/ml) (145-2C11, BD Bioscience) and recombinant hTGF-β (0.6 or 3 ng/ml) (Cell 
Science or R&D Systems) for 5 days. For each Rar–/– mouse, the appropriate littermate 
controls were used. The precise ratio of T cells to DC used is provided in the text.  In 
some experiments the following were included in the cococulture conditions:  
1. All-trans retinoic acid (Sigma) or vehicle control at varying concentrations  
2. Retinoic acid receptor inhibitors: LE540 (Wako Chemicals USA) and LE135 
(Tocris Bioscience) or vehicle control. Each were added at 1µM 
3. α-TGF-β mAb (1D11.16.8) or isotype control mAb MOPC (31C) (both from 
ATCC) at 10µg/ml.  
 151 
All-trans retinoic acid, LE540 and LE135 were resuspended in Biotechnology 
Performance Certified DMSO (Sigma). Human recombinant hIL-2 (5 ng/ml) (Peprotech) 
was added to cultures wells every other day beginning on day 2. On day 5, cells were 
stained with α-CD4 mAb (RM4-5) and 7-AAD, to discriminate live/dead cells. Foxp3+ 
cells were then detected either by eGFP expression and/or α−Foxp3 (FJK-16) following 
fixation and permeabilization with the kit provided by eBioscience in accordance with the 
manufacturerʼs protocol.  
 
For viability assays, cultured cells were additionally stained with annexin V (BD 
Biosciences) and 7-AAD (1:50) in annexin-V binding buffer (BD Biosciences) per 
manufacturer’s instructions to detect dying/dead cells.  
 
For phenotypic assessment, eGFP+CD4+ cells were further stained for α-CD103 (2E7) or 
α-α4β7 (DATK32) mAb, α-CD25 (PC61.5) and 7-AAD. Live cells were analyzed by flow 
cytometry. 
 
In vitro suppression Assays: 
Treg ability to suppress T cell proliferation was determined as previously reported 
(Thornton and Shevach, 1998). Briefly, CD4+GFP+ Treg that were obtained after sorting 
cells from SpDC cocultures, LpDC cocultures or ex vivo were cultured in 96-well flat-
bottom plates (Costar) with 5 x 104 freshly isolated CD4+GFP- T cells used as responder 
T cells. For antigen presenting cells, splenocytes were depleted of CD90+ cells using a 
positive selecting isolation kit and running through an autoMACs™. They were then 
irradiated and cultured at 105 per well. Cells were stimulated with 0.5 µg/ml α-CD3 (145-
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2C11) mAb for 72 hours in an incubator at 37ºC/5% CO2. Cultures were pulsed with 
[3H]TdR (MP Biomedicals, Solon, OH) at 1 µCi/well for the last 8 hours of culture.  
 
Retinal dehydrogenase (RALDH) activity in DC:  
Single-cell suspensions were incubated in ice-cold HBSS with blocking α-CD16/32 
(2.4G2) and 0.2mg/ml Rat IgG, and stained with the following fluorochrome-conjugated 
mAb: α-CD11c (N418), MHC II (M5/114.15.2), α-CD11b (M1/70), α-F4/80 (BM8), α-
CD103 (2E7) and α-TCR-β (H57-597) for 15min on ice. Surface labeled cells were then 
washed and resuspended in 100µl of ALDEFLUOR assay buffer containing 1/100 
ALDEFLUOR® reagent. Control wells were pre-incubated with (1/25) DEAB solution that 
came with the kit. Samples were then stored in an incubator at 37oC/5% CO2 for 30min 
away from light. Cells were then washed with 150ml of fresh ALDEFLUOR assay buffer, 
centrifuged, and resuspended in 200ml of ALDEFLUOR assay buffer containing 
0.3µg/ml DAPI (Sigma Aldrich) to discriminate living/dead cells. All reagents were 
prepared according to the manufacturer’s protocol (STEMCELL Technologies). 
Chapter	  3:	  
 
T cell phenotype:  
Single-cell suspensions were stained with fluorochrome-conjugated to the following 
antibodies: α-TCR-β (H57-597), α-CD4 (RM4-5), α-CD8α (53-6.7), α-CD25 (PC61.5) in 
the presence of for 15min on ice. For examination of transcription factors and cellular 
proliferation, cells were subsequently treated with the Foxp3 staining kit (ebioscience) in 
accord with the manufacturer’s instructions and stained for 30-45 min on ice with Ki-67 
(B56, BD Pharmingen), Foxp3 (FJK-16s), T-bet (eBio4B10) and/or RORγ(t) (AFKJS-9) 
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or isotype controls: mouse IgG1 (BD Pharmingen) rat IgG2a (eBR2a), mouse IgG1 
(clone P3) - in 1/100 α-mouse CD16/32 and 0.2mg/ml purified Rat IgG.  
 
In vitro T cell/LpDC coculture assays: 
CD4+eGFP– T cells or CD4+CD25–CD62+CD44– naïve T cells from Foxp3eGFP, Tlr9–/–
Foxp3eGFP, WT, Tlr9–/– or Myd88–/– mice were cocultured with purified LpDC at a 1:10 ratio in 
complete medium, as described above, in Foxp3+ Treg cell polarizing conditions. These 
conditions included soluble α−CD3 (1 µg/ml) (145-2C11) and rhTGF-β (0.6 ng/ml) (R&D 
Systems). 5 ng/ml of rhIL-2 was supplemented in cocultures every 2 days. In experiments 
detailed in Figure 17 the following were added to co-coculture conditions: a) peptidoglycan 
(PGN, from Staphylococcus aureus), ultra-pure lipopolysaccharide (LPS, E. coli K12), 
flagellin (Flgn, from S. typhimurium), ODN 1826 (CpG, 5ʼ-tccatgacgttcctgacgtt-3ʼ) at the 
indicated concentrations. All were purchased from Invivogen. In experiments detailed in 
Figures 20 and 21, various combinations of mAb including: α-IL-6 (MP5-20F3), α-IL-6R 
(D7715A7), α-IL12/23p40 (C17.8), α-IL27p28 (R&D) and/or α-IFN-γ (XMG1.2 or 11B11), or 
isotype controls α-IgG1κ (R3-34) and/or α-IgG2α (R35-95) were added at the initiation of 
cocultures in Foxp3+ Treg cell polarizing conditions containing CpG (10 µg/ml). All antibodies 
were purchased from BD Biosciences, excluding α-IL27p28, which was purchased from R&D 
Systems. On day 5, cells were surface stained with the following fluorochrome-conjugated 
antibodies: α-CD4 (RM4-5), α-α4β7 (DATK32), α-CD25 (PC61.5), and the viability marker 7-
AAD. Foxp3 cells were detected by eGFP expression and/or α−Foxp3 (FJK-16) following 
fixation and permeabilization with the kit provided by eBioscience in accordance with the 
manufacturerʼs protocol.  
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ELISA: 
Upon harvest of coculture supernatants, IL-4, IL-10, IFN-γ and IL-17A were quantitated 
with the DuoSet® ELISA system (R&D Systems) per the manufacturer’s instructions.  
 
Gut flora DNA extraction: 
Gut contents from the caecum and the colon of naïve C57BL/6 mice were collected and 
washed in cold PBS. The pellet was resuspended in lysis buffer (10 mM Tris/HCl, 50 mM 
EDTA, pH 8.0) containing lysozyme (0.5 mg/ml; Sigma-Aldrich). After incubation at 37°C for 
2 h, 2 mg/ml of proteinase K and 1% SDS were added and the sample incubated at 60°C for 
3 h. DNA was then purified by a series of 7 consecutive phenol-chloroform-isoamyl alcohol 
affinity extractions. 
 
Intracellular cytokine staining of ex vivo isolated cells from naïve mice: 
For assessment of CD4+ T cells from WT Foxp3eGFP and Tlr9–/–Foxp3eGFP mice, cell 
suspensions were enriched for T cells by incubating with CD90.2 positive selecting 
magnetic beads (Miltenyi Biotec) in accordance with the manufacturer’s protocol. T cells 
were obtained by running the labeled suspension through an autoMACs™ on the 
program Posseld2. Enriched T cell suspensions were then mitogenically stimulated with 
phorbol 12-myristate 13-acetate (PMA, 50ng/ml) + ionomycin (5µg/ml) for 4 hours in U-
Bottom 96-well plates containing complete (200µl/well) media and Brefeldin A (BFA, 
GolgiPlug™). Residual DMSO was then washed from wells and cells were incubated 
with 1/500 of Molecular Probes LIVE/DEAD® Fixable Blue Dead cell stain kit (Invitrogen) 
in HBSS according to the manufacturer’s guidelines to distinguish healthy from dying 
cells, and subsequently fixed in 1.6% paraformaldehyde (PFA, Electron Microscopy 
Sciences) prior to staining intracellularly for cytokines. For intracellular cytokine staining, 
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cells were stained with the following fluorochrome-conjugated antibodies: α-TCR-β, α-
CD4, α-CD8α, α-IFN-γ (XMG1.2), α-IL-17A (eBio17B7), α-IL-10 (JES5-16E3) or isotype 
controls: rat IgG1, rat IgG2a, ratIgG2b, and mouse IgG1 (clone P3) in the presence of α-
mouse CD16/32 and 0.2mg/ml of Rat IgG for 45 min on ice in FACS buffer containing 
0.5% saponin from Quillaja bark (Sigma).  
 
E. cuniculi infection Protocol: 
Parasite cultivation: A rabbit isolate of E. cuniculi was obtained from Waterborne Inc. 
and used throughout the study. The parasites were maintained by continuous passage 
in rabbit kidney (RK13) cells obtained from the American Type Culture Collection (ATCC 
#CCL37) and maintained as previously described (Bouladoux et al., 2003).  
 
For infection: Spores were resuspended in sterile PBS, and immediately used for 
inoculation of mice or cell cultures. Mice were infected by intragastric gavage with 5×106 
fresh spores in a volume of 200 µl. In some experiments, mice were infected i.p. using 
the same number of spores of E. cuniculi.  
 
For CD25+ cell depletion: C57BL/6 and Tlr9−/− mice were injected i.p. with 0.5 mg of anti-
CD25 (clone PC61.5) or the corresponding isotype control (clone GL113) 3 days 
preceding and on day 0 and day 7 of infection. 
 
Quantification of E. cuniculi in tissues:  
 
Duodenum (1cm piece starting at 3cm) and liver (weighed out piece from same lobe) 
were removed from infected mice and instantly snap frozen in liquid nitrogen. Tissues 
were next homogenized and then digested with proteinase K (Invitrogen or Qiagen). 
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DNA was subsequently extracted either with phenol-chloroform-isoamyl alcohol followed 
by ethanol precipitation or with the DNeasy® Tissue kit from Qiagen. Quantitative 
real-time PCR was performed in triplicates with 50 ng of total tissue DNA, the iQ SYBR 
Green Supermix (BioRad), and the following primers specific for a 268-bp DNA 
sequence of the SSU rRNA gene from E. cuniculi (Weiss and Vossbrinck, 1998): forward 
5’-GTGAGACCCTTTGACGGTGT-3’ and reverse 5’-CTCAGACCTTCCGATCTTCG-3’. 
Real-time PCR was conducted on a Bio-Rad iCycler under the following conditions: 
3 min at 95°C; 40 cycles of: 45 s at 95°C, 60 s at 60°C, and 45 s at 72°C. Genomic DNA 
were extracted from known amounts of E. cuniculi with the QIAamp DNA stool mini-kit 
(Qiagen) and used as PCR standards. A standard curve was generated by linear 
regression on plotted cycle threshold (CT) values of the standards against the logarithms 
of parasite numbers using iCycler iQ Optical System software (version 3.1; Bio-Rad). 
 
In vitro recall assay to E. cuniculi 
 
Single-cell suspensions of Sp, mln, IEL, Lp, and Pp of vaccinated or E. cuniculi-infected mice 
were prepared as described above. BMDC were generated as previously described (Lutz et 
al., 1999). Leukocytes (5×105) were incubated with 1×105 BMDC in 250 µl RPMI, 55 mM 
2-β mercaptoethanol, and 10% FBS per well of a 96-well U-bottom plate. BMDC were 
previously incubated for 8 hrs with or without recombinant vaccinia virus expressing OVA 
protein (10 pfu / BMDC), E. cuniculi spores (parasite:BMDC ratio, 10:1) or OVA peptide (1 
µg/ml)  in the presence of 20 ng/ml GM-CSF (Peprotech) and washed before culture with 
leukocytes. After 3 days at 37°C in 5% CO2, culture supernatants were collected for cytokine 
assays. IFN-γ, IL-4, IL-6, IL-10, and IL-17 were quantitated in culture supernatants of 
restimulated leukocytes using the DuoSet® ELISA system. 
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Antibiotic treatment: 
3-wk or 8-wk-old C57BL/6 male mice were provided ampicillin (1 g/l), vancomycin 
(500 mg/l), neomycin trisulfate (1 g/l), and metronidazole (1 g/l) in drinking water as 
previously described (Rakoff-Nahoum et al., 2004). All antibiotics were purchased from 
Sigma-Aldrich. Where indicated, mice also orally received: 100 µg CpG ODN 1826 in 
sterile PBS (Coley Pharmaceutical) or 500 µg of extracted gut floral DNA in sterile water 
or 25 mg/kg of LPS from Escherichia coli (serotype 026:B6 from Sigma-Aldrich) once 
weekly from the start of the antibiotic course. 
Chapter	  4:	  
 
T cell phenotype:  
Single-cell suspensions were incubated in ice-cold HBSS with 1/100 α-mouse CD16/32, 
1/500 LIVE/DEAD® to exclude dead cells, and stained with the following fluorochrome-
conjugated antibodies: α-TCR-β (H57-597), α-CD4 (RM4-5), α-CD8α (53-6.7), α-CD25 
(PC61.5), α-CD44 (IM7), α-CD62L (MEL-14), α-CD103 (2E7), and α-α4β7 (DATK32) for 
15min on ice. For examination of transcription factors and cellular proliferation, cells 
were subsequently treated with the Foxp3 staining kit (eBioscience) in accord with the 
manufacturer’s instructions and stained for 30-45 min on ice with Ki-67 (B56, BD 
Pharmingen), Foxp3 (FJK-16s), T-bet (eBio4B10) and/or RORγ(t) (AFKJS-9) or isotype 
controls: mouse IgG1 (BD Pharmingen) rat IgG2a (eBR2a), mouse IgG1 (clone P3) - in 
1/100 α-mouse CD16/32 and 0.2mg/ml purified Rat IgG.  
 
E. coli LT (R129G)Vaccine Protocol: 
For vaccination, mice were orally inoculated with an isotonic bicarbonate buffer (7.5%, 
200µl/mouse). 10min later, mice were gavaged with a 200µl mixture of 1mg of OVA and 
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20 µg of the mutant form of E. coli LT (R129G) prepared in the same buffer. For 
reconstitution experiments with RA, mice were vaccinated again on day 4. Immune 
responses were then assessed on day 8. For all other experiments, mice were 
vaccinated once per week and immune responses were assessed one week after the 
final challenge.  
 
T. gondii Infection Protocol: 
The parental ME-49 type II strain (ATCC no. 50840) (American Type Culture Collection, 
Manassas, VA, USA) of T. gondii was electroporated with RFP and selected for red 
fluorescence. ME-49 clone C1 was established and passed through mice. To obtain 
tissue cysts, brains were removed from C57BL/6 mice that were inoculated with three 
cysts by gavage 1–2 months prior and homogenized in 1 ml of phosphate buffer saline 
(pH 7.2). Cysts were counted on the basis of 2 aliquots of 20 µl. Diet study mice were 
infected orally with 10 cysts at 9.5-11.5 wks of age. STAg was prepared as previously 
described (Grunvald et al., 1996). 
 
Parasite Burden: 
Human fibroblast (Hs27; ATCC no. CRL-1634) cultures were used to quantify parasite 
burden as described previously (Pfefferkorn and Pfefferkorn, 1976) and (Roos et al., 
1994). In brief, titrations of single-cell tissue suspensions (1x104 up to 1x106 cells) were 
added onto confluent fibroblast monolayers cultured in DMEM (Sigma) supplemented 
with 100mg/ml Penn/Strep and 10% FBS (in 24-well plates). Plaques were detected by 
fluorescence using an Axiovert 40 inverted microscope (Zeiss) outfitted with an RFP 
filter. Titration results are reported in Plaque Forming Units (PFUs). 
 
In vivo RA reconstitution: 
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250µg of all-trans-RA (Sigma Aldrich), resuspended in 30µl of Biotechnology 
Performance Certified DMSO was administered intraperitoneally to vitamin A insufficient 
(VAI) mice every other day. 24hrs after the 3rd injection, mice were infected with T. gondii 
or vaccinated. Injection of RA continued until takedown of the mice. Mice not receiving 
RA, received DMSO vehicle instead. RA was stored at -80oC in pure DMSO in amber 
ependorf tubes. Aliquots were one use only. 
 
Intracellular cytokine staining: 
Tissues were harvested from infected or vaccinated mice, pooled by group, and 
enriched for T cells by incubating with CD90.2 selecting magnetic beads (Miltenyi) in 
accord with the manufacturer’s protocol. T cells were obtained by running the labeled 
suspension through an Automacs (Miltenyi) on the program Posseld2. For T. gondii, T 
cells (2.5x105) were incubated with irradiated BMDCs (5x104) ± STAg (5mg/ml). For 
vaccine, T cells (2.5x105) were incubated with SpDC (5x104) ± OVA (100mg/ml) 
(Worthington). Cells were cultured for 14 hrs in an incubator at 37oC/5%CO2 in 
250µl/well in 96-well flat bottom plates. BFA was added for the final 7 hrs of culture. 
Cells were washed with FACS buffer and stained with 1/500 LIVE/DEAD® fixable Blue 
Dead cell stain kit in HBSS on ice for 15min. After washing 1X with FACS buffer, cells 
were fixed with 1.6% PFA for 20 min at room temp. For intracellular cytokine staining, 
cells were stained with the following fluorochrome-conjugated antibodies: α-TCR-β, α-
CD4, α-CD8α, α-IFN-γ (XMG1.2), α-IL-17A (eBio17B7), α-Foxp3 (FJK-16), α-T-bet 
(eBio4B10), or isotype controls: rat IgG1, rat IgG2a, and mouse IgG1 (clone P3) in the 
presence of α-mouse CD16/32 and 0.2mg/ml purified Rat IgG for 45 min on ice in FACS 
buffer containing 0.5% saponin. All antibodies were purchased from eBioscience. 
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ELISA: 
Tissues were harvested from infected or vaccinated mice, pooled by group, and 
enriched for T cells as described above. For T. gondii, T cells (2.5x105) were incubated 
with irradiated day-6 BMDCs (5x104) ± STAg (5mg/ml) in 250ml/well in 96-well round 
bottom plates for 48 hrs at 37oC, 5% CO2. For vaccine, T cells (2.5x105) were incubated 
with day-7 BMDCs (5x104) that had been infected or not for 8hrs with recombinant 
vaccinia virus expressing OVA (MOI 10:1) for 72hrs at 37oC, 5% CO2. Upon harvest of 
supernatants, IFN-γ and IL-17A was quantitated with the DuoSet® system. In initial 
vaccine experiments, pooled suspensions were not T cell enriched, but rather cultured at 
5x105 cells to 1x105 infected or uninfected BMDCs. 
 
CD4+ T cell activation/ polarization assays: 
Cells were extracted from the Sp and secondary LNs of Rarα–/– or littermate WT mice 
and enriched for CD4+ CD62Lhi T cells using the CD4+ CD62Lhi T cell isolation kit II 
(Miltenyi Biotec) in accordance with the manufacturer’s protocol. For magnetic selection 
steps, cells were 40µm filtered and subsequently passed through manual columns. Cells 
were then CFSE labeled as described above, plated in complete media at 3.38-3.5x105 
cells/well into 96-well flat bottom plates, and stimulated with 1µg/ml of plate-bound α-
CD3ε (BD Pharmingen, 145-2C11, coated over night in 100ml at 4oC) + soluble α-CD28 
(BD Pharmingen, 37.51) + 50U of rhIL-2 (Peprotech). To assess activation, cells were 
harvested after 18hrs and stained for CD4, CD25, CD69 (H1.2F3), and CD71 (R17217) 
in HBSS containing 1/500 of the LIVE/DEAD® stain kit, 1/100 of blocking α-CD16/32, 
and 0.2mg/ml purified Rat IgG for 15 min on ice. Expression of markers was compared 
to unstimulated cells. To assess polarization, cells were further cultured in TH-1 or TH-17 
(no rhIL-2) biased conditions, which included: purified α-IL-4 (11B11) + 10ng/ml of rmIL-
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12; or purified α-IL-4 + α-IFN-γ (R4-6A2) + 20ng/ml rmIL-6 + 0.7ng/ml rhTGF-b, 
respectively. All cytokines, except hIL-2, were purchased from R&D Systems. 48hrs 
post-activation, half the supernatant from each well was removed and measured for the 
cytokines (IFN-γ and IL-17A) by ELISA. Complete media, including polarizing cytokines 
+ blocking antibodies were replenished as cells were removed from αCD3ε and 
transferred into 96-well round bottom plates for 24hrs. CFSE proliferation was then 
measured. 
 
Real-time quantitative PCR: 
Naïve CD4+ T cells were purified from splenic and peripheral LN of 2 mice/assay. RNA 
was then extracted with RNAeasy columns (QIAGEN) and analyzed by quantitative RT-
PCR according to the manufacturer's instructions using primers for murine Rara, Rarb, 
and Rarg (QIAGEN). 
 
Immunoblotting and Reagents: 
Lysates were immunoblotted with the following antibodies: anti-phosphoSer473Akt and 
anti-Akt (Cell Signaling Technology). 
 
 162 
References:	  
 
Acin-Perez, R., Hoyos, B., Zhao, F., Vinogradov, V., Fischman, D.A., Harris, R.A., 
Leitges, M., Wongsiriroj, N., Blaner, W.S., Manfredi, G., and Hammerling, U. Control of 
oxidative phosphorylation by vitamin A illuminates a fundamental role in mitochondrial 
energy homoeostasis. FASEB J 24, 627-636. 
 
Acosta-Rodriguez, E.V., Rivino, L., Geginat, J., Jarrossay, D., Gattorno, M., 
Lanzavecchia, A., Sallusto, F., and Napolitani, G. (2007). Surface phenotype and 
antigenic specificity of human interleukin 17-producing T helper memory cells. Nat 
Immunol 8, 639-646. 
 
Ahern, P.P., Schiering, C., Buonocore, S., McGeachy, M.J., Cua, D.J., Maloy, K.J., and 
Powrie, F. Interleukin-23 drives intestinal inflammation through direct activity on T cells. 
Immunity 33, 279-288. 
 
Ahmad-Nejad, P., Hacker, H., Rutz, M., Bauer, S., Vabulas, R.M., and Wagner, H. 
(2002). Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at 
distinct cellular compartments. Eur J Immunol 32, 1958-1968. 
 
Ahmed, F., Jones, D.B., and Jackson, A.A. (1990). The interaction of vitamin A 
deficiency and rotavirus infection in the mouse. Br J Nutr 63, 363-373. 
 
Allen, C.D., and Cyster, J.G. (2008). Follicular dendritic cell networks of primary 
follicles and germinal centers: phenotype and function. Semin Immunol 20, 14-25. 
 
Annacker, O., Coombes, J.L., Malmstrom, V., Uhlig, H.H., Bourne, T., Johansson-
Lindbom, B., Agace, W.W., Parker, C.M., and Powrie, F. (2005). Essential role for 
CD103 in the T cell-mediated regulation of experimental colitis. J Exp Med 202, 1051-
1061. 
 
Annes, J.P., Munger, J.S., and Rifkin, D.B. (2003). Making sense of latent TGFbeta 
activation. J Cell Sci 116, 217-224. 
 
Anthony, R.M., Rutitzky, L.I., Urban, J.F., Jr., Stadecker, M.J., and Gause, W.C. (2007). 
Protective immune mechanisms in helminth infection. Nat Rev Immunol 7, 975-987. 
 
Apostolou, I., and von Boehmer, H. (2004). In vivo instruction of suppressor 
commitment in naive T cells. J Exp Med 199, 1401-1408. 
 
Artis, D. (2008). Epithelial-cell recognition of commensal bacteria and maintenance of 
immune homeostasis in the gut. Nat Rev Immunol 8, 411-420. 
 
 163 
Atarashi, K., Nishimura, J., Shima, T., Umesaki, Y., Yamamoto, M., Onoue, M., Yagita, 
H., Ishii, N., Evans, R., Honda, K., and Takeda, K. (2008). ATP drives lamina propria 
T(H)17 cell differentiation. Nature 455, 808-812. 
 
Aujla, S.J., Chan, Y.R., Zheng, M., Fei, M., Askew, D.J., Pociask, D.A., Reinhart, T.A., 
McAllister, F., Edeal, J., Gaus, K., et al. (2008). IL-22 mediates mucosal host defense 
against Gram-negative bacterial pneumonia. Nat Med 14, 275-281. 
 
Bajenoff, M., Granjeaud, S., and Guerder, S. (2003). The strategy of T cell antigen-
presenting cell encounter in antigen-draining lymph nodes revealed by imaging of initial 
T cell activation. J Exp Med 198, 715-724. 
 
Banchereau, J., and Steinman, R.M. (1998). Dendritic cells and the control of immunity. 
Nature 392, 245-252. 
 
Bargatze, R.F., Jutila, M.A., and Butcher, E.C. (1995). Distinct roles of L-selectin and 
integrins alpha 4 beta 7 and LFA-1 in lymphocyte homing to Peyer's patch-HEV in situ: 
the multistep model confirmed and refined. Immunity 3, 99-108. 
 
Barnard, J.A., Warwick, G.J., and Gold, L.I. (1993). Localization of transforming growth 
factor beta isoforms in the normal murine small intestine and colon. Gastroenterology 
105, 67-73. 
 
Bashir, M.E., Louie, S., Shi, H.N., and Nagler-Anderson, C. (2004). Toll-like receptor 4 
signaling by intestinal microbes influences susceptibility to food allergy. J Immunol 172, 
6978-6987. 
 
Belkaid, Y., Piccirilo.A.C., Mendez,S.,Shevack,E.Sacks,D.L. (2002). CD4+CD25+ 
regulatory T cells control Leishmania major persistence and immunity. Nature 420, 502-
507. 
 
Belkaid, Y., and Tarbell, K. (2009). Regulatory T cells in the control of host-
microorganism interactions (*). Annu Rev Immunol 27, 551-589. 
 
Bennett, C.L., Christie, J., Ramsdell, F., Brunkow, M.E., Ferguson, P.J., Whitesell, L., 
Kelly, T.E., Saulsbury, F.T., Chance, P.F., and Ochs, H.D. (2001). The immune 
dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by 
mutations of FOXP3. Nat Genet 27, 20-21. 
 
Benson, M.J., Pino-Lagos, K., Rosemblatt, M., and Noelle, R.J. (2007). All-trans retinoic 
acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of 
high levels of co-stimulation. J Exp Med 204, 1765-1774. 
 
Berger, M., Krebs, P., Crozat, K., Li, X., Croker, B.A., Siggs, O.M., Popkin, D., Du, X., 
Lawson, B.R., Theofilopoulos, A.N., et al. An Slfn2 mutation causes lymphoid and 
myeloid immunodeficiency due to loss of immune cell quiescence. Nat Immunol 11, 335- 
 164 
343. 
 
Berlin, C., Berg, E.L., Briskin, M.J., Andrew, D.P., Kilshaw, P.J., Holzmann, B., 
Weissman, I.L., Hamann, A., and Butcher, E.C. (1993). Alpha 4 beta 7 integrin mediates 
lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74, 185-195. 
 
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T.B., Oukka, M., Weiner, H.L., and  
Kuchroo, V.K. (2006). Reciprocal developmental pathways for the generation of 
pathogenic effector TH17 and regulatory T cells. Nature 441, 235-238. 
 
Biesalski, H.K., and Nohr, D. (2004). New aspects in vitamin a metabolism: the role of 
retinyl esters as systemic and local sources for retinol in mucous epithelia. J Nutr 134, 
3453S-3457S. 
 
Bogunovic, M., Ginhoux, F., Helft, J., Shang, L., Hashimoto, D., Greter, M., Liu, K., 
Jakubzick, C., Ingersoll, M.A., Leboeuf, M., et al. (2009). Origin of the lamina propria 
dendritic cell network. Immunity 31, 513-525. 
 
Bohnhoff, M., Miller, C.P., and Martin, W.R. (1964). Resistance of the Mouse's Intestinal 
Tract to Experimental Salmonella Infection. I. Factors Which Interfere with the Initiation 
of Infection by Oral Inoculation. J Exp Med 120, 805-816. 
 
Bonneville, M., Janeway, C.A., Jr., Ito, K., Haser, W., Ishida, I., Nakanishi, N., and 
Tonegawa, S. (1988). Intestinal intraepithelial lymphocytes are a distinct set of gamma 
delta T cells. Nature 336, 479-481. 
 
Bouladoux, N., Biligui, S., and Desportes-Livage, I. (2003). A new monoclonal antibody 
enzyme-linked immunosorbent assay to measure in vitro multiplication of the 
microsporidium Encephalitozoon intestinalis. J Microbiol Methods 53, 377-385. 
 
Bouskra, D., Brezillon, C., Berard, M., Werts, C., Varona, R., Boneca, I.G., and Eberl, G. 
(2008). Lymphoid tissue genesis induced by commensals through NOD1 regulates 
intestinal homeostasis. Nature 456, 507-510. 
 
Bradley, P.J., and Sibley, L.D. (2007). Rhoptries: an arsenal of secreted virulence factors. 
Curr Opin Microbiol 10, 582-587. 
 
Brandl, K., Plitas, G., Mihu, C.N., Ubeda, C., Jia, T., Fleisher, M., Schnabl, B., 
DeMatteo, R.P., and Pamer, E.G. (2008). Vancomycin-resistant enterococci exploit 
antibiotic-induced innate immune deficits. Nature 455, 804-807. 
 
Brenchley, J.M., Price, D.A., Schacker, T.W., Asher, T.E., Silvestri, G., Rao, S., Kazzaz, 
Z., Bornstein, E., Lambotte, O., Altmann, D., et al. (2006). Microbial translocation is a 
cause of systemic immune activation in chronic HIV infection. Nat Med 12, 1365-1371. 
 
 165 
Brogdon, J.L., Leitenberg, D., and Bottomly, K. (2002). The potency of TCR signaling 
differentially regulates NFATc/p activity and early IL-4 transcription in naive CD4+ T 
cells. J Immunol 168, 3825-3832. 
 
Brown, S.L., Riehl, T.E., Walker, M.R., Geske, M.J., Doherty, J.M., Stenson, W.F., and 
Stappenbeck, T.S. (2007). Myd88-dependent positioning of Ptgs2-expressing stromal 
cells maintains colonic epithelial proliferation during injury. J Clin Invest 117, 258-269. 
 
Brustle, A., Heink, S., Huber, M., Rosenplanter, C., Stadelmann, C., Yu, P., Arpaia, E., 
Mak, T.W., Kamradt, T., and Lohoff, M. (2007). The development of inflammatory 
T(H)-17 cells requires interferon-regulatory factor 4. Nat Immunol 8, 958-966. 
 
Bucci, C., Parton, R.G., Mather, I.H., Stunnenberg, H., Simons, K., Hoflack, B., and 
Zerial, M. (1992). The small GTPase rab5 functions as a regulatory factor in the early 
endocytic pathway. Cell 70, 715-728. 
 
Bucy, R.P., Chen, C.L., Cihak, J., Losch, U., and Cooper, M.D. (1988). Avian T cells 
expressing gamma delta receptors localize in the splenic sinusoids and the intestinal 
epithelium. J Immunol 141, 2200-2205. 
 
Bucy, R.P., Chen, C.L., and Cooper, M.D. (1989). Tissue localization and CD8 accessory 
molecule expression of T gamma delta cells in humans. J Immunol 142, 3045-3049. 
 
Cantorna, M.T., Nashold, F.E., and Hayes, C.E. (1994). In vitamin A deficiency multiple 
mechanisms establish a regulatory T helper cell imbalance with excess Th1 and 
insufficient Th2 function. J Immunol 152, 1515-1522. 
 
Caramalho, I., Lopes-Carvalho, T., Ostler, D., Zelenay, S., Haury, M., and Demengeot, J. 
(2003). Regulatory T cells selectively express toll-like receptors and are activated by 
lipopolysaccharide. J Exp Med 197, 403-411. 
 
Carman, J.A., Pond, L., Nashold, F., Wassom, D.L., and Hayes, C.E. (1992). Immunity to 
Trichinella spiralis infection in vitamin A-deficient mice. J Exp Med 175, 111-120. 
 
Casciotti, L., Ely, K.H., Williams, M.E., and Khan, I.A. (2002). CD8(+)-T-cell immunity 
against Toxoplasma gondii can be induced but not maintained in mice lacking 
conventional CD4(+) T cells. Infect Immun 70, 434-443. 
 
Cerutti, A., and Rescigno, M. (2008). The biology of intestinal immunoglobulin A 
responses. Immunity 28, 740-750. 
 
Cha, H.R., Chang, S.Y., Chang, J.H., Kim, J.O., Yang, J.Y., Kim, C.H., and Kweon, 
M.N. Downregulation of Th17 cells in the small intestine by disruption of gut flora in the 
absence of retinoic acid. J Immunol 184, 6799-6806. 
 
 166 
Chambon, P. (1996). A decade of molecular biology of retinoic acid receptors. FASEB J 
10, 940-954. 
 
Chapellier, B., Mark, M., Garnier, J.M., LeMeur, M., Chambon, P., and Ghyselinck, N.B. 
(2002). A conditional floxed (loxP-flanked) allele for the retinoic acid receptor alpha 
(RARalpha) gene. Genesis 32, 87-90. 
 
Chassin, C., Kocur, M., Pott, J., Duerr, C.U., Gutle, D., Lotz, M., and Hornef, M.W. 
miR-146a mediates protective innate immune tolerance in the neonate intestine. Cell Host 
Microbe 8, 358-368. 
 
Chen, W., Jin, W., Hardegen, N., Lei, K.J., Li, L., Marinos, N., McGrady, G., and Wahl, 
S.M. (2003). Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ 
regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198, 
1875-1886. 
 
Chen, Y., Chou, K., Fuchs, E., Havran, W.L., and Boismenu, R. (2002). Protection of the 
intestinal mucosa by intraepithelial gamma delta T cells. Proc Natl Acad Sci U S A 99, 
14338-14343. 
 
Chen, Y., Inobe, J., Marks, R., Gonnella, P., Kuchroo, V.K., and Weiner, H.L. (1995). 
Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 376, 177-180. 
 
Chen, Y., Kuchroo, V.K., Inobe, J., Hafler, D.A., and Weiner, H.L. (1994). Regulatory T 
cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. 
Science 265, 1237-1240. 
 
Chiba, M., Ohta, H., Nagasaki, A., Arakawa, H., and Masamune, O. (1986). Lymphoid 
cell subsets in normal human small intestine. Gastroenterol Jpn 21, 336-343. 
 
Chieppa, M., Rescigno, M., Huang, A.Y., and Germain, R.N. (2006). Dynamic imaging 
of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR 
engagement. J Exp Med 203, 2841-2852. 
 
Chinen, T., Volchkov, P.Y., Chervonsky, A.V., and Rudensky, A.Y. A critical role for 
regulatory T cell-mediated control of inflammation in the absence of commensal 
microbiota. J Exp Med 207, 2323-2330. 
 
Chirdo, F.G., Millington, O.R., Beacock-Sharp, H., and Mowat, A.M. (2005). 
Immunomodulatory dendritic cells in intestinal lamina propria. Eur J Immunol 35, 1831-
1840. 
 
Chong, C., Friberg, M., and Clements, J.D. (1998). LT(R192G), a non-toxic mutant of 
the heat-labile enterotoxin of Escherichia coli, elicits enhanced humoral and cellular 
immune responses associated with protection against lethal oral challenge with 
Salmonella spp. Vaccine 16, 732-740. 
 167 
Cohen, J. (2002). The immunopathogenesis of sepsis. Nature 420, 885-891. 
 
Combe, C.L., Curiel, T.J., Moretto, M.M., and Khan, I.A. (2005). NK cells help to induce 
CD8(+)-T-cell immunity against Toxoplasma gondii in the absence of CD4(+) T cells. 
Infect Immun 73, 4913-4921. 
 
Constant, S., Pfeiffer, C., Woodard, A., Pasqualini, T., and Bottomly, K. (1995). Extent 
of T cell receptor ligation can determine the functional differentiation of naive CD4+ T 
cells. J Exp Med 182, 1591-1596. 
 
Conti, H.R., Shen, F., Nayyar, N., Stocum, E., Sun, J.N., Lindemann, M.J., Ho, A.W., 
Hai, J.H., Yu, J.J., Jung, J.W., et al. (2009). Th17 cells and IL-17 receptor signaling are 
essential for mucosal host defense against oral candidiasis. J Exp Med 206, 299-311. 
 
Coombes, J.L., Siddiqui, K.R., Arancibia-Carcamo, C.V., Hall, J., Sun, C.M., Belkaid, 
Y., and Powrie, F. (2007). A functionally specialized population of mucosal CD103+ 
DCs induces Foxp3+ regulatory T cells via a TGF-{beta}- and retinoic acid-dependent 
mechanism. J Exp Med. 
 
Corlazzoli, F., Rossetti, S., Bistulfi, G., Ren, M., and Sacchi, N. (2009). Derangement of 
a factor upstream of RARalpha triggers the repression of a pleiotropic epigenetic 
network. PLoS One 4, e4305. 
 
Couper, K.N., Blount, D.G., de Souza, J.B., Suffia, I., Belkaid, Y., and Riley, E.M. 
(2007). Incomplete depletion and rapid regeneration of Foxp3+ regulatory T cells 
following anti-CD25 treatment in malaria-infected mice. J Immunol 178, 4136-4146. 
 
Crellin, N.K., Garcia, R.V., Hadisfar, O., Allan, S.E., Steiner, T.S., and Levings, M.K. 
(2005). Human CD4+ T cells express TLR5 and its ligand flagellin enhances the 
suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells. J 
Immunol 175, 8051-8059. 
 
Cua, D.J., Sherlock, J., Chen, Y., Murphy, C.A., Joyce, B., Seymour, B., Lucian, L., To, 
W., Kwan, S., Churakova, T., et al. (2003). Interleukin-23 rather than interleukin-12 is 
the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744-748. 
 
Cua, D.J., and Tato, C.M. Innate IL-17-producing cells: the sentinels of the immune 
system. Nat Rev Immunol 10, 479-489. 
 
Cui, D., Moldoveanu, Z., and Stephensen, C.B. (2000). High-level dietary vitamin A 
enhances T-helper type 2 cytokine production and secretory immunoglobulin A response 
to influenza A virus infection in BALB/c mice. J Nutr 130, 1132-1139. 
 
Curotto de Lafaille, M.A., Kutchukhidze, N., Shen, S., Ding, Y., Yee, H., and Lafaille, 
J.J. (2008). Adaptive Foxp3+ regulatory T cell-dependent and -independent control of 
allergic inflammation. Immunity 29, 114-126. 
 168 
D'Cruz, L.M., and Klein, L. (2005). Development and function of agonist-induced 
CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling. Nat Immunol 
6, 1152-1159. 
 
Dalpke, A., Frank, J., Peter, M., and Heeg, K. (2006). Activation of toll-like receptor 9 by 
DNA from different bacterial species. Infect Immun 74, 940-946. 
 
Dardalhon, V., Awasthi, A., Kwon, H., Galileos, G., Gao, W., Sobel, R.A., Mitsdoerffer, 
M., Strom, T.B., Elyaman, W., Ho, I.C., et al. (2008). IL-4 inhibits TGF-beta-induced 
Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T 
cells. Nat Immunol 9, 1347-1355. 
 
de Lera, A.R., Bourguet, W., Altucci, L., and Gronemeyer, H. (2007). Design of selective 
nuclear receptor modulators: RAR and RXR as a case study. Nat Rev Drug Discov 6, 
811-820. 
 
Delgoffe, G.M., Kole, T.P., Zheng, Y., Zarek, P.E., Matthews, K.L., Xiao, B., Worley, 
P.F., Kozma, S.C., and Powell, J.D. (2009). The mTOR kinase differentially regulates 
effector and regulatory T cell lineage commitment. Immunity 30, 832-844. 
 
Denning, T.L., Wang, Y.C., Patel, S.R., Williams, I.R., and Pulendran, B. (2007). Lamina 
propria macrophages and dendritic cells differentially induce regulatory and interleukin 
17-producing T cell responses. Nat Immunol 8, 1086-1094. 
 
Didier, E.S. (2005). Microsporidiosis: an emerging and opportunistic infection in humans 
and animals. Acta Trop 94, 61-76. 
 
Didier, E.S., Stovall, M.E., Green, L.C., Brindley, P.J., Sestak, K., and Didier, P.J. 
(2004). Epidemiology of microsporidiosis: sources and modes of transmission. Vet 
Parasitol 126, 145-166. 
 
Dignass, A.U., and Podolsky, D.K. (1993). Cytokine modulation of intestinal epithelial 
cell restitution: central role of transforming growth factor beta. Gastroenterology 105, 
1323-1332. 
 
Dong, C., Yang, D.D., Tournier, C., Whitmarsh, A.J., Xu, J., Davis, R.J., and Flavell, 
R.A. (2000). JNK is required for effector T-cell function but not for T-cell activation. 
Nature 405, 91-94. 
 
Duggan, C., Gannon, J., and Walker, W.A. (2002). Protective nutrients and functional 
foods for the gastrointestinal tract. Am J Clin Nutr 75, 789-808. 
 
El-Asady, R., Yuan, R., Liu, K., Wang, D., Gress, R.E., Lucas, P.J., Drachenberg, C.B., 
and Hadley, G.A. (2005). TGF-{beta}-dependent CD103 expression by CD8(+) T cells 
promotes selective destruction of the host intestinal epithelium during graft-versus-host 
disease. J Exp Med 201, 1647-1657. 
 169 
Elias, K.M., Laurence, A., Davidson, T.S., Stephens, G., Kanno, Y., Shevach, E.M., and 
O'Shea, J.J. (2008). Retinoic acid inhibits Th17 polarization and enhances FoxP3 
expression through a Stat-3/Stat-5 independent signaling pathway. Blood 111, 1013-
1020. 
 
Else, K.J., Finkelman, F.D., Maliszewski, C.R., and Grencis, R.K. (1994). Cytokine-
mediated regulation of chronic intestinal helminth infection. J Exp Med 179, 347-351. 
 
Engel, A., and Barton, G.M. Compartment-Specific Control of Signaling from a DNA-
Sensing Immune Receptor. Sci Signal 3, pe45. 
 
Ertesvag, A., Austenaa, L.M., Carlsen, H., Blomhoff, R., and Blomhoff, H.K. (2009). 
Retinoic acid inhibits in vivo interleukin-2 gene expression and T-cell activation in mice. 
Immunology 126, 514-522. 
 
Ertesvag, A., Engedal, N., Naderi, S., and Blomhoff, H.K. (2002). Retinoic acid 
stimulates the cell cycle machinery in normal T cells: involvement of retinoic acid 
receptor-mediated IL-2 secretion. J Immunol 169, 5555-5563. 
 
Ewald, S.E., Lee, B.L., Lau, L., Wickliffe, K.E., Shi, G.P., Chapman, H.A., and Barton, 
G.M. (2008). The ectodomain of Toll-like receptor 9 is cleaved to generate a functional 
receptor. Nature 456, 658-662. 
 
Ewaschuk, J.B., Backer, J.L., Churchill, T.A., Obermeier, F., Krause, D.O., and Madsen, 
K.L. (2007). Surface expression of Toll-like receptor 9 is upregulated on intestinal 
epithelial cells in response to pathogenic bacterial DNA. Infect Immun 75, 2572-2579. 
 
Fagarasan, S., Kawamoto, S., Kanagawa, O., and Suzuki, K. Adaptive immune regulation 
in the gut: T cell-dependent and T cell-independent IgA synthesis. Annu Rev Immunol 
28, 243-273. 
 
Fagarasan, S., Muramatsu, M., Suzuki, K., Nagaoka, H., Hiai, H., and Honjo, T. (2002). 
Critical roles of activation-induced cytidine deaminase in the homeostasis of gut flora. 
Science 298, 1424-1427. 
 
Fantini, M.C., Becker, C., Monteleone, G., Pallone, F., Galle, P.R., and Neurath, M.F. 
(2004). Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells 
through Foxp3 induction and down-regulation of Smad7. J Immunol 172, 5149-5153. 
 
Farthing, M.J. (2006). Treatment options for the eradication of intestinal protozoa. Nat 
Clin Pract Gastroenterol Hepatol 3, 436-445. 
 
Favre, D., Mold, J., Hunt, P.W., Kanwar, B., Loke, P., Seu, L., Barbour, J.D., Lowe, 
M.M., Jayawardene, A., Aweeka, F., et al. Tryptophan catabolism by indoleamine 2,3-
dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci Transl 
Med 2, 32ra36. 
 170 
Ferreira, F.M., Bezerra, L., Santos, M.B., Bernardes, R.M., Avelino, I., and Silva, M.L. 
(2001). Intestinal microsporidiosis: a current infection in HIV-seropositive patients in 
Portugal. Microbes Infect 3, 1015-1019. 
 
Feske, S., Giltnane, J., Dolmetsch, R., Staudt, L.M., and Rao, A. (2001). Gene regulation 
mediated by calcium signals in T lymphocytes. Nat Immunol 2, 316-324. 
 
Finlay, B.B., and Medzhitov, R. (2007). Host-microbe interactions: fulfilling a niche. 
Cell Host Microbe 1, 3-4. 
 
Fisher, G.J., Talwar, H.S., Lin, J., Lin, P., McPhillips, F., Wang, Z., Li, X., Wan, Y., 
Kang, S., and Voorhees, J.J. (1998). Retinoic acid inhibits induction of c-Jun protein by 
ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein 
kinase pathways in human skin in vivo. J Clin Invest 101, 1432-1440. 
 
Fontenot, J.D., Gavin, M.A., and Rudensky, A.Y. (2003). Foxp3 programs the 
development and function of CD4+CD25+ regulatory T cells.[comment]. Nat Immunol 4, 
330-336. 
 
Fontenot, J.D., Rasmussen, J.P., Gavin, M.A., and Rudensky, A.Y. (2005). A function for 
interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 6, 1142-1151. 
 
Gaboriau-Routhiau, V., Rakotobe, S., Lecuyer, E., Mulder, I., Lan, A., Bridonneau, C., 
Rochet, V., Pisi, A., De Paepe, M., Brandi, G., et al. (2009). The key role of segmented 
filamentous bacteria in the coordinated maturation of gut helper T cell responses. 
Immunity 31, 677-689. 
 
Garrett, W.S., Gordon, J.I., and Glimcher, L.H. Homeostasis and inflammation in the 
intestine. Cell 140, 859-870. 
 
Garrett, W.S., Lord, G.M., Punit, S., Lugo-Villarino, G., Mazmanian, S.K., Ito, S., 
Glickman, J.N., and Glimcher, L.H. (2007). Communicable ulcerative colitis induced by 
T-bet deficiency in the innate immune system. Cell 131, 33-45. 
 
Gavin, M.A., Rasmussen, J.P., Fontenot, J.D., Vasta, V., Manganiello, V.C., Beavo, J.A., 
and Rudensky, A.Y. (2007). Foxp3-dependent programme of regulatory T-cell 
differentiation. Nature 445, 771-775. 
 
Gazzinelli, R., Xu, Y., Hieny, S., Cheever, A., and Sher, A. (1992). Simultaneous 
depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection 
with Toxoplasma gondii. J Immunol 149, 175-180. 
 
Gazzinelli, R.T., Wysocka, M., Hieny, S., Scharton-Kersten, T., Cheever, A., Kuhn, R., 
Muller, W., Trinchieri, G., and Sher, A. (1996). In the absence of endogenous IL-10, 
mice acutely infected with Toxoplasma gondii succumb to a lethal immune response 
 171 
dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma 
and TNF-alpha. J Immunol 157, 798-805. 
 
Geissmann, F., Revy, P., Brousse, N., Lepelletier, Y., Folli, C., Durandy, A., Chambon, 
P., and Dy, M. (2003). Retinoids regulate survival and antigen presentation by immature 
dendritic cells. J Exp Med 198, 623-634. 
 
Gelman, A.E., LaRosa, D.F., Zhang, J., Walsh, P.T., Choi, Y., Sunyer, J.O., and Turka, 
L.A. (2006). The adaptor molecule MyD88 activates PI-3 kinase signaling in CD4+ T 
cells and enables CpG oligodeoxynucleotide-mediated costimulation. Immunity 25, 783-
793. 
 
Gelman, A.E., Zhang, J., Choi, Y., and Turka, L.A. (2004). Toll-like receptor ligands 
directly promote activated CD4+ T cell survival. J Immunol 172, 6065-6073. 
 
Gerdes, J., Schwab, U., Lemke, H., and Stein, H. (1983). Production of a mouse 
monoclonal antibody reactive with a human nuclear antigen associated with cell 
proliferation. Int J Cancer 31, 13-20. 
 
Gonzalez-Navajas, J.M., Fine, S., Law, J., Datta, S.K., Nguyen, K.P., Yu, M., Corr, M., 
Katakura, K., Eckman, L., Lee, J., and Raz, E. TLR4 signaling in effector CD4+ T cells 
regulates TCR activation and experimental colitis in mice. J Clin Invest 120, 570-581. 
 
Goswami, S., Angkasekwinai, P., Shan, M., Greenlee, K.J., Barranco, W.T., Polikepahad, 
S., Seryshev, A., Song, L.Z., Redding, D., Singh, B., et al. (2009). Divergent functions 
for airway epithelial matrix metalloproteinase 7 and retinoic acid in experimental asthma. 
Nat Immunol 10, 496-503. 
 
Grunvald, E., Chiaramonte, M., Hieny, S., Wysocka, M., Trinchieri, G., Vogel, S.N., 
Gazzinelli, R.T., and Sher, A. (1996). Biochemical characterization and protein kinase C 
dependency of monokine-inducing activities of Toxoplasma gondii. Infect Immun 64, 
2010-2018. 
 
Guertin, D.A., Stevens, D.M., Thoreen, C.C., Burds, A.A., Kalaany, N.Y., Moffat, J., 
Brown, M., Fitzgerald, K.J., and Sabatini, D.M. (2006). Ablation in mice of the mTORC 
components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to 
Akt-FOXO and PKCalpha, but not S6K1. Dev Cell 11, 859-871. 
 
Hall, J.A., Bouladoux, N., Sun, C., Wohlfert, E.A., Blank, R.B., Zhu, Q., Grigg, M.E., 
Berzofsky, J.A., and Belkaid, Y. (2008). Commensal DNA limits regulatory T cell 
conversion and is a natural adjuvant of intestinal immune responses. Immunity. 
 
Hammerschmidt, S.I., Ahrendt, M., Bode, U., Wahl, B., Kremmer, E., Forster, R., and 
Pabst, O. (2008). Stromal mesenteric lymph node cells are essential for the generation of 
gut-homing T cells in vivo. J Exp Med 205, 2483-2490. 
 172 
Happel, K.I., Dubin, P.J., Zheng, M., Ghilardi, N., Lockhart, C., Quinton, L.J., Odden, 
A.R., Shellito, J.E., Bagby, G.J., Nelson, S., and Kolls, J.K. (2005). Divergent roles of 
IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J Exp Med 202, 761-769. 
 
Harrington, L., Srikanth, C.V., Antony, R., Rhee, S.J., Mellor, A.L., Shi, H.N., and 
Cherayil, B.J. (2008). Deficiency of indoleamine 2,3-dioxygenase enhances commensal-
induced antibody responses and protects against Citrobacter rodentium-induced colitis. 
Infect Immun 76, 3045-3053. 
 
Harrington, L.E., Hatton, R.D., Mangan, P.R., Turner, H., Murphy, T.L., Murphy, K.M., 
and Weaver, C.T. (2005). Interleukin 17-producing CD4+ effector T cells develop via a 
lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6, 1123-1132. 
 
Harrison, E.H. (2005). Mechanisms of digestion and absorption of dietary vitamin A. 
Annu Rev Nutr 25, 87-103. 
 
Hayday, A., Theodoridis, E., Ramsburg, E., and Shires, J. (2001). Intraepithelial 
lymphocytes: exploring the Third Way in immunology. Nat Immunol 2, 997-1003. 
 
Heimesaat, M.M., Bereswill, S., Fischer, A., Fuchs, D., Struck, D., Niebergall, J., Jahn, 
H.K., Dunay, I.R., Moter, A., Gescher, D.M., et al. (2006). Gram-negative bacteria 
aggravate murine small intestinal Th1-type immunopathology following oral infection 
with Toxoplasma gondii. J Immunol 177, 8785-8795. 
 
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., 
Hoshino, K., Wagner, H., Takeda, K., and Akira, S. (2000). A Toll-like receptor 
recognizes bacterial DNA. Nature 408, 740-745. 
 
Hieshima, K., Kawasaki, Y., Hanamoto, H., Nakayama, T., Nagakubo, D., Kanamaru, A., 
and Yoshie, O. (2004). CC chemokine ligands 25 and 28 play essential roles in intestinal 
extravasation of IgA antibody-secreting cells. J Immunol 173, 3668-3675. 
 
Hill, D.A., Hoffmann, C., Abt, M.C., Du, Y., Kobuley, D., Kirn, T.J., Bushman, F.D., 
and Artis, D. Metagenomic analyses reveal antibiotic-induced temporal and spatial 
changes in intestinal microbiota with associated alterations in immune cell homeostasis. 
Mucosal Immunol 3, 148-158. 
 
Hill, J.A., Hall, J.A., Sun, C.M., Cai, Q., Ghyselinck, N., Chambon, P., Belkaid, Y., 
Mathis, D., and Benoist, C. (2008). Retinoic acid enhances Foxp3 induction indirectly by 
relieving inhibition from CD4+CD44hi Cells. Immunity 29, 758-770. 
 
Hirota, K., Hashimoto, M., Yoshitomi, H., Tanaka, S., Nomura, T., Yamaguchi, T., 
Iwakura, Y., Sakaguchi, N., and Sakaguchi, S. (2007). T cell self-reactivity forms a 
cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune 
arthritis. J Exp Med 204, 41-47. 
 173 
Holz, M.K., Ballif, B.A., Gygi, S.P., and Blenis, J. (2005). mTOR and S6K1 mediate 
assembly of the translation preinitiation complex through dynamic protein interchange 
and ordered phosphorylation events. Cell 123, 569-580. 
 
Hooper, L.V., and Gordon, J.I. (2001). Commensal host-bacterial relationships in the gut. 
Science 292, 1115-1118. 
 
Hooper, L.V., Midtvedt, T., and Gordon, J.I. (2002). How host-microbial interactions 
shape the nutrient environment of the mammalian intestine. Annu Rev Nutr 22, 283-307. 
 
Hori, S., Nomura, T., and Sakaguchi, S. (2003). Control of regulatory T cell development 
by the transcription factor Foxp3.[comment]. Science 299, 1057-1061. 
 
Hosken, N.A., Shibuya, K., Heath, A.W., Murphy, K.M., and O'Garra, A. (1995). The 
effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-
alpha beta-transgenic model. J Exp Med 182, 1579-1584. 
 
Hu, X., and Ivashkiv, L.B. (2009). Cross-regulation of signaling pathways by interferon-
gamma: implications for immune responses and autoimmune diseases. Immunity 31, 539-
550. 
 
Hua, S., Kittler, R., and White, K.P. (2009). Genomic antagonism between retinoic acid 
and estrogen signaling in breast cancer. Cell 137, 1259-1271. 
 
Huang, F.P., Platt, N., Wykes, M., Major, J.R., Powell, T.J., Jenkins, C.D., and 
MacPherson, G.G. (2000). A discrete subpopulation of dendritic cells transports apoptotic 
intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J Exp Med 191, 435-
444. 
 
Iliev, I.D., Mileti, E., Matteoli, G., Chieppa, M., and Rescigno, M. (2009). Intestinal 
epithelial cells promote colitis-protective regulatory T-cell differentiation through 
dendritic cell conditioning. Mucosal Immunol 2, 340-350. 
 
Ishigame, H., Kakuta, S., Nagai, T., Kadoki, M., Nambu, A., Komiyama, Y., Fujikado, 
N., Tanahashi, Y., Akitsu, A., Kotaki, H., et al. (2009). Differential roles of interleukin-
17A and -17F in host defense against mucoepithelial bacterial infection and allergic 
responses. Immunity 30, 108-119. 
 
Israelski, D.M., and Remington, J.S. (1988). Toxoplasmic encephalitis in patients with 
AIDS. Infect Dis Clin North Am 2, 429-445. 
 
Ivanov, II, Atarashi, K., Manel, N., Brodie, E.L., Shima, T., Karaoz, U., Wei, D., 
Goldfarb, K.C., Santee, C.A., Lynch, S.V., et al. (2009). Induction of intestinal Th17 
cells by segmented filamentous bacteria. Cell 139, 485-498. 
 
 174 
Ivanov, II, Frutos Rde, L., Manel, N., Yoshinaga, K., Rifkin, D.B., Sartor, R.B., Finlay, 
B.B., and Littman, D.R. (2008). Specific microbiota direct the differentiation of IL-17-
producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4, 337-
349. 
 
Ivanov, II, McKenzie, B.S., Zhou, L., Tadokoro, C.E., Lepelley, A., Lafaille, J.J., Cua, 
D.J., and Littman, D.R. (2006). The orphan nuclear receptor RORgammat directs the 
differentiation program of proinflammatory IL-17+ T helper cells. Cell 126, 1121-1133. 
 
Iwata, M., Eshima, Y., and Kagechika, H. (2003). Retinoic acids exert direct effects on T 
cells to suppress Th1 development and enhance Th2 development via retinoic acid 
receptors. Int Immunol 15, 1017-1025. 
 
Iwata, M., Hirakiyama, A., Eshima, Y., Kagechika, H., Kato, C., and Song, S.Y. (2004). 
Retinoic acid imprints gut-homing specificity on T cells. Immunity 21, 527-538. 
 
Izcue, A., Coombes, J.L., and Powrie, F. (2006). Regulatory T cells suppress systemic 
and mucosal immune activation to control intestinal inflammation. Immunol Rev 212, 
256-271. 
 
Izcue, A., Hue, S., Buonocore, S., Arancibia-Carcamo, C.V., Ahern, P.P., Iwakura, Y., 
Maloy, K.J., and Powrie, F. (2008). Interleukin-23 restrains regulatory T cell activity to 
drive T cell-dependent colitis. Immunity 28, 559-570. 
 
Jabri, B., and Ebert, E. (2007). Human CD8+ intraepithelial lymphocytes: a unique 
model to study the regulation of effector cytotoxic T lymphocytes in tissue. Immunol Rev 
215, 202-214. 
 
Jaensson, E., Uronen-Hansson, H., Pabst, O., Eksteen, B., Tian, J., Coombes, J.L., Berg, 
P.L., Davidsson, T., Powrie, F., Johansson-Lindbom, B., and Agace, W.W. (2008). Small 
intestinal CD103+ dendritic cells display unique functional properties that are conserved 
between mice and humans. J Exp Med. 
 
Jalkanen, S., Bargatze, R.F., de los Toyos, J., and Butcher, E.C. (1987). Lymphocyte 
recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD 
glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, 
or synovial endothelial cells. J Cell Biol 105, 983-990. 
 
James, T.Y., Kauff, F., Schoch, C.L., Matheny, P.B., Hofstetter, V., Cox, C.J., Celio, G., 
Gueidan, C., Fraker, E., Miadlikowska, J., et al. (2006). Reconstructing the early 
evolution of Fungi using a six-gene phylogeny. Nature 443, 818-822. 
 
Jang, M.H., Kweon, M.N., Iwatani, K., Yamamoto, M., Terahara, K., Sasakawa, C., 
Suzuki, T., Nochi, T., Yokota, Y., Rennert, P.D., et al. (2004). Intestinal villous M cells: 
an antigen entry site in the mucosal epithelium. Proc Natl Acad Sci U S A 101, 6110-
6115. 
 175 
Jang, M.H., Sougawa, N., Tanaka, T., Hirata, T., Hiroi, T., Tohya, K., Guo, Z., 
Umemoto, E., Ebisuno, Y., Yang, B.G., et al. (2006). CCR7 is critically important for 
migration of dendritic cells in intestinal lamina propria to mesenteric lymph nodes. J 
Immunol 176, 803-810. 
 
Johansson, M.E., Phillipson, M., Petersson, J., Velcich, A., Holm, L., and Hansson, G.C. 
(2008). The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of 
bacteria. Proc Natl Acad Sci U S A 105, 15064-15069. 
 
Johansson-Lindbom, B., Svensson, M., Pabst, O., Palmqvist, C., Marquez, G., Forster, 
R., and Agace, W.W. (2005). Functional specialization of gut CD103+ dendritic cells in 
the regulation of tissue-selective T cell homing. J Exp Med 202, 1063-1073. 
 
Johansson-Lindbom, B., Svensson, M., Wurbel, M.A., Malissen, B., Marquez, G., and 
Agace, W. (2003). Selective generation of gut tropic T cells in gut-associated lymphoid 
tissue (GALT): requirement for GALT dendritic cells and adjuvant. J Exp Med 198, 963-
969. 
 
Jordan, M.S., Boesteanu, A., Reed, A.J., Petrone, A.L., Holenbeck, A.E., Lerman, M.A., 
Naji, A., and Caton, A.J. (2001). Thymic selection of CD4+CD25+ regulatory T cells 
induced by an agonist self-peptide. Nat Immunol 2, 301-306. 
 
Josefowicz, S.Z., and Rudensky, A. (2009). Control of regulatory T cell lineage 
commitment and maintenance. Immunity 30, 616-625. 
 
Jovanovic, D.V., Di Battista, J.A., Martel-Pelletier, J., Jolicoeur, F.C., He, Y., Zhang, M., 
Mineau, F., and Pelletier, J.P. (1998). IL-17 stimulates the production and expression of 
proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol 
160, 3513-3521. 
 
Kane, M.A., Folias, A.E., and Napoli, J.L. (2008a). HPLC/UV quantitation of retinal, 
retinol, and retinyl esters in serum and tissues. Anal Biochem 378, 71-79. 
 
Kane, M.A., Folias, A.E., Wang, C., and Napoli, J.L. (2008b). Quantitative profiling of 
endogenous retinoic acid in vivo and in vitro by tandem mass spectrometry. Anal Chem 
80, 1702-1708. 
 
Kao, C.Y., Chen, Y., Thai, P., Wachi, S., Huang, F., Kim, C., Harper, R.W., and Wu, R. 
(2004). IL-17 markedly up-regulates beta-defensin-2 expression in human airway 
epithelium via JAK and NF-kappaB signaling pathways. J Immunol 173, 3482-3491. 
 
Kawaguchi, R., Yu, J., Honda, J., Hu, J., Whitelegge, J., Ping, P., Wiita, P., Bok, D., and 
Sun, H. (2007). A membrane receptor for retinol binding protein mediates cellular uptake 
of vitamin A. Science 315, 820-825. 
 
 176 
Kawai, T., and Akira, S. The role of pattern-recognition receptors in innate immunity: 
update on Toll-like receptors. Nat Immunol 11, 373-384. 
 
Keeble, E. (2001). Encephalitozoon cuniculi in rabbits. Vet Rec 149, 688. 
 
Khader, S.A., Gaffen, S.L., and Kolls, J.K. (2009). Th17 cells at the crossroads of innate 
and adaptive immunity against infectious diseases at the mucosa. Mucosal Immunol 2, 
403-411. 
 
Khan, I.A., and Moretto, M. (1999). Role of gamma interferon in cellular immune 
response against murine Encephalitozoon cuniculi infection. Infect Immun 67, 1887-
1893. 
 
Khattri, R., Cox, T., Yasayko, S.A., and Ramsdell, F. (2003). An essential role for 
Scurfin in CD4+CD25+ T regulatory cells.[comment]. Nat Immunol 4, 337-342. 
 
Kim, H.Y., DeKruyff, R.H., and Umetsu, D.T. The many paths to asthma: phenotype 
shaped by innate and adaptive immunity. Nat Immunol 11, 577-584. 
 
Kim, J.M., Rasmussen, J.P., and Rudensky, A.Y. (2007). Regulatory T cells prevent 
catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 8, 191-197. 
 
Klaasen, H.L., Van der Heijden, P.J., Stok, W., Poelma, F.G., Koopman, J.P., Van den 
Brink, M.E., Bakker, M.H., Eling, W.M., and Beynen, A.C. (1993). Apathogenic, 
intestinal, segmented, filamentous bacteria stimulate the mucosal immune system of 
mice. Infect Immun 61, 303-306. 
 
Knoechel, B., Lohr, J., Kahn, E., Bluestone, J.A., and Abbas, A.K. (2005). Sequential 
development of interleukin 2-dependent effector and regulatory T cells in response to 
endogenous systemic antigen. J Exp Med 202, 1375-1386. 
 
Kobayashi, K.S., Chamaillard, M., Ogura, Y., Henegariu, O., Inohara, N., Nunez, G., and 
Flavell, R.A. (2005). Nod2-dependent regulation of innate and adaptive immunity in the 
intestinal tract. Science 307, 731-734. 
 
Komano, H., Fujiura, Y., Kawaguchi, M., Matsumoto, S., Hashimoto, Y., Obana, S., 
Mombaerts, P., Tonegawa, S., Yamamoto, H., Itohara, S., and et al. (1995). Homeostatic 
regulation of intestinal epithelia by intraepithelial gamma delta T cells. Proc Natl Acad 
Sci U S A 92, 6147-6151. 
 
Korn, T., Bettelli, E., Gao, W., Awasthi, A., Jager, A., Strom, T.B., Oukka, M., and 
Kuchroo, V.K. (2007). IL-21 initiates an alternative pathway to induce proinflammatory 
T(H)17 cells. Nature 448, 484-487. 
 
Korn, T., Bettelli, E., Oukka, M., and Kuchroo, V.K. (2009). IL-17 and Th17 Cells. Annu 
Rev Immunol 27, 485-517. 
 177 
Koski, K.G., and Scott, M.E. (2001). Gastrointestinal nematodes, nutrition and immunity: 
breaking the negative spiral. Annu Rev Nutr 21, 297-321. 
 
Kotake, S., Udagawa, N., Takahashi, N., Matsuzaki, K., Itoh, K., Ishiyama, S., Saito, S., 
Inoue, K., Kamatani, N., Gillespie, M.T., et al. (1999). IL-17 in synovial fluids from 
patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin 
Invest 103, 1345-1352. 
 
Kretschmer, K., Apostolou, I., Hawiger, D., Khazaie, K., Nussenzweig, M.C., and von 
Boehmer, H. (2005). Inducing and expanding regulatory T cell populations by foreign 
antigen. Nat Immunol 6, 1219-1227. 
 
Kunkel, E.J., Campbell, J.J., Haraldsen, G., Pan, J., Boisvert, J., Roberts, A.I., Ebert, 
E.C., Vierra, M.A., Goodman, S.B., Genovese, M.C., et al. (2000). Lymphocyte CC 
chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression 
distinguish the small intestinal immune compartment: Epithelial expression of tissue-
specific chemokines as an organizing principle in regional immunity. J Exp Med 192, 
761-768. 
 
Kurasawa, K., Hirose, K., Sano, H., Endo, H., Shinkai, H., Nawata, Y., Takabayashi, K., 
and Iwamoto, I. (2000). Increased interleukin-17 production in patients with systemic 
sclerosis. Arthritis Rheum 43, 2455-2463. 
 
Lacy-Hulbert, A., Smith, A.M., Tissire, H., Barry, M., Crowley, D., Bronson, R.T., Roes, 
J.T., Savill, J.S., and Hynes, R.O. (2007). Ulcerative colitis and autoimmunity induced by 
loss of myeloid alphav integrins. Proc Natl Acad Sci U S A 104, 15823-15828. 
 
Lahl, K., Loddenkemper, C., Drouin, C., Freyer, J., Arnason, J., Eberl, G., Hamann, A., 
Wagner, H., Huehn, J., and Sparwasser, T. (2007). Selective depletion of Foxp3+ 
regulatory T cells induces a scurfy-like disease. J Exp Med 204, 57-63. 
 
Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y.H., Homey, B., Cao, W., 
Su, B., Nestle, F.O., Zal, T., et al. (2007). Plasmacytoid dendritic cells sense self-DNA 
coupled with antimicrobial peptide. Nature 449, 564-569. 
 
Larosa, D.F., Gelman, A.E., Rahman, A.H., Zhang, J., Turka, L.A., and Walsh, P.T. 
(2007). CpG DNA inhibits CD4+CD25+ Treg suppression through direct MyD88-
dependent costimulation of effector CD4+ T cells. Immunol Lett 108, 183-188. 
 
LaRosa, D.F., Stumhofer, J.S., Gelman, A.E., Rahman, A.H., Taylor, D.K., Hunter, C.A., 
and Turka, L.A. (2008). T cell expression of MyD88 is required for resistance to 
Toxoplasma gondii. Proc Natl Acad Sci U S A 105, 3855-3860. 
 
Lathrop, S.K., Santacruz, N.A., Pham, D., Luo, J., and Hsieh, C.S. (2008). Antigen-
specific peripheral shaping of the natural regulatory T cell population. J Exp Med 205, 
3105-3117. 
 178 
Latz, E., Schoenemeyer, A., Visintin, A., Fitzgerald, K.A., Monks, B.G., Knetter, C.F., 
Lien, E., Nilsen, N.J., Espevik, T., and Golenbock, D.T. (2004). TLR9 signals after 
translocating from the ER to CpG DNA in the lysosome. Nat Immunol 5, 190-198. 
 
Laurence, A., Tato, C.M., Davidson, T.S., Kanno, Y., Chen, Z., Yao, Z., Blank, R.B., 
Meylan, F., Siegel, R., Hennighausen, L., et al. (2007). Interleukin-2 signaling via 
STAT5 constrains T helper 17 cell generation. Immunity 26, 371-381. 
 
Lavelle, E.C., Murphy, C., O'Neill, L.A., and Creagh, E.M. The role of TLRs, NLRs, and 
RLRs in mucosal innate immunity and homeostasis. Mucosal Immunol 3, 17-28. 
 
Lee, H.Y., Sueoka, N., Hong, W.K., Mangelsdorf, D.J., Claret, F.X., and Kurie, J.M. 
(1999). All-trans-retinoic acid inhibits Jun N-terminal kinase by increasing dual-
specificity phosphatase activity. Mol Cell Biol 19, 1973-1980. 
 
Lee, J., Mo, J.H., Katakura, K., Alkalay, I., Rucker, A.N., Liu, Y.T., Lee, H.K., Shen, C., 
Cojocaru, G., Shenouda, S., et al. (2006). Maintenance of colonic homeostasis by 
distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol 8, 1327-
1336. 
 
Lee, K., Gudapati, P., Dragovic, S., Spencer, C., Joyce, S., Killeen, N., Magnuson, M.A., 
and Boothby, M. Mammalian target of rapamycin protein complex 2 regulates 
differentiation of Th1 and Th2 cell subsets via distinct signaling pathways. Immunity 32, 
743-753. 
 
Lee, Y.K., Turner, H., Maynard, C.L., Oliver, J.R., Chen, D., Elson, C.O., and Weaver, 
C.T. (2009). Late developmental plasticity in the T helper 17 lineage. Immunity 30, 92-
107. 
 
LeibundGut-Landmann, S., Gross, O., Robinson, M.J., Osorio, F., Slack, E.C., Tsoni, 
S.V., Schweighoffer, E., Tybulewicz, V., Brown, G.D., Ruland, J., and Reis e Sousa, C. 
(2007). Syk- and CARD9-dependent coupling of innate immunity to the induction of T 
helper cells that produce interleukin 17. Nat Immunol 8, 630-638. 
 
Li, M.O., and Flavell, R.A. (2008). Contextual regulation of inflammation: a duet by 
transforming growth factor-beta and interleukin-10. Immunity 28, 468-476. 
 
Li, M.O., Sanjabi, S., and Flavell, R.A. (2006). Transforming growth factor-beta controls 
development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -
independent mechanisms. Immunity 25, 455-471. 
 
Li, M.O., Wan, Y.Y., and Flavell, R.A. (2007). T cell-produced transforming growth 
factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. 
Immunity 26, 579-591. 
 
 179 
Li, X.M., Serebrisky, D., Lee, S.Y., Huang, C.K., Bardina, L., Schofield, B.H., Stanley, 
J.S., Burks, A.W., Bannon, G.A., and Sampson, H.A. (2000). A murine model of peanut 
anaphylaxis: T- and B-cell responses to a major peanut allergen mimic human responses. 
J Allergy Clin Immunol 106, 150-158. 
 
Liesenfeld, O., Kosek, J., Remington, J.S., and Suzuki, Y. (1996). Association of CD4+ 
T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic 
susceptibility of mice to peroral infection with Toxoplasma gondii. J Exp Med 184, 597-
607. 
 
Lin, W., Haribhai, D., Relland, L.M., Truong, N., Carlson, M.R., Williams, C.B., and 
Chatila, T.A. (2007). Regulatory T cell development in the absence of functional Foxp3. 
Nat Immunol 8, 359-368. 
 
Lin, Y., Ritchea, S., Logar, A., Slight, S., Messmer, M., Rangel-Moreno, J., Guglani, L., 
Alcorn, J.F., Strawbridge, H., Park, S.M., et al. (2009). Interleukin-17 is required for T 
helper 1 cell immunity and host resistance to the intracellular pathogen Francisella 
tularensis. Immunity 31, 799-810. 
 
Liu, C., and Hermann, T.E. (1978). Characterization of ionomycin as a calcium 
ionophore. J Biol Chem 253, 5892-5894. 
 
Liu, H., Komai-Koma, M., Xu, D., and Liew, F.Y. (2006). Toll-like receptor 2 signaling 
modulates the functions of CD4+ CD25+ regulatory T cells. Proc Natl Acad Sci U S A 
103, 7048-7053. 
 
Liu, K., Victora, G.D., Schwickert, T.A., Guermonprez, P., Meredith, M.M., Yao, K., 
Chu, F.F., Randolph, G.J., Rudensky, A.Y., and Nussenzweig, M. (2009). In vivo 
analysis of dendritic cell development and homeostasis. Science 324, 392-397. 
 
Liu, Y., Zhang, P., Li, J., Kulkarni, A.B., Perruche, S., and Chen, W. (2008). A critical 
function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ 
regulatory T cells. Nat Immunol 9, 632-640. 
 
Locksley, R.M. (2009). Nine lives: plasticity among T helper cell subsets. J Exp Med 
206, 1643-1646. 
 
Loewith, R., Jacinto, E., Wullschleger, S., Lorberg, A., Crespo, J.L., Bonenfant, D., 
Oppliger, W., Jenoe, P., and Hall, M.N. (2002). Two TOR complexes, only one of which 
is rapamycin sensitive, have distinct roles in cell growth control. Mol Cell 10, 457-468. 
 
Long, K.Z., Estrada-Garcia, T., Rosado, J.L., Ignacio Santos, J., Haas, M., Firestone, M., 
Bhagwat, J., Young, C., DuPont, H.L., Hertzmark, E., and Nanthakumar, N.N. (2006a). 
The effect of vitamin A supplementation on the intestinal immune response in Mexican 
children is modified by pathogen infections and diarrhea. J Nutr 136, 1365-1370. 
 180 
Long, K.Z., Garcia, C., Santos, J.I., Rosado, J.L., Hertzmark, E., Dupont, H.L., and Ko, 
G. (2007a). Vitamin A supplementation has divergent effects on norovirus infections and 
clinical symptoms among Mexican children. J Infect Dis 196, 978-985. 
 
Long, K.Z., Rosado, J.L., DuPont, H.L., Hertzmark, E., and Santos, J.I. (2007b). 
Supplementation with vitamin A reduces watery diarrhoea and respiratory infections in 
Mexican children. Br J Nutr 97, 337-343. 
 
Long, K.Z., Santos, J.I., Rosado, J.L., Lopez-Saucedo, C., Thompson-Bonilla, R., 
Abonce, M., DuPont, H.L., Hertzmark, E., and Estrada-Garcia, T. (2006b). Impact of 
vitamin A on selected gastrointestinal pathogen infections and associated diarrheal 
episodes among children in Mexico City, Mexico. J Infect Dis 194, 1217-1225. 
 
Loots, G.G., Locksley, R.M., Blankespoor, C.M., Wang, Z.E., Miller, W., Rubin, E.M., 
and Frazer, K.A. (2000). Identification of a coordinate regulator of interleukins 4, 13, and 
5 by cross-species sequence comparisons. Science 288, 136-140. 
 
Lotz, M., Gutle, D., Walther, S., Menard, S., Bogdan, C., and Hornef, M.W. (2006). 
Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. J Exp Med 203, 
973-984. 
 
Lufkin, T., Lohnes, D., Mark, M., Dierich, A., Gorry, P., Gaub, M.P., LeMeur, M., and 
Chambon, P. (1993). High postnatal lethality and testis degeneration in retinoic acid 
receptor alpha mutant mice. Proc Natl Acad Sci U S A 90, 7225-7229. 
 
Lund, J.M., Hsing, L., Pham, T.T., and Rudensky, A.Y. (2008). Coordination of Early 
Protective Immunity to Viral Infection by Regulatory T Cells. Science. 
 
Lund, J.M., Linehan, M.M., Iijima, N., and Iwasaki, A. (2006). Cutting Edge: 
Plasmacytoid dendritic cells provide innate immune protection against mucosal viral 
infection in situ. J Immunol 177, 7510-7514. 
 
Lutz, M.B., Kukutsch, N., Ogilvie, A.L., Rossner, S., Koch, F., Romani, N., and Schuler, 
G. (1999). An advanced culture method for generating large quantities of highly pure 
dendritic cells from mouse bone marrow. J Immunol Methods 223, 77-92. 
 
Maizels, R.M., Pearce, E.J., Artis, D., Yazdanbakhsh, M., and Wynn, T.A. (2009). 
Regulation of pathogenesis and immunity in helminth infections. J Exp Med 206, 2059-
2066. 
 
Manel, N., Unutmaz, D., and Littman, D.R. (2008). The differentiation of human T(H)-17 
cells requires transforming growth factor-beta and induction of the nuclear receptor 
RORgammat. Nat Immunol 9, 641-649. 
 
 181 
Mangan, P.R., Harrington, L.E., O'Quinn, D.B., Helms, W.S., Bullard, D.C., Elson, C.O., 
Hatton, R.D., Wahl, S.M., Schoeb, T.R., and Weaver, C.T. (2006). Transforming growth 
factor-beta induces development of the T(H)17 lineage. Nature 441, 231-234. 
 
Manicassamy, S., Ravindran, R., Deng, J., Oluoch, H., Denning, T.L., Kasturi, S.P., 
Rosenthal, K.M., Evavold, B.D., and Pulendran, B. (2009). Toll-like receptor 2-
dependent induction of vitamin A-metabolizing enzymes in dendritic cells promotes T 
regulatory responses and inhibits autoimmunity. Nat Med 15, 401-409. 
 
Marie, J.C., Liggitt, D., and Rudensky, A.Y. (2006). Cellular mechanisms of fatal early-
onset autoimmunity in mice with the T cell-specific targeting of transforming growth 
factor-beta receptor. Immunity 25, 441-454. 
 
Masia, S., Alvarez, S., de Lera, A.R., and Barettino, D. (2007). Rapid, nongenomic 
actions of retinoic acid on phosphatidylinositol-3-kinase signaling pathway mediated by 
the retinoic acid receptor. Mol Endocrinol 21, 2391-2402. 
 
Mathews, A., Hotard, A., and Hale-Donze, H. (2009). Innate immune responses to 
Encephalitozoon species infections. Microbes Infect 11, 905-911. 
 
Maynard, C.L., Harrington, L.E., Janowski, K.M., Oliver, J.R., Zindl, C.L., Rudensky, 
A.Y., and Weaver, C.T. (2007). Regulatory T cells expressing interleukin 10 develop 
from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10. Nat Immunol 8, 
931-941. 
Mayrhofer, G., Pugh, C.W., and Barclay, A.N. (1983). The distribution, ontogeny and 
origin in the rat of Ia-positive cells with dendritic morphology and of Ia antigen in 
epithelia, with special reference to the intestine. Eur J Immunol 13, 112-122. 
 
Mazmanian, S.K., Liu, C.H., Tzianabos, A.O., and Kasper, D.L. (2005). An 
immunomodulatory molecule of symbiotic bacteria directs maturation of the host 
immune system. Cell 122, 107-118. 
 
Mc, C.E. (1952). Early experiences with vitamin A--a retrospect. Nutr Rev 10, 161-163. 
McGeachy, M.J., Bak-Jensen, K.S., Chen, Y., Tato, C.M., Blumenschein, W., 
McClanahan, T., and Cua, D.J. (2007). TGF-beta and IL-6 drive the production of IL-17 
and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 8, 
1390-1397. 
 
McGeachy, M.J., Chen, Y., Tato, C.M., Laurence, A., Joyce-Shaikh, B., Blumenschein, 
W.M., McClanahan, T.K., O'Shea, J.J., and Cua, D.J. (2009). The interleukin 23 receptor 
is essential for the terminal differentiation of interleukin 17-producing effector T helper 
cells in vivo. Nat Immunol 10, 314-324. 
 
Medzhitov, R., Preston-Hurlburt, P., Kopp, E., Stadlen, A., Chen, C., Ghosh, S., and 
Janeway, C.A., Jr. (1998). MyD88 is an adaptor protein in the hToll/IL-1 receptor family 
signaling pathways. Mol Cell 2, 253-258. 
 182 
Mempel, T.R., Pittet, M.J., Khazaie, K., Weninger, W., Weissleder, R., von Boehmer, H., 
and von Andrian, U.H. (2006). Regulatory T cells reversibly suppress cytotoxic T cell 
function independent of effector differentiation. Immunity 25, 129-141. 
 
Mertens, R.B., Didier, E.S., Fishbein, M.C., Bertucci, D.C., Rogers, L.B., and Orenstein, 
J.M. (1997). Encephalitozoon cuniculi microsporidiosis: infection of the brain, heart, 
kidneys, trachea, adrenal glands, and urinary bladder in a patient with AIDS. Mod Pathol 
10, 68-77. 
 
Mic, F.A., Molotkov, A., Benbrook, D.M., and Duester, G. (2003). Retinoid activation of 
retinoic acid receptor but not retinoid X receptor is sufficient to rescue lethal defect in 
retinoic acid synthesis. Proc Natl Acad Sci U S A 100, 7135-7140. 
 
Min, B., Thornton, A., Caucheteux, S.M., Younes, S.A., Oh, K., Hu-Li, J., and Paul, 
W.E. (2007). Gut flora antigens are not important in the maintenance of regulatory T cell 
heterogeneity and homeostasis. Eur J Immunol 37, 1916-1923. 
 
Minns, L.A., Menard, L.C., Foureau, D.M., Darche, S., Ronet, C., Mielcarz, D.W., 
Buzoni-Gatel, D., and Kasper, L.H. (2006). TLR9 is required for the gut-associated 
lymphoid tissue response following oral infection of Toxoplasma gondii. J Immunol 176, 
7589-7597. 
 
Montoya, J.G., and Liesenfeld, O. (2004). Toxoplasmosis. Lancet 363, 1965-1976. 
 
Mora, J.R., Bono, M.R., Manjunath, N., Weninger, W., Cavanagh, L.L., Rosemblatt, M., 
and Von Andrian, U.H. (2003). Selective imprinting of gut-homing T cells by Peyer's 
patch dendritic cells. Nature 424, 88-93. 
 
Mora, J.R., Iwata, M., Eksteen, B., Song, S.Y., Junt, T., Senman, B., Otipoby, K.L., 
Yokota, A., Takeuchi, H., Ricciardi-Castagnoli, P., et al. (2006). Generation of gut-
homing IgA-secreting B cells by intestinal dendritic cells. Science 314, 1157-1160. 
 
Mora, J.R., Iwata, M., and von Andrian, U.H. (2008). Vitamin effects on the immune 
system: vitamins A and D take centre stage. Nat Rev Immunol. 
 
Moretto, M., Weiss, L.M., and Khan, I.A. (2004). Induction of a rapid and strong 
antigen-specific intraepithelial lymphocyte response during oral Encephalitozoon 
cuniculi infection. J Immunol 172, 4402-4409. 
 
Moro, K., Yamada, T., Tanabe, M., Takeuchi, T., Ikawa, T., Kawamoto, H., Furusawa, J., 
Ohtani, M., Fujii, H., and Koyasu, S. Innate production of T(H)2 cytokines by adipose 
tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 463, 540-544. 
 
Mosmann, T.R., Cherwinski, H., Bond, M.W., Giedlin, M.A., and Coffman, R.L. (1986). 
Two types of murine helper T cell clone. I. Definition according to profiles of 
lymphokine activities and secreted proteins. J Immunol 136, 2348-2357. 
 183 
Mosser, D.M., and Edwards, J.P. (2008). Exploring the full spectrum of macrophage 
activation. Nat Rev Immunol 8, 958-969. 
 
Mowat, A.M. (2003). Anatomical basis of tolerance and immunity to intestinal antigens. 
Nat Rev Immunol 3, 331-341. 
 
Mucida, D., Kutchukhidze, N., Erazo, A., Russo, M., Lafaille, J.J., and Curotto de 
Lafaille, M.A. (2005). Oral tolerance in the absence of naturally occurring Tregs. J Clin 
Invest 115, 1923-1933. 
 
Mucida, D., Park, Y., Kim, G., Turovskaya, O., Scott, I., Kronenberg, M., and Cheroutre, 
H. (2007). Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic 
acid. Science 317, 256-260. 
 
Mullen, A.C., High, F.A., Hutchins, A.S., Lee, H.W., Villarino, A.V., Livingston, D.M., 
Kung, A.L., Cereb, N., Yao, T.P., Yang, S.Y., and Reiner, S.L. (2001). Role of T-bet in 
commitment of TH1 cells before IL-12-dependent selection. Science 292, 1907-1910. 
 
Murai, M., Turovskaya, O., Kim, G., Madan, R., Karp, C.L., Cheroutre, H., and 
Kronenberg, M. (2009). Interleukin 10 acts on regulatory T cells to maintain expression 
of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat 
Immunol 10, 1178-1184. 
 
Murphy, C.A., Langrish, C.L., Chen, Y., Blumenschein, W., McClanahan, T., Kastelein, 
R.A., Sedgwick, J.D., and Cua, D.J. (2003). Divergent pro- and antiinflammatory roles 
for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 198, 1951-1957. 
 
Nagler-Anderson, C. (2001). Man the barrier! Strategic defences in the intestinal mucosa. 
Nat Rev Immunol 1, 59-67. 
 
Neill, D.R., Wong, S.H., Bellosi, A., Flynn, R.J., Daly, M., Langford, T.K., Bucks, C., 
Kane, C.M., Fallon, P.G., Pannell, R., et al. Nuocytes represent a new innate effector 
leukocyte that mediates type-2 immunity. Nature 464, 1367-1370. 
 
Nenci, A., Becker, C., Wullaert, A., Gareus, R., van Loo, G., Danese, S., Huth, M., 
Nikolaev, A., Neufert, C., Madison, B., et al. (2007). Epithelial NEMO links innate 
immunity to chronic intestinal inflammation. Nature 446, 557-561. 
 
Neutra, M.R., Mantis, N.J., and Kraehenbuhl, J.P. (2001). Collaboration of epithelial 
cells with organized mucosal lymphoid tissues. Nat Immunol 2, 1004-1009. 
 
Newberry, R.D., and Lorenz, R.G. (2005). Organizing a mucosal defense. Immunol Rev 
206, 6-21. 
 
Niess, J.H., and Reinecker, H.C. (2005). Lamina propria dendritic cells in the physiology 
and pathology of the gastrointestinal tract. Curr Opin Gastroenterol 21, 687-691. 
 184 
Nolting, J., Daniel, C., Reuter, S., Stuelten, C., Li, P., Sucov, H., Kim, B.G., Letterio, J.J., 
Kretschmer, K., Kim, H.J., and von Boehmer, H. (2009). Retinoic acid can enhance 
conversion of naive into regulatory T cells independently of secreted cytokines. J Exp 
Med 206, 2131-2139. 
 
Nurieva, R., Yang, X.O., Martinez, G., Zhang, Y., Panopoulos, A.D., Ma, L., Schluns, 
K., Tian, Q., Watowich, S.S., Jetten, A.M., and Dong, C. (2007). Essential autocrine 
regulation by IL-21 in the generation of inflammatory T cells. Nature 448, 480-483. 
 
Okayasu, I., Hatakeyama, S., Yamada, M., Ohkusa, T., Inagaki, Y., and Nakaya, R. 
(1990). A novel method in the induction of reliable experimental acute and chronic 
ulcerative colitis in mice. Gastroenterology 98, 694-702. 
 
Oldenhove, G., Bouladoux, N., Wohlfert, E.A., Hall, J.A., Chou, D., Dos Santos, L., 
O'Brien, S., Blank, R., Lamb, E., Natarajan, S., et al. (2009). Decrease of Foxp3+ Treg 
cell number and acquisition of effector cell phenotype during lethal infection. Immunity 
31, 772-786. 
 
Orenstein, J.M., Tenner, M., and Kotler, D.P. (1992). Localization of infection by the 
microsporidian Enterocytozoon bieneusi in the gastrointestinal tract of AIDS patients 
with diarrhea. AIDS 6, 195-197. 
 
Ouyang, W., Beckett, O., Ma, Q., and Li, M.O. Transforming growth factor-beta 
signaling curbs thymic negative selection promoting regulatory T cell development. 
Immunity 32, 642-653. 
 
Pamer, E.G. (2007). Immune responses to commensal and environmental microbes. Nat 
Immunol 8, 1173-1178. 
 
Park, S.H., Guy-Grand, D., Lemonnier, F.A., Wang, C.R., Bendelac, A., and Jabri, B. 
(1999). Selection and expansion of CD8alpha/alpha(1) T cell receptor alpha/beta(1) 
intestinal intraepithelial lymphocytes in the absence of both classical major 
histocompatibility complex class I and nonclassical CD1 molecules. J Exp Med 190, 885-
890. 
 
Pasare, C., and Medzhitov, R. (2003). Toll pathway-dependent blockade of CD4+CD25+ 
T cell-mediated suppression by dendritic cells.[comment]. Science 299, 1033-1036. 
Paul, W.E., and Zhu, J. How are T(H)2-type immune responses initiated and amplified? 
Nat Rev Immunol 10, 225-235. 
 
Paulos, C.M., Wrzesinski, C., Kaiser, A., Hinrichs, C.S., Chieppa, M., Cassard, L., 
Palmer, D.C., Boni, A., Muranski, P., Yu, Z., et al. (2007). Microbial translocation 
augments the function of adoptively transferred self/tumor-specific CD8+ T cells via 
TLR4 signaling. J Clin Invest 117, 2197-2204. 
 185 
Peng, G., Guo, Z., Kiniwa, Y., Voo, K.S., Peng, W., Fu, T., Wang, D.Y., Li, Y., Wang, 
H.Y., and Wang, R.F. (2005). Toll-like receptor 8-mediated reversal of CD4+ regulatory 
T cell function. Science 309, 1380-1384. 
 
Perruche, S., Zhang, P., Liu, Y., Saas, P., Bluestone, J.A., and Chen, W. (2008). CD3-
specific antibody-induced immune tolerance involves transforming growth factor-beta 
from phagocytes digesting apoptotic T cells. Nat Med 14, 528-535. 
 
Petnicki-Ocwieja, T., Hrncir, T., Liu, Y.J., Biswas, A., Hudcovic, T., Tlaskalova-
Hogenova, H., and Kobayashi, K.S. (2009). Nod2 is required for the regulation of 
commensal microbiota in the intestine. Proc Natl Acad Sci U S A 106, 15813-15818. 
 
Pfefferkorn, E.R., and Pfefferkorn, L.C. (1976). Toxoplasma gondii: isolation and 
preliminary characterization of temperature-sensitive mutants. Exp Parasitol 39, 365-376. 
 
Pfeiffer, C., Stein, J., Southwood, S., Ketelaar, H., Sette, A., and Bottomly, K. (1995). 
Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J Exp Med 
181, 1569-1574. 
 
Pitta, M.G., Romano, A., Cabantous, S., Henri, S., Hammad, A., Kouriba, B., Argiro, L., 
el Kheir, M., Bucheton, B., Mary, C., et al. (2009). IL-17 and IL-22 are associated with 
protection against human kala azar caused by Leishmania donovani. J Clin Invest 119, 
2379-2387. 
 
Pollard, M., and Sharon, N. (1970). Responses of the Peyer's Patches in Germ-Free Mice 
to Antigenic Stimulation. Infect Immun 2, 96-100. 
 
Rahman, A.H., Cui, W., Larosa, D.F., Taylor, D.K., Zhang, J., Goldstein, D.R., Wherry, 
E.J., Kaech, S.M., and Turka, L.A. (2008). MyD88 plays a critical T cell-intrinsic role in 
supporting CD8 T cell expansion during acute lymphocytic choriomeningitis virus 
infection. J Immunol 181, 3804-3810. 
 
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., and Medzhitov, R. 
(2004). Recognition of commensal microflora by toll-like receptors is required for 
intestinal homeostasis. Cell 118, 229-241. 
 
Ren, M., Pozzi, S., Bistulfi, G., Somenzi, G., Rossetti, S., and Sacchi, N. (2005). 
Impaired retinoic acid (RA) signal leads to RARbeta2 epigenetic silencing and RA 
resistance. Mol Cell Biol 25, 10591-10603. 
 
Rescigno, M. (2009). Before they were gut dendritic cells. Immunity 31, 454-456. 
 
Rescigno, M., Urbano, M., Valzasina, B., Francolini, M., Rotta, G., Bonasio, R., 
Granucci, F., Kraehenbuhl, J.P., and Ricciardi-Castagnoli, P. (2001). Dendritic cells 
express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. 
Nat Immunol 2, 361-367. 
 186 
Rimoldi, M., Chieppa, M., Salucci, V., Avogadri, F., Sonzogni, A., Sampietro, G.M., 
Nespoli, A., Viale, G., Allavena, P., and Rescigno, M. (2005). Intestinal immune 
homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat 
Immunol 6, 507-514. 
 
Rochette-Egly, C., and Germain, P. (2009). Dynamic and combinatorial control of gene 
expression by nuclear retinoic acid receptors (RARs). Nucl Recept Signal 7, e005. 
 
Roos, D.S., Donald, R.G., Morrissette, N.S., and Moulton, A.L. (1994). Molecular tools 
for genetic dissection of the protozoan parasite Toxoplasma gondii. Methods Cell Biol 
45, 27-63. 
 
Rubtsov, Y.P., Rasmussen, J.P., Chi, E.Y., Fontenot, J., Castelli, L., Ye, X., Treuting, P., 
Siewe, L., Roers, A., Henderson, W.R., Jr., et al. (2008). Regulatory T cell-derived 
interleukin-10 limits inflammation at environmental interfaces. Immunity 28, 546-558. 
 
Saemann, M.D., Bohmig, G.A., Osterreicher, C.H., Burtscher, H., Parolini, O., Diakos, 
C., Stockl, J., Horl, W.H., and Zlabinger, G.J. (2000). Anti-inflammatory effects of 
sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-
10 production. FASEB J 14, 2380-2382. 
 
Saenz, S.A., Siracusa, M.C., Perrigoue, J.G., Spencer, S.P., Urban, J.F., Jr., Tocker, J.E., 
Budelsky, A.L., Kleinschek, M.A., Kastelein, R.A., Kambayashi, T., et al. IL25 elicits a 
multipotent progenitor cell population that promotes T(H)2 cytokine responses. Nature 
464, 1362-1366. 
 
Saijo, S., Ikeda, S., Yamabe, K., Kakuta, S., Ishigame, H., Akitsu, A., Fujikado, N., 
Kusaka, T., Kubo, S., Chung, S.H., et al. Dectin-2 recognition of alpha-mannans and 
induction of Th17 cell differentiation is essential for host defense against Candida 
albicans. Immunity 32, 681-691. 
 
Sakaguchi, S., and Sakaguchi, N. (1990). Thymus and autoimmunity: capacity of the 
normal thymus to produce pathogenic self-reactive T cells and conditions required for 
their induction of autoimmune disease. J Exp Med 172, 537-545. 
 
Sakaguchi, S., Yamaguchi, T., Nomura, T., and Ono, M. (2008). Regulatory T cells and 
immune tolerance. Cell 133, 775-787. 
 
Salat, J., Horka, H., Sak, B., and Kopecky, J. (2006). Pure CD4+ T lymphocytes fail to 
protect perorally infected SCID mice from lethal microsporidiosis caused by 
Encephalitozoon cuniculi. Parasitol Res 99, 682-686. 
 
Salzman, N.H., Hung, K., Haribhai, D., Chu, H., Karlsson-Sjoberg, J., Amir, E., Teggatz, 
P., Barman, M., Hayward, M., Eastwood, D., et al. Enteric defensins are essential 
regulators of intestinal microbial ecology. Nat Immunol 11, 76-83. 
 187 
Sanos, S.L., Bui, V.L., Mortha, A., Oberle, K., Heners, C., Johner, C., and Diefenbach, 
A. (2009). RORgammat and commensal microflora are required for the differentiation of 
mucosal interleukin 22-producing NKp46+ cells. Nat Immunol 10, 83-91. 
 
Sansonetti, P.J., and Di Santo, J.P. (2007). Debugging how bacteria manipulate the 
immune response. Immunity 26, 149-161. 
 
Schambach, F., Schupp, M., Lazar, M.A., and Reiner, S.L. (2007). Activation of retinoic 
acid receptor-alpha favours regulatory T cell induction at the expense of IL-17-secreting 
T helper cell differentiation. Eur J Immunol 37, 2396-2399. 
 
Schug, T.T., Berry, D.C., Shaw, N.S., Travis, S.N., and Noy, N. (2007). Opposing effects 
of retinoic acid on cell growth result from alternate activation of two different nuclear 
receptors. Cell 129, 723-733. 
 
Schule, R., Rangarajan, P., Yang, N., Kliewer, S., Ransone, L.J., Bolado, J., Verma, I.M., 
and Evans, R.M. (1991). Retinoic acid is a negative regulator of AP-1-responsive genes. 
Proc Natl Acad Sci U S A 88, 6092-6096. 
 
Schulz, O., Jaensson, E., Persson, E.K., Liu, X., Worbs, T., Agace, W.W., and Pabst, O. 
(2009). Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph 
and serve classical dendritic cell functions. J Exp Med 206, 3101-3114. 
 
Scott, P. (1991). IFN-gamma modulates the early development of Th1 and Th2 responses 
in a murine model of cutaneous leishmaniasis. J Immunol 147, 3149-3155. 
 
Shafiani, S., Tucker-Heard, G., Kariyone, A., Takatsu, K., and Urdahl, K.B. Pathogen-
specific regulatory T cells delay the arrival of effector T cells in the lung during early 
tuberculosis. J Exp Med 207, 1409-1420. 
 
Sigmundsdottir, H., and Butcher, E.C. (2008). Environmental cues, dendritic cells and the 
programming of tissue-selective lymphocyte trafficking. Nat Immunol 9, 981-987. 
 
Smith, S.M., Levy, N.S., and Hayes, C.E. (1987). Impaired immunity in vitamin A-
deficient mice. J Nutr 117, 857-865. 
 
Sommer, A. (2008). Vitamin a deficiency and clinical disease: an historical overview. J 
Nutr 138, 1835-1839. 
 
Stappenbeck, T.S., Hooper, L.V., and Gordon, J.I. (2002). Developmental regulation of 
intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci U S 
A 99, 15451-15455. 
 
Staudt, V., Bothur, E., Klein, M., Lingnau, K., Reuter, S., Grebe, N., Gerlitzki, B., 
Hoffmann, M., Ulges, A., Taube, C., et al. Interferon-regulatory factor 4 is essential for 
the developmental program of T helper 9 cells. Immunity 33, 192-202. 
 188 
Steinfelder, S., Andersen, J.F., Cannons, J.L., Feng, C.G., Joshi, M., Dwyer, D., Caspar, 
P., Schwartzberg, P.L., Sher, A., and Jankovic, D. (2009). The major component in 
schistosome eggs responsible for conditioning dendritic cells for Th2 polarization is a T2 
ribonuclease (omega-1). J Exp Med 206, 1681-1690. 
 
Stepankova, R., Kovaru, F., and Kruml, J. (1980). Lymphatic tissue of the intestinal tract 
of germfree and conventional rabbits. Folia Microbiol (Praha) 25, 491-495. 
 
Stephensen, C.B. (2001). Vitamin A, infection, and immune function. Annu Rev Nutr 21, 
167-192. 
 
Stumhofer, J.S., Silver, J.S., Laurence, A., Porrett, P.M., Harris, T.H., Turka, L.A., Ernst, 
M., Saris, C.J., O'Shea, J.J., and Hunter, C.A. (2007). Interleukins 27 and 6 induce 
STAT3-mediated T cell production of interleukin 10. Nat Immunol 8, 1363-1371. 
 
Sun, C.M., Hall, J.A., Blank, R.B., Bouladoux, N., Oukka, M., Mora, J.R., and Belkaid, 
Y. (2007). Small intestine lamina propria dendritic cells promote de novo generation of 
Foxp3 T reg cells via retinoic acid. J Exp Med. 
 
Sutmuller, R.P., den Brok, M.H., Kramer, M., Bennink, E.J., Toonen, L.W., Kullberg, 
B.J., Joosten, L.A., Akira, S., Netea, M.G., and Adema, G.J. (2006). Toll-like receptor 2 
controls expansion and function of regulatory T cells. J Clin Invest 116, 485-494. 
 
Suzuki, K., Maruya, M., Kawamoto, S., Sitnik, K., Kitamura, H., Agace, W.W., and 
Fagarasan, S. The sensing of environmental stimuli by follicular dendritic cells promotes 
immunoglobulin A generation in the gut. Immunity 33, 71-83. 
 
Suzuki, Y., Orellana, M.A., Schreiber, R.D., and Remington, J.S. (1988). Interferon-
gamma: the major mediator of resistance against Toxoplasma gondii. Science 240, 516-
518. 
 
Svensson, M., Johansson-Lindbom, B., Zapata, F., Jaensson, E., Austenaa, L.M., 
Blomhoff, R., and Agace, W.W. (2008). Retinoic acid receptor signaling levels and 
antigen dose regulate gut homing receptor expression on CD8+ T cells. Mucosal 
Immunol 1, 38-48. 
 
Szabo, S.J., Kim, S.T., Costa, G.L., Zhang, X., Fathman, C.G., and Glimcher, L.H. 
(2000). A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100, 
655-669. 
 
Szatmari, I., and Nagy, L. (2008). Nuclear receptor signalling in dendritic cells connects 
lipids, the genome and immune function. EMBO J 27, 2353-2362. 
 
Tadokoro, C.E., Shakhar, G., Shen, S., Ding, Y., Lino, A.C., Maraver, A., Lafaille, J.J., 
and Dustin, M.L. (2006). Regulatory T cells inhibit stable contacts between CD4+ T cells 
and dendritic cells in vivo. J Exp Med 203, 505-511. 
 189 
Talmage, D.A., and Lackey, R.S. (1992). Retinoic acid receptor alpha suppresses 
polyomavirus transformation and c-fos expression in rat fibroblasts. Oncogene 7, 1837-
1845. 
 
Tang, Q., Adams, J.Y., Tooley, A.J., Bi, M., Fife, B.T., Serra, P., Santamaria, P., 
Locksley, R.M., Krummel, M.F., and Bluestone, J.A. (2006). Visualizing regulatory T 
cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol 7, 83-92. 
 
Theofilopoulos, A.N., Baccala, R., Beutler, B., and Kono, D.H. (2005). Type I interferons 
(alpha/beta) in immunity and autoimmunity. Annu Rev Immunol 23, 307-336. 
 
Thery, C., Ostrowski, M., and Segura, E. (2009). Membrane vesicles as conveyors of 
immune responses. Nat Rev Immunol 9, 581-593. 
 
Thornton, A.M., and Shevach, E.M. (1998). CD4+CD25+ immunoregulatory T cells 
suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp 
Med 188, 287-296. 
 
Torchinsky, M.B., Garaude, J., Martin, A.P., and Blander, J.M. (2009). Innate immune 
recognition of infected apoptotic cells directs T(H)17 cell differentiation. Nature 458, 78-
82. 
 
Travis, M.A., Reizis, B., Melton, A.C., Masteller, E., Tang, Q., Proctor, J.M., Wang, Y., 
Bernstein, X., Huang, X., Reichardt, L.F., et al. (2007). Loss of integrin alpha(v)beta8 on 
dendritic cells causes autoimmunity and colitis in mice. Nature 449, 361-365. 
 
Trieu, A., Roberts, T.L., Dunn, J.A., Sweet, M.J., and Stacey, K.J. (2006). DNA motifs 
suppressing TLR9 responses. Crit Rev Immunol 26, 527-544. 
 
Trinchieri, G., Pflanz, S., and Kastelein, R.A. (2003). The IL-12 family of heterodimeric 
cytokines: new players in the regulation of T cell responses. Immunity 19, 641-644. 
 
Trombetta, E.S., and Mellman, I. (2005). Cell biology of antigen processing in vitro and 
in vivo. Annu Rev Immunol 23, 975-1028. 
 
Troy, E.B., and Kasper, D.L. Beneficial effects of Bacteroides fragilis polysaccharides on 
the immune system. Front Biosci 15, 25-34. 
 
Tsuji, M., Suzuki, K., Kitamura, H., Maruya, M., Kinoshita, K., Ivanov, II, Itoh, K., 
Littman, D.R., and Fagarasan, S. (2008). Requirement for lymphoid tissue-inducer cells 
in isolated follicle formation and T cell-independent immunoglobulin A generation in the 
gut. Immunity 29, 261-271. 
 
Turer, E.E., Tavares, R.M., Mortier, E., Hitotsumatsu, O., Advincula, R., Lee, B., Shifrin, 
N., Malynn, B.A., and Ma, A. (2008). Homeostatic MyD88-dependent signals cause 
lethal inflamMation in the absence of A20. J Exp Med 205, 451-464. 
 190 
Turner, J.R. (2009). Intestinal mucosal barrier function in health and disease. Nat Rev 
Immunol 9, 799-809. 
 
Uematsu, S., Fujimoto, K., Jang, M.H., Yang, B.G., Jung, Y.J., Nishiyama, M., Sato, S., 
Tsujimura, T., Yamamoto, M., Yokota, Y., et al. (2008). Regulation of humoral and 
cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5. 
Nat Immunol 9, 769-776. 
 
Uematsu, S., Jang, M.H., Chevrier, N., Guo, Z., Kumagai, Y., Yamamoto, M., Kato, H., 
Sougawa, N., Matsui, H., Kuwata, H., et al. (2006). Detection of pathogenic intestinal 
bacteria by Toll-like receptor 5 on intestinal CD11c+ lamina propria cells. Nat Immunol 
7, 868-874. 
 
Underwood, B.A. (2004). Vitamin A deficiency disorders: international efforts to control 
a preventable "pox". J Nutr 134, 231S-236S. 
 
Vaishnava, S., Behrendt, C.L., Ismail, A.S., Eckmann, L., and Hooper, L.V. (2008). 
Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal 
host-microbial interface. Proc Natl Acad Sci U S A 105, 20858-20863. 
 
Vallon-Eberhard, A., Landsman, L., Yogev, N., Verrier, B., and Jung, S. (2006). 
Transepithelial pathogen uptake into the small intestinal lamina propria. J Immunol 176, 
2465-2469. 
 
van Santen, H.M., Benoist, C., and Mathis, D. (2004). Number of T reg cells that 
differentiate does not increase upon encounter of agonist ligand on thymic epithelial 
cells. J Exp Med 200, 1221-1230. 
 
Varol, C., Vallon-Eberhard, A., Elinav, E., Aychek, T., Shapira, Y., Luche, H., Fehling, 
H.J., Hardt, W.D., Shakhar, G., and Jung, S. (2009). Intestinal lamina propria dendritic 
cell subsets have different origin and functions. Immunity 31, 502-512. 
 
Veldhoen, M., Hirota, K., Christensen, J., O'Garra, A., and Stockinger, B. (2009). Natural 
agonists for aryl hydrocarbon receptor in culture medium are essential for optimal 
differentiation of Th17 T cells. J Exp Med 206, 43-49. 
 
Veldhoen, M., Hirota, K., Westendorf, A.M., Buer, J., Dumoutier, L., Renauld, J.C., and 
Stockinger, B. (2008a). The aryl hydrocarbon receptor links TH17-cell-mediated 
autoimmunity to environmental toxins. Nature 453, 106-109. 
 
Veldhoen, M., Hocking, R.J., Atkins, C.J., Locksley, R.M., and Stockinger, B. (2006). 
TGFbeta in the context of an inflammatory cytokine milieu supports de novo 
differentiation of IL-17-producing T cells. Immunity 24, 179-189. 
 
Veldhoen, M., Uyttenhove, C., van Snick, J., Helmby, H., Westendorf, A., Buer, J., 
Martin, B., Wilhelm, C., and Stockinger, B. (2008b). Transforming growth factor-beta 
 191 
'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-
producing subset. Nat Immunol 9, 1341-1346. 
 
Villamor, E., and Fawzi, W.W. (2000). Vitamin A supplementation: implications for 
morbidity and mortality in children. J Infect Dis 182 Suppl 1, S122-133. 
 
Volpe, E., Servant, N., Zollinger, R., Bogiatzi, S.I., Hupe, P., Barillot, E., and Soumelis, 
V. (2008). A critical function for transforming growth factor-beta, interleukin 23 and 
proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat 
Immunol 9, 650-657. 
 
von Boehmer, H. (2007). Oral tolerance: is it all retinoic acid? J Exp Med 204, 1737-
1739. 
 
von Essen, M.R., Kongsbak, M., Schjerling, P., Olgaard, K., Odum, N., and Geisler, C. 
Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nat 
Immunol 11, 344-349. 
 
Wagner, N., Lohler, J., Kunkel, E.J., Ley, K., Leung, E., Krissansen, G., Rajewsky, K., 
and Muller, W. (1996). Critical role for beta7 integrins in formation of the gut-associated 
lymphoid tissue. Nature 382, 366-370. 
 
Walker, L.S., Chodos, A., Eggena, M., Dooms, H., and Abbas, A.K. (2003). Antigen-
dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J Exp Med 198, 249-
258. 
 
Walkley, C.R., Olsen, G.H., Dworkin, S., Fabb, S.A., Swann, J., McArthur, G.A., 
Westmoreland, S.V., Chambon, P., Scadden, D.T., and Purton, L.E. (2007). A 
microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor 
gamma deficiency. Cell 129, 1097-1110. 
 
Wan, Y.Y., and Flavell, R.A. (2005). Identifying Foxp3-expressing suppressor T cells 
with a bicistronic reporter. Proc Natl Acad Sci U S A 102, 5126-5131. 
 
Wanachiwanawin, D., Manatsathit, S., Lertlaituan, P., Thakerngpol, K., and Suwanagool, 
P. (1998). Intestinal microsporidiosis in HIV infected patients with chronic diarrhea in 
Thailand. Southeast Asian J Trop Med Public Health 29, 767-771. 
 
Wang, C., Kang, S.G., Hogenesch, H., Love, P.E., and Kim, C.H. Retinoic Acid 
Determines the Precise Tissue Tropism of Inflammatory Th17 Cells in the Intestine. J 
Immunol. 
 
Watanabe, N., Wang, Y.H., Lee, H.K., Ito, T., Cao, W., and Liu, Y.J. (2005). Hassall's 
corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human 
thymus. Nature 436, 1181-1185. 
 192 
Wei, J., Duramad, O., Perng, O.A., Reiner, S.L., Liu, Y.J., and Qin, F.X. (2007). 
Antagonistic nature of T helper 1/2 developmental programs in opposing peripheral 
induction of Foxp3+ regulatory T cells. Proc Natl Acad Sci U S A 104, 18169-18174. 
 
Weiss, L.M., and Vossbrinck, C.R. (1998). Microsporidiosis: molecular and diagnostic 
aspects. Adv Parasitol 40, 351-395. 
 
Wikoff, W.R., Anfora, A.T., Liu, J., Schultz, P.G., Lesley, S.A., Peters, E.C., and 
Siuzdak, G. (2009). Metabolomics analysis reveals large effects of gut microflora on 
mammalian blood metabolites. Proc Natl Acad Sci U S A 106, 3698-3703. 
 
Wildin, R.S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.L., Buist, N., Levy-
Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001). X-linked neonatal diabetes 
mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse 
scurfy. Nat Genet 27, 18-20. 
 
Wilson, E.H., Wille-Reece, U., Dzierszinski, F., and Hunter, C.A. (2005). A critical role 
for IL-10 in limiting inflammation during toxoplasmic encephalitis. J Neuroimmunol 
165, 63-74. 
 
Winslow, M.M., Neilson, J.R., and Crabtree, G.R. (2003). Calcium signalling in 
lymphocytes. Curr Opin Immunol 15, 299-307. 
 
Wolf, G. (2007). Identification of a membrane receptor for retinol-binding protein 
functioning in the cellular uptake of retinol. Nutr Rev 65, 385-388. 
 
Wolk, K., Kunz, S., Witte, E., Friedrich, M., Asadullah, K., and Sabat, R. (2004). IL-22 
increases the innate immunity of tissues. Immunity 21, 241-254. 
 
Worbs, T., Bode, U., Yan, S., Hoffmann, M.W., Hintzen, G., Bernhardt, G., Forster, R., 
and Pabst, O. (2006). Oral tolerance originates in the intestinal immune system and relies 
on antigen carriage by dendritic cells. J Exp Med 203, 519-527. 
 
Wu, Y., Borde, M., Heissmeyer, V., Feuerer, M., Lapan, A.D., Stroud, J.C., Bates, D.L., 
Guo, L., Han, A., Ziegler, S.F., et al. (2006). FOXP3 controls regulatory T cell function 
through cooperation with NFAT. Cell 126, 375-387. 
 
Wullschleger, S., Loewith, R., and Hall, M.N. (2006). TOR signaling in growth and 
metabolism. Cell 124, 471-484. 
 
Xiao, S., Jin, H., Korn, T., Liu, S.M., Oukka, M., Lim, B., and Kuchroo, V.K. (2008). 
Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells 
by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor 
expression. J Immunol 181, 2277-2284. 
 
 193 
Xu, Q., Konta, T., Furusu, A., Nakayama, K., Lucio-Cazana, J., Fine, L.G., and 
Kitamura, M. (2002). Transcriptional induction of mitogen-activated protein kinase 
phosphatase 1 by retinoids. Selective roles of nuclear receptors and contribution to the 
antiapoptotic effect. J Biol Chem 277, 41693-41700. 
 
Yamada, H., Mizuno, S., Ross, A.C., and Sugawara, I. (2007). Retinoic acid therapy 
attenuates the severity of tuberculosis while altering lymphocyte and macrophage 
numbers and cytokine expression in rats infected with Mycobacterium tuberculosis. J 
Nutr 137, 2696-2700. 
 
Yamamoto, M., Takeda, K., and Akira, S. (2004). TIR domain-containing adaptors define 
the specificity of TLR signaling. Mol Immunol 40, 861-868. 
 
Yamane, H., Zhu, J., and Paul, W.E. (2005). Independent roles for IL-2 and GATA-3 in 
stimulating naive CD4+ T cells to generate a Th2-inducing cytokine environment. J Exp 
Med 202, 793-804. 
 
Yang, Q., Graham, T.E., Mody, N., Preitner, F., Peroni, O.D., Zabolotny, J.M., Kotani, 
K., Quadro, L., and Kahn, B.B. (2005). Serum retinol binding protein 4 contributes to 
insulin resistance in obesity and type 2 diabetes. Nature 436, 356-362. 
 
Yang, X.O., Pappu, B.P., Nurieva, R., Akimzhanov, A., Kang, H.S., Chung, Y., Ma, L., 
Shah, B., Panopoulos, A.D., Schluns, K.S., et al. (2008). T helper 17 lineage 
differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. 
Immunity 28, 29-39. 
 
Ye, P., Rodriguez, F.H., Kanaly, S., Stocking, K.L., Schurr, J., Schwarzenberger, P., 
Oliver, P., Huang, W., Zhang, P., Zhang, J., et al. (2001). Requirement of interleukin 17 
receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor 
expression, neutrophil recruitment, and host defense. J Exp Med 194, 519-527. 
 
Yokota, A., Takeuchi, H., Maeda, N., Ohoka, Y., Kato, C., Song, S.Y., and Iwata, M. 
(2009). GM-CSF and IL-4 synergistically trigger dendritic cells to acquire retinoic acid-
producing capacity. Int Immunol 21, 361-377. 
 
Yrlid, U., Cerovic, V., Milling, S., Jenkins, C.D., Zhang, J., Crocker, P.R., Klavinskis, 
L.S., and MacPherson, G.G. (2006a). Plasmacytoid dendritic cells do not migrate in 
intestinal or hepatic lymph. J Immunol 177, 6115-6121. 
 
Yrlid, U., Milling, S.W., Miller, J.L., Cartland, S., Jenkins, C.D., and MacPherson, G.G. 
(2006b). Regulation of intestinal dendritic cell migration and activation by plasmacytoid 
dendritic cells, TNF-alpha and type 1 IFNs after feeding a TLR7/8 ligand. J Immunol 
176, 5205-5212. 
 
 194 
Zaph, C., Troy, A.E., Taylor, B.C., Berman-Booty, L.D., Guild, K.J., Du, Y., Yost, E.A., 
Gruber, A.D., May, M.J., Greten, F.R., et al. (2007). Epithelial-cell-intrinsic IKK-beta 
expression regulates intestinal immune homeostasis. Nature 446, 552-556. 
 
Zhang, N., Schroppel, B., Lal, G., Jakubzick, C., Mao, X., Chen, D., Yin, N., Jessberger, 
R., Ochando, J.C., Ding, Y., and Bromberg, J.S. (2009a). Regulatory T cells sequentially 
migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune 
response. Immunity 30, 458-469. 
 
Zhang, Y., Reynolds, J.M., Chang, S.H., Martin-Orozco, N., Chung, Y., Nurieva, R.I., 
and Dong, C. (2009b). MKP-1 is necessary for T cell activation and function. J Biol 
Chem 284, 30815-30824. 
 
Zheng, Y., Collins, S.L., Lutz, M.A., Allen, A.N., Kole, T.P., Zarek, P.E., and Powell, 
J.D. (2007). A role for mammalian target of rapamycin in regulating T cell activation 
versus anergy. J Immunol 178, 2163-2170. 
 
Zheng, Y., Josefowicz, S., Chaudhry, A., Peng, X.P., Forbush, K., and Rudensky, A.Y. 
Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. 
Nature 463, 808-812. 
 
Zheng, Y., Valdez, P.A., Danilenko, D.M., Hu, Y., Sa, S.M., Gong, Q., Abbas, A.R., 
Modrusan, Z., Ghilardi, N., de Sauvage, F.J., and Ouyang, W. (2008). Interleukin-22 
mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 
14, 282-289. 
 
Zhou, L., Ivanov, II, Spolski, R., Min, R., Shenderov, K., Egawa, T., Levy, D.E., 
Leonard, W.J., and Littman, D.R. (2007). IL-6 programs T(H)-17 cell differentiation by 
promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 8, 967-
974. 
 
Zhou, L., Lopes, J.E., Chong, M.M., Ivanov, II, Min, R., Victora, G.D., Shen, Y., Du, J., 
Rubtsov, Y.P., Rudensky, A.Y., et al. (2008). TGF-beta-induced Foxp3 inhibits T(H)17 
cell differentiation by antagonizing RORgammat function. Nature 453, 236-240. 
 
Ziolkowska, M., Koc, A., Luszczykiewicz, G., Ksiezopolska-Pietrzak, K., Klimczak, E., 
Chwalinska-Sadowska, H., and Maslinski, W. (2000). High levels of IL-17 in rheumatoid 
arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive 
mechanism. J Immunol 164, 2832-2838. 
 
Ziouzenkova, O., Orasanu, G., Sharlach, M., Akiyama, T.E., Berger, J.P., Viereck, J., 
Hamilton, J.A., Tang, G., Dolnikowski, G.G., Vogel, S., et al. (2007). Retinaldehyde 
represses adipogenesis and diet-induced obesity. Nat Med 13, 695-702. 
 
 195 
Ziouzenkova, O., and Plutzky, J. (2008). Retinoid metabolism and nuclear receptor 
responses: New insights into coordinated regulation of the PPAR-RXR complex. FEBS 
Lett 582, 32-38. 
 
 
